Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- View all (1433)
- Volume 14, 2021 (160)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Journal Articles:
- 1,433 records -
LncRNA PVT1 Regulates High Glucose-Induced Viability, Oxidative Stress, Fibrosis, and Inflammation in Diabetic Nephropathy via miR-325-3p/Snail1 Axis
Qin B, Cao X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1741-1750
Published Date: 19 April 2021
Physical Activity of Type 2 Diabetes Mellitus Patients and Non-Diabetes Participants in Yangon, Myanmar: A Case-Control Study Applying the International Physical Activity Questionnaires (IPAQ-S)
Ahmad I, Aung MN, Ueno S, Khin ET, Latt TS, Moolphate S, Yuasa M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1729-1739
Published Date: 20 April 2021
Consensus on Medical Nutrition Therapy for Diabesity (CoMeND) in Adults: A South Asian Perspective
Kapoor N, Sahay R, Kalra S, Bajaj S, Dasgupta A, Shrestha D, Dhakal G, Tiwaskar M, Sahay M, Somasundaram N, Reddy R, Bhattacharya S, Reddy VB, Viswanathan V, Krishnan D, Baruah M, Das AK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1703-1728
Published Date: 16 April 2021
Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Chen HJ, Huang WH, Chan HL, Hwang LC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1695-1702
Published Date: 16 April 2021
Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy
Song Z, Xiao C, Jia X, Luo C, Shi L, Xia R, Zhu J, Zhang S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1681-1693
Published Date: 16 April 2021
The Involvement of Selenium in Type 2 Diabetes Development Related to Obesity and Low Grade Inflammation
Wongdokmai R, Shantavasinkul PC, Chanprasertyothin S, Panpunuan P, Matchariyakul D, Sritara P, Sirivarasai J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1669-1680
Published Date: 14 April 2021
Incidence of Cardiovascular Complications and Nephropathy in Patients with Type 2 Diabetes in a Primary Care Setting in Riyadh, Saudi Arabia
Alsaidan M, Alkhenizan A, Amber ST, Alsoghayer S, AlFakhri L, Abudaia J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1663-1667
Published Date: 15 April 2021
Astragaloside IV Inhibits Mitochondrial-Dependent Apoptosis of the Dorsal Root Ganglion in Diabetic Peripheral Neuropathy Rats Through Modulation of the SIRT1/p53 Signaling Pathway
Ben Y, Hao J, Zhang Z, Xiong Y, Zhang C, Chang Y, Yang F, Li H, Zhang T, Wang X, Xu Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1647-1661
Published Date: 14 April 2021
Atorvastatin Regulates MALAT1/miR-200c/NRF2 Activity to Protect Against Podocyte Pyroptosis Induced by High Glucose
Zuo Y, Chen L, He X, Ye Z, Li L, Liu Z, Zhou S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1631-1645
Published Date: 13 April 2021
A Clinical Study on the Association of Sodium-Glucose Cotransporter 2 Inhibitors and Acute Kidney Injury Among Diabetic Chinese Population
Shen L, Yang H, Fang X, Huang H, Yao W, Chen D, Shen Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1621-1630
Published Date: 13 April 2021
Visceral Obesity-Related Indices in the Identification of Individuals with Metabolic Syndrome Among Different Ethnicities in Xinjiang, China
Zhang X, Ding Y, Shao Y, He J, Ma J, Guo H, Keerman M, Liu J, Si H, Guo S, Ma R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1609-1620
Published Date: 12 April 2021
Serum Human Epididymis Protein 4 is a Potential Biomarker for Early Chronic Kidney Disease in an Obese Population
Tan S, Zeng Y, Kuang S, Li J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1601-1608
Published Date: 16 April 2021
Differences in Several Factors in the Development of Erosive Esophagitis Among Patients at Various Stages of Metabolic Syndrome: A Cross-Sectional Study
Sogabe M, Okahisa T, Kurihara T, Kagawa M, Kagemoto K, Kida Y, Tomonari T, Taniguchi T, Okamoto K, Miyamoto H, Sato Y, Nakasono M, Takayama T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1589-1600
Published Date: 12 April 2021
Anaemia and Related Nutritional Deficiencies in Chinese Patients with Obesity, 12 Months Following Laparoscopic Sleeve Gastrectomy
Zhang C, Chen X, Li J, Liu Z, Liu W, Zhang J, Zhou Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1575-1587
Published Date: 12 April 2021
Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
Tangjarusritaratorn T, Tangjittipokin W, Kunavisarut T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1563-1574
Published Date: 9 April 2021
Insulin Autoimmune Syndrome as Part of Pre-Clinical LADA
Sutkowska E, Ostrowska M, Sutkowska M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1557-1561
Published Date: 9 April 2021
The Triglyceride–Glucose Index is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes: A Hospital-Based, Nested, Case–Control Study
Yao L, Wang X, Zhong Y, Wang Y, Wu J, Geng J, Zhou Y, Chen J, Guan P, Xu Y, Chen L, Liu L, Hu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1547-1555
Published Date: 9 April 2021
Significant Association Between Left Ventricular Diastolic Dysfunction, Left Atrial Performance and Liver Stiffness in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
Parvanescu T, Vitel A, Sporea I, Mare R, Buz B, Bordejevic DA, Tomescu MC, Arnautu SF, Morariu VI, Citu IM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1535-1545
Published Date: 9 April 2021
Aspects to Consider for a More Useful, Discriminative Predictive Tool for CAP Mortality in T2DM [Letter]
Geltser D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1533-1534
Published Date: 7 April 2021
DPP-4 Inhibitors Have Different Effects on Endothelial Low-Grade Inflammation and on the M1-M2 Macrophage Polarization Under Hyperglycemic Conditions
De Nigris V, Prattichizzo F, Iijima H, Ceriello A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1519-1531
Published Date: 6 April 2021
Insulin, but Not Metformin, Supports Wound Healing Process in Rats with Streptozotocin-Induced Diabetes
Mieczkowski M, Mrozikiewicz-Rakowska B, Siwko T, Bujalska-Zadrozny M, de Corde-Skurska A, Wolinska R, Gasinska E, Grzela T, Foltynski P, Kowara M, Mieczkowska Z, Czupryniak L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1505-1517
Published Date: 6 April 2021
Microbiological Concordance in the Management of Diabetic Foot Ulcer Infections with Osteomyelitis, on the Basis of Cultures of Different Specimens at a Diabetic Foot Center in China
Li X, Cheng Q, Du Z, Zhu S, Cheng C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1493-1503
Published Date: 6 April 2021
Early Predictors in the Onset of Type 2 Diabetes at Different Fasting Blood Glucose Levels
Xie X, Bai G, Liu H, Zhang L, He Y, Qiang D, Zou X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1485-1492
Published Date: 31 March 2021
The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan
Lee YS, Hwang LC, Hsu HY, Tsou MT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1473-1483
Published Date: 30 March 2021
Metabolic Syndrome and Psoriasis: A Case–Control Study in Kabul, Afghanistan
Aalemi AK, Bahain MB, Hamdard AG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1465-1471
Published Date: 30 March 2021
The Prevalence and Components of Metabolic Syndrome in Men from Infertile Couples and Its Relation on Semen Analysis
Le MT, Tran NQT, Nguyen ND, Nguyen QHV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1453-1463
Published Date: 29 March 2021
Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM
Wu X, Li Y, Man B, Li D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1445-1451
Published Date: 29 March 2021
Evaluation of Eight Anthropometric Indices for Identification of Metabolic Syndrome in Adults with Diabetes
Guo X, Ding Q, Liang M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1431-1443
Published Date: 30 March 2021
Attitudes and Awareness Towards Diabetic Retinopathy Among Patients with Diabetes in Amman, Jordan
Al-latayfeh M, Shatnawi R, Al Shdaifat AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1425-1430
Published Date: 26 March 2021
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
Ran Y, Yi Q, Li C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1419-1424
Published Date: 25 March 2021
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1
Hao Y, Miao J, Liu W, Cai K, Huang X, Peng L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1405-1418
Published Date: 25 March 2021
Glutathione S-Transferase (GSTT1 rs17856199) and Nitric Oxide Synthase (NOS2 rs2297518) Genotype Combination as Potential Oxidative Stress-Related Molecular Markers for Type 2 Diabetes Mellitus
Gusti AMT, Qusti SY, Bahijri SM, Toraih EA, Bokhari S, Attallah SM, Alzahrani A, Alshehri WMA, Alotaibi H, Fawzy MS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1385-1403
Published Date: 25 March 2021
Optimal Cut-Off Values of Visceral Fat Area for Predicting Metabolic Syndrome Among Type 2 Diabetes Patients in Ningbo, China
Yang X, Lin Y, Xu G, Chen Y, Zhou Y, Sun J, Li L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1375-1383
Published Date: 25 March 2021
Asymptomatic Hyperuricemia and Metabolically Unhealthy Obesity: A Cross-Sectional Analysis in the Tianning Cohort
Yu J, Sun H, Zhu J, Wei X, Shi H, Shen B, Ren L, He Y, Zhang R, Zhang M, Peng H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1367-1374
Published Date: 25 March 2021
The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population
Ma CM, Wang N, Su QW, Yan Y, Yin FZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1359-1366
Published Date: 23 March 2021
Patterns of Calcium- and Chloride-Ion Disorders and Predictors among Obese Outpatient Adults in Southern Ethiopia
Timerga A, Haile K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1349-1358
Published Date: 23 March 2021
Identification of Hepatic Steatosis in Premenopausal and Postmenopausal Women Based on Phenotypes Combining Triglyceride Levels and Anthropometric Indices: A Cross-Sectional Study
Liu PJ, Lou HP, Zhu YN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1339-1347
Published Date: 23 March 2021
Computed Tomography-Estimated Pancreatic Steatosis is Associated with Carotid Plaque in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study from China
Sun P, Fan C, Wang R, Chu T, Sun X, Zhang D, Du X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1329-1337
Published Date: 22 March 2021
Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial
Hu X, Deng H, Zhang Y, Guo X, Cai M, Ling C, Li K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1315-1327
Published Date: 22 March 2021
Incidence of Diabetic Retinopathy and Its Predictors Among Newly Diagnosed Type 1 and Type 2 Diabetic Patients: A Retrospective Follow-up Study at Tertiary Health-care Setting of Ethiopia
Debele GR, Kanfe SG, Weldesenbet AB, Ayana GM, Jifar WW, Raru TB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1305-1313
Published Date: 22 March 2021
Influence of Pain on the Quality of Life and Disease Acceptance in Patients with Complicated Diabetic Foot Syndrome
Krzemińska S, Kostka A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1295-1303
Published Date: 19 March 2021
Long-Term Visual Function Effects of Pan-Retinal Photocoagulation in Diabetic Retinopathy and Its Impact in Real Life
Baptista PM, Marta AA, Heitor J, José D, Almeida D, Ribeiro A, Barbosa I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1281-1293
Published Date: 19 March 2021
The Effect of Rooibos (Aspalathus linearis), Honeybush (Cyclopia intermedia) and Sutherlandia (Lessertia frutescens) on Testicular Insulin Signalling in Streptozotocin-Induced Diabetes in Wistar Rats
Omolaoye TS, Windvogel SL, Du Plessis SS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1267-1280
Published Date: 19 March 2021
Emodin Ameliorates Renal Damage and Podocyte Injury in a Rat Model of Diabetic Nephropathy via Regulating AMPK/mTOR-Mediated Autophagy Signaling Pathway
Liu H, Wang Q, Shi G, Yang W, Zhang Y, Chen W, Wan S, Xiong F, Wang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1253-1266
Published Date: 18 March 2021
Comparison Between Pioglitazone/Metformin Combination Therapy and Sitagliptin/Metformin Combination Therapy on the Efficacy in Chinese Type 2 Diabetic Adults Insufficiently Controlled with Metformin: Study Protocol of an Open-Label, Multicenter, Non-Inferiority Parallel-Group Randomized Controlled Trial
Zhang F, Tang L, Li J, Yan Z, Li J, Tong N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1243-1252
Published Date: 18 March 2021
The β3 Adrenergic Receptor Agonist CL316243 Ameliorates the Metabolic Abnormalities of High-Fat Diet-Fed Rats by Activating AMPK/PGC-1α Signaling in Skeletal Muscle
Ding LN, Cheng Y, Xu LY, Zhou LQ, Guan L, Liu HM, Zhang YX, Li RM, Xu JW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1233-1241
Published Date: 18 March 2021
A Stronger Association of Epicardial Fat Volume with Non-Valvular Atrial Fibrillation Than Measures of General Obesity in Chinese Patients Undergoing Computed Tomography Coronary Angiography
Zhu J, Yang Z, Chen X, Liu J, Zheng L, Zhang L, Pi J, Li G, Zhuang T, Liu C, Wang Y, Liu L, Fan L, Chan P, Tomlinson B, Li Y, Liu Z, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1223-1232
Published Date: 18 March 2021
A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose
Kress S, Borck A, Zisman A, Bramlage P, Siegmund T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1215-1222
Published Date: 18 March 2021
Knowledge and Practice on Diabetic Foot Self-Care and Associated Factors Among Diabetic Patients at Dessie Referral Hospital, Northeast Ethiopia: Mixed Method
Tuha A, Getie Faris A, Andualem A, Ahmed Mohammed S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1203-1214
Published Date: 17 March 2021
Increased Serum GDF15 Related to Improvement in Metabolism by Lifestyle Intervention Among Young Overweight and Obese Adults
Cai L, Li C, Wang Y, Mo Y, Yin J, Ma X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1195-1202
Published Date: 17 March 2021
Silencing of miR-20b-5p Exerts Inhibitory Effect on Diabetic Retinopathy via Inactivation of THBS1 Gene Induced VEGF/Akt/PI3K Pathway
Ma Y, Dong C, Chen X, Zhu R, Wang J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1183-1193
Published Date: 16 March 2021
Determinants and Prevalence of Impotence among Diabetic Patients in Northwestern Hospitals of Nefasit, Eretria
Degavi G, Panari H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1177-1182
Published Date: 16 March 2021
Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
Alswat K, Sanai FM, Al-hamoudi W, Ismail M, Dahlan Y, AlGhamdi HS, Altraif I, Alalwan A, Babatin MMA, Alqahtani SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1167-1175
Published Date: 16 March 2021
Antihyperglycemic Activity of TLC Isolates from the Leaves of Aloe megalacantha Baker in Streptozotocin-Induced Diabetic Mice
Araya TY, Karim A, Hailu GS, Periasamy G, Kahsay G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1153-1166
Published Date: 15 March 2021
Associations of Metabolic/Obesity Phenotypes with Insulin Resistance and C-Reactive Protein: Results from the CNTR Study
Liao C, Gao W, Cao W, Lv J, Yu C, Wang S, Pang Z, Cong L, Wang H, Wu X, Li L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1141-1151
Published Date: 15 March 2021
Gene Expression Profiling of Apoptotic Proteins in Circulating Peripheral Blood Mononuclear Cells in Type II Diabetes Mellitus and Modulation by Metformin
Al Dubayee M, Alshahrani A, Aljada D, Zahra M, Alotaibi A, Ababtain I, Alnaim M, Alahmari A, Aljarallah A, Elahi MA, Fakhoury HMA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1129-1139
Published Date: 15 March 2021
Adipose Tissue Insulin Resistance is Closely Associated with Metabolic Syndrome in Northern Chinese Populations
Zhang K, Pan H, Wang L, Yang H, Zhu H, Gong F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1117-1128
Published Date: 12 March 2021
The Predictive Value of Visceral Adiposity Index and Lipid Accumulation Index for Microalbuminuria in Newly Diagnosed Type 2 Diabetes Patients
Qi L, Kang N, Li Y, Zhao H, Chen S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1107-1115
Published Date: 11 March 2021
GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice
Nakamura T, Tanimoto H, Okamoto M, Takeuchi M, Tsubamoto Y, Noda H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1095-1105
Published Date: 9 March 2021
Effectiveness of a WeChat Combined Continuous Flash Glucose Monitoring System on Glycemic Control in Juvenile Type 1 Diabetes Mellitus Management: Randomized Controlled Trial
Xu Y, Xu L, Zhao W, Li Q, Li M, Lu W, Zeng H, Yan J, Yang D, Wu W, Weng J, Pan J, Liu F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1085-1094
Published Date: 9 March 2021
Factors to Consider When Determining Whether Lipotoxicity Solely Causes B-Cell Decompensation in KPT2D [Letter]
Geltser D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1083-1084
Published Date: 9 March 2021
A High Incidence of Metabolic Syndrome Traits in Mexicans Points at Obesity-Related Metabolic Dysfunction
Bello-Chavolla OY, Vargas-Vázquez A, Antonio-Villa NE, Del Razo-Olvera FM, Elías-López D, Aguilar-Salinas CA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1073-1082
Published Date: 9 March 2021
Interaction of General or Central Obesity and Hypertension on Diabetes: Sex-Specific Differences in a Rural Population in Northeast China
Chen MQ, Shi WR, Wang HY, Li Z, Guo XF, Sun YX
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1061-1072
Published Date: 9 March 2021
Double-Blind Controlled Trial of Vitamin E Effects on Serum Lipid Profile in Menopausal Women
Rezasoltani P, Elliyoun N, Ziaie T, Sobhani A, Kazemnezhjad Leyli E, Kazemi Aski S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1053-1060
Published Date: 9 March 2021
Association Between Body Mass Index and Male Sperm Apoptosis and Apoptosis-Related Factors
Zhu G, Zhang Y, Dong J, Liu Y, Zhao F, Li T, Shi Z, Zhang Y, Song N, Song W, Lv Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1043-1051
Published Date: 9 March 2021
Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
Zhai M, Yan X, Liu J, Long Z, Zhao S, Li W, Liu Y, Hai C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1035-1042
Published Date: 8 March 2021
Islet Autoantibodies in the Patients with Sjogren’s Syndrome and Thyroid Disease and Risk of Progression to Latent Autoimmune Diabetes in Adults: A Case Series
Wen S, Jiang W, Zhou L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1025-1033
Published Date: 5 March 2021
Prevalence and Correlates of Cardio-Metabolic Risk Factors Among Regular Street Food Consumers in Dar es Salaam, Tanzania
B Kagaruki G, J Mahande M, D Kimaro G, S Ngadaya E, Mayige T M, Selemani M, Jaacks LM, Jaffar S, Mfinanaga SG, Bonfoh B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1011-1024
Published Date: 5 March 2021
Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review
Cheng D, Zhao X, Yang S, Cui H, Wang G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:991-1010
Published Date: 4 March 2021
Research Progress on Gestational Diabetes Mellitus and Endothelial Dysfunction Markers
He Y, Wu N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:983-990
Published Date: 3 March 2021
Hepatic Knockdown of Endothelin Type A Receptor (ETAR) Ameliorates Hepatic Insulin Resistance and Hyperglycemia Through Suppressing p66Shc-Mediated Mitochondrial Fragmentation in High-Fat Diet-Fed Mice
Feng L, Wang S, Chen F, Zhang C, Wang Q, Zhao Y, Zhang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:963-981
Published Date: 2 March 2021
Risk Factors Screening for Gestational Diabetes Mellitus Heterogeneity in Chinese Pregnant Women: A Case–Control Study
Wang N, Peng Y, Wang L, Song L, Sun B, Wei J, Wang T, Mi Y, Cui W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:951-961
Published Date: 2 March 2021
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
Kwon YJ, Lee H, Nam CM, Chang HJ, Yoon YR, Lee HS, Lee JW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:941-950
Published Date: 2 March 2021
Effects of Curcumin on High Glucose-Induced Epithelial-to-Mesenchymal Transition in Renal Tubular Epithelial Cells Through the TLR4-NF-κB Signaling Pathway
Liu X, Zhang X, Cai X, Dong J, Chi Y, Chi Z, Gu HF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:929-940
Published Date: 2 March 2021
Determinants of Dietary Adherence Among Type 2 Diabetes Patients Aimed COVID-19 at the University of Gondar Comprehensive Specialized Hospital
Mekonnen CK, Ferede YM, Abate HK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:917-927
Published Date: 2 March 2021
Magnitude of Overweight and Obesity and Associated Factors Among Public and Private Secondary School Adolescent Students in Mekelle City, Tigray Region, Ethiopia, 2019: Comparative Cross-Sectional Study
Andargie M, Gebremariam K, Hailu T, Addisu A, Zereabruk K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:901-915
Published Date: 2 March 2021
Relationship Between Serum Amyloid A1 (SAA1) Gene Polymorphisms Studies with Obesity in the Saudi Population
Alharbi KK, Alshammary AF, Aljabri OS, Ali Khan I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:895-900
Published Date: 1 March 2021
Predictive Value of GAD Antibody for Diabetes in Normal Chinese Adults: A Retrospective Cohort Study in China
Li J, Lin S, Deng C, Xu T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:885-893
Published Date: 1 March 2021
Prevalence of Metabolic Syndrome and Factors Associated With It Among Adults of West Gojjam: A Community-Based Cross-Sectional Study
Walle B, Reba K, Debela Y, Tadele K, Biadglegne F, Gutema H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:875-883
Published Date: 26 February 2021
Platelet Indices and Its Association with Microvascular Complications Among Type 2 Diabetes Mellitus Patients in Northeast Ethiopia: A Cross-Sectional Study
Taderegew MM, Woldeamanuel GG, Emeria MS, Tilahun M, Yitbarek GY, Zegeye B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:865-874
Published Date: 25 February 2021
Increased Serum Cystatin C Levels Were Associated with Depressive Symptoms in Patients with Type 2 Diabetes
Huang Y, Huang W, Wei J, Yin Z, Liu H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:857-863
Published Date: 25 February 2021
The Relationship Between Earlier Onset of Natural Menopause and Elevated Urinary Albumin-Creatinine Ratio in Postmenopausal Chinese Women
Yao M, Liu H, Li B, Liu Y, Mu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:847-856
Published Date: 25 February 2021
A Clinical Epidemiological Analysis of Prognostic Nutritional Index Associated with Diabetic Retinopathy
Yang L, Yu W, Pan W, Chen S, Ye X, Gu X, Hu X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:839-846
Published Date: 25 February 2021
lncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values
Li J, Du B, Geng X, Zhou L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:831-838
Published Date: 23 February 2021
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Mortality in Patients with Diabetic Foot Ulcers Undergoing Amputations
Chen W, Chen K, Xu Z, Hu Y, Liu Y, Liu W, Hu X, Ye T, Hong J, Zhu H, Shen F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:821-829
Published Date: 24 February 2021
Opportunities for Prevention of Gestational Diabetes Before 24 Weeks of Gestation
Cheng D, Li F, Zhou X, Xu X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:813-819
Published Date: 24 February 2021
The Psychometric Properties of General Adherence Scale in Chinese (GAS-C) in Patients with Type 2 Diabetes Using Insulin
Shi Z, Chang J, Ma X, Yin F, Ma M, Li W, Zhu B, Ai Z, Zhao X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:801-811
Published Date: 22 February 2021
No Association Between ADIPOQ or MTHFR Polymorphisms and Gestational Diabetes Mellitus in South African Women
Dias S, Adam S, Rheeder P, Pheiffer C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:791-800
Published Date: 24 February 2021
Increased Incidence of Pediatric Diabetic Ketoacidosis After COVID-19: A Two-Center Retrospective Study in Korea
Han MJ, Heo JH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:783-790
Published Date: 22 February 2021
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
Hisanaga K, Uchino H, Kakisu N, Miyagi M, Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:773-781
Published Date: 22 February 2021
Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism
Chen X, Daniels NA, Cottrill D, Cao Y, Wang X, Li Y, Shriwas P, Qian Y, Archer MW, Whitticar NB, Jahan I, Nunemaker CS, Guo A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:759-772
Published Date: 24 February 2021
A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
Wu L, Li B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:753-757
Published Date: 18 February 2021
Health-Related Quality of Life and Associated Factors Among Type Two Diabetic Patients on Follow-Up in Dessie Comprehensive Specialized Hospital, Dessie, North East Ethiopia, 2020 [Corrigendum]
Girma M, Wodajo S, Ademe S, Edmealem A, W/Selassie Snr M, Mesafint G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:751-752
Published Date: 17 February 2021
Normalized Hand Grip and Back Muscle Strength as Risk Factors for Incident Type 2 Diabetes Mellitus: 16 Years of Follow-Up in a Population-Based Cohort Study
Jeon YJ, Lee SK, Shin C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:741-750
Published Date: 17 February 2021
CircHIPK3 Alleviates High Glucose Toxicity to Human Renal Tubular Epithelial HK-2 Cells Through Regulation of miR-326/miR-487a-3p/SIRT1
Zhuang L, Wang Z, Hu X, Yang Q, Pei X, Jin G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:729-740
Published Date: 17 February 2021
miR-7a Targets Insulin Receptor Substrate-2 Gene and Suppresses Viability and Invasion of Cells in Diabetic Retinopathy Mice via PI3K-Akt-VEGF Pathway
Ji Z, Luo J, Su T, Chen C, Su Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:719-728
Published Date: 16 February 2021
Evaluation of Stress and Associated Biochemical Changes in Patients with Type 2 Diabetes Mellitus and Obesity
Tyagi K, Agarwal NB, Kapur P, Kohli S, Jalali RK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:705-717
Published Date: 16 February 2021
Electrodiagnostics or Ultrasound for Diagnosing Diabetic Peripheral Neuropathy [Letter]
Hernandez Fustes OJ, Hernandez Fustes OJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:703-704
Published Date: 16 February 2021
Evaluation of Anthropometric Indices and Lipid Parameters to Predict Metabolic Syndrome Among Adults in Mexico
Datta Banik S, Pacheco-Pantoja E, Lugo R, Gómez-de-Regil L, Chim Aké R, Méndez González RM, Gutiérrez Solis AL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:691-701
Published Date: 16 February 2021
Diabetes-Related Distress Among People with Type 2 Diabetes in Ho Chi Minh City, Vietnam: Prevalence and Associated Factors
Huynh G, Tran TT, Do THT, Truong TTD, Ong PT, Nguyen TNH, Pham LA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:683-690
Published Date: 15 February 2021
Overexpression of miR125b Promotes Osteoporosis Through miR-125b-TRAF6 Pathway in Postmenopausal Ovariectomized Rats
Wang G, Zhang L, Yan C, Wang F, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:671-682
Published Date: 15 February 2021
Obesity and Heath-Carter Somatotyping of 3438 Adults in the Xinjiang Uygur Autonomous Region of China by Multivariate Analysis
Liu X, Li W, Wen Y, Xu G, Zhou G, Qu Q, Hu Y, Saitierding Y, Mohetaer M, Buerlan Y, Zhong X, Xi H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:659-670
Published Date: 15 February 2021
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
Lu Y, Zhu S, Wang X, Liu J, Li Y, Wang W, Wang S, Wang F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:647-657
Published Date: 11 February 2021
Doxycycline in Extremely Low Dose Improves Glycemic Control and Islet Morphology in Mice Fed a High-Fat Diet
Chen Y, Chen Y, Wang N, Gu S, Wang M, Fu Y, Wei C, Xu W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:637-646
Published Date: 11 February 2021
Serum Uric Acid Levels and Metabolic Indices in an Obese Population: A Cross-Sectional Study
Li F, Chen S, Qiu X, Wu J, Tan M, Wang M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:627-635
Published Date: 11 February 2021
Comorbidity Profiles among Obese–Diabetic End-Stage Renal Disease Patients: Data from REIN Registry of PACA Region of France
Kakar A, Mouelhi Y, Loundou A, Crémades A, Gentile S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:617-625
Published Date: 11 February 2021
An Integrated Approach Based on Network Pharmacology Combined with Experimental Verification Reveals AMPK/PI3K/Akt Signaling is an Important Way for the Anti-Type 2 Diabetic Activity of Silkworm Excrement
Duan H, Zhang Q, Liu J, Li R, Peng W, Wu C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:601-616
Published Date: 11 February 2021
Magnitude and Associated Factors of Metabolic Syndrome Among Adult Urban Dwellers of Northern Ethiopia
Gebreegziabiher G, Belachew T, Mehari K, Tamiru D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:589-600
Published Date: 10 February 2021
Revisional Surgeries of Laparoscopic Sleeve Gastrectomy
Li S, Jiao S, Zhang S, Zhou J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:575-588
Published Date: 10 February 2021
Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
Gurgel Penaforte-Saboia J, Couri CEB, Vasconcelos Albuquerque N, Silva VLL, Bitar da Cunha Olegario N, Oliveira Fernandes V, Montenegro RM Junior
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:565-573
Published Date: 10 February 2021
The Associations Between Vitamin D Receptor BsmI and ApaI Polymorphisms and Obesity in Korean Patients with Type 2 Diabetes Mellitus
Nam SW, Choi J, Jeon HJ, Oh TK, Lee DH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:557-564
Published Date: 10 February 2021
Hyperglycemic Crisis Characteristics and Outcome of Care in Adult Patients without and with a History of Diabetes in Tigrai, Ethiopia: Comparative Study
Gebremedhin G, Enqueselassie F, Yifter H, Deyessa N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:547-556
Published Date: 9 February 2021
Self-care Related Knowledge, Attitude, and Practice and Associated Factors Among Patients with Type 2 Diabetes in JMC, Ethiopia
Mekonnen Y, Hussien N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:535-546
Published Date: 5 February 2021
Effects of a Single Oral Megadose of Vitamin D3 on Inflammation and Oxidative Stress Markers in Overweight and Obese Women: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Pessoa Mamede LCG, de Lima RLFC, Silva AS, Rodrigues Pita JCL, Galdino Gomes NI, de Sena EA, Moraes Nobrega RP, Scarano Alcântara JO, Fontes de Souza JH, Cardoso GA, de Brito Alves JL, Rodrigues Gonçalves MC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:525-534
Published Date: 4 February 2021
Diabetes Mellitus and Its Associated Factors in Tuberculosis Patients in Maekel Region, Eritrea: Analytical Cross-Sectional Study
Araia ZZ, Mesfin AB, Mebrahtu AH, Tewelde AG, Osman R, Tuumzghi HA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:515-523
Published Date: 4 February 2021
Depression Among Patients with Type 2 Diabetes Mellitus: Prevalence and Associated Factors in Hue City, Vietnam
Tran NMH, Nguyen QNL, Vo TH, Le TTA, Ngo NH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:505-513
Published Date: 4 February 2021
Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals
Ye S, Ran H, Zhang H, Wu H, Li W, Du S, Su Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:497-504
Published Date: 4 February 2021
The Impact of Vitamin D in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Patients with Morbid Obesity
Borges-Canha M, Neves JS, Mendonça F, Silva MM, Costa C, Cabral PM, Guerreiro V, Lourenço R, Meira P, Salazar D, Ferreira MJ, Pedro J, Leite AR, von-Hafe M, Vale C, Viana S, Sande A, Belo S, Lau E, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:487-495
Published Date: 3 February 2021
Presence of Adenovirus-36 DNA in Adipose Tissue of Women: Relationship with Adipocyte Morphology and the Expression of C/EBPβ and HIF-1α
Barrera-Alcocer J, García-Benavides L, Muñoz-Valle JF, de la Cruz-Mosso U, González RA, Luquín S, Alarcón-Romero LDC, Marino-Ortega LA, Matia-Garcia I, Parra-Rojas I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:477-486
Published Date: 3 February 2021
Anemia among Adult Diabetic Patients Attending a General Hospital in Eastern Ethiopia: a Cross-sectional Study
Tujuba T, Ayele BH, Fage SG, Weldegebreal F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:467-476
Published Date: 2 February 2021
Prevalence of Overweight and Obesity, and Its Associated Factors Among Health-care Workers, Teachers, and Bankers in Arusha City, Tanzania
Zubery D, Kimiywe J, Martin HD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:455-465
Published Date: 2 February 2021
A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China
Xue M, Yang X, Zou Y, Liu T, Su Y, Li C, Yao H, Wang S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:443-454
Published Date: 2 February 2021
Epigenetic Regulation of PDX-1 in Type 2 Diabetes Mellitus
Liu J, Lang G, Shi J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:431-442
Published Date: 2 February 2021
Non-Surgical Interventions for Hospitalized Adults with Class II or Class III Obesity: A Scoping Review
Rees M, Collins CE, De Vlieger N, McDonald VM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:417-429
Published Date: 2 February 2021
Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation
Mehanna O, El Askary A, Ali E, El Esawy B, FathAlla T, Gharib AF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:409-415
Published Date: 29 January 2021
Association of Metabolic Obesity Phenotypes and Total Testosterone in Chinese Male Population
Liu L, Liu S, Song Q, Luo D, Su Y, Qi X, Wang Q, Ning J, Lv Y, Guan Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:399-408
Published Date: 29 January 2021
Dihydromyricetin Alleviates High Glucose-Induced Oxidative Stress and Apoptosis in Human Retinal Pigment Epithelial Cells by Downregulating miR-34a Expression
Li W, Xiao H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:387-397
Published Date: 27 January 2021
Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients
Zhou X, Luo M, Zhou S, Cheng Z, Chen Z, Yu X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:379-385
Published Date: 27 January 2021
Overview of Clinical Trials on Type 2 Diabetes Mellitus: A Comprehensive Analysis of the ClinicalTrials.gov Database
Long J, Liang R, Zheng Q, Yuan G, Xin Z, Chen X, Lai F, Liu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:367-377
Published Date: 26 January 2021
PARP-1 and SIRT-1 are Interacted in Diabetic Nephropathy by Activating AMPK/PGC-1α Signaling Pathway
Zhu H, Fang Z, Chen J, Yang Y, Gan J, Luo L, Zhan X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:355-366
Published Date: 25 January 2021
Obesity and Prediabetes are Jointly Associated with Lipid Abnormalities Among Adolescents: A Cross-Sectional Study
Almari M, Mohammad A, Abubaker J, Ziyab AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:345-353
Published Date: 22 January 2021
Epigenetic Histone Modifications in the Pathogenesis of Diabetic Kidney Disease
Lu HC, Dai WN, He LY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:329-344
Published Date: 22 January 2021
Progress of Clinical Trials for the Treatment of Gestational Diabetes Mellitus
Chen T, Liu D, Yao X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:315-327
Published Date: 22 January 2021
The Effectiveness of a Self-Efficacy-Focused Structured Education Program (SSEP) in Improving Metabolic Control and Psychological Outcomes of Type 2 Diabetes Patients: A 12-Month Follow-Up of a Multicenter Randomized Controlled Trial
Jiang XJ, Jiang H, Chen Y, Wu XA, Yu XL, Liu L, Li MZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:305-313
Published Date: 22 January 2021
Correlation Between Daily Energy Intake from Fat with Insulin Resistance in Patients with Polycystic Ovary Syndrome
Zheng X, Chen Y, Ma D, Zhang M, Huang Y, Tong M, Yan B, Lin S, Yan X, Liu C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:295-303
Published Date: 22 January 2021
Characteristics of Gut Microbiota in Cerulein-Induced Chronic Pancreatitis
Wu C, Li M, Chen W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:285-294
Published Date: 25 January 2021
A Differential Study into Body Fat in Healthy and Hypertensive Populations Using Multiple Indexes
Wang R, Wang Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:279-284
Published Date: 20 January 2021
Downregulation of lncRNA EPB41L4A-AS1 Mediates Activation of MYD88-Dependent NF-κB Pathway in Diabetes-Related Inflammation
Wang Z, Liao W, Liu F, Yang T, Xie W, Liao M, Gu D, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:265-277
Published Date: 20 January 2021
NDSP 09: Risk Assessment of Pakistani Individual for Diabetes (RAPID) – Findings from Second National Diabetes Survey of Pakistan (NDSP) 2016–2017
Abdul Basit K, Fawwad A, Riaz M, Tahir B, Khalid M, Basit A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:257-263
Published Date: 19 January 2021
Direct and Indirect Effect of Honey as a Functional Food Against Metabolic Syndrome and Its Skeletal Complications
Mohd Ramli ES, Sukalingam K, Kamaruzzaman MA, Soelaiman IN, Pang KL, Chin KY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:241-256
Published Date: 18 January 2021
Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy
Zhang Z, Ni L, Zhang L, Zha D, Hu C, Zhang L, Feng H, Wei X, Wu X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:227-240
Published Date: 18 January 2021
Current Perspectives on the Role of Very-Low-Energy Diets in the Treatment of Obesity and Type 2 Diabetes in Youth
Gow ML, Pham-Short A, Jebeile H, Varley BJ, Craig ME
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:215-225
Published Date: 18 January 2021
Dietary Knowledge, Attitude and Practice (KAP) Among the Family Members of Patients with Type 2 Diabetes Mellitus (T2DM) and Its Influence on the KAP of T2DM Patients
Hu X, Zhang Y, Lin S, Guo X, Yang D, Cai M, Gao L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:205-213
Published Date: 15 January 2021
Impact of Cognitive Impairment on Adherence to Treatment and Self-Care in Patients with Type 2 Diabetes Mellitus
Świątoniowska-Lonc N, Polański J, Tański W, Jankowska-Polańska B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:193-203
Published Date: 15 January 2021
Evaluation of Antihyperglycemic Effect of Extract of Moringa stenopetala (Baker f.) Aqueous Leaves on Alloxan-Induced Diabetic Rats
Woldekidan S, Mulu A, Ergetie W, Teka F, Meressa A, Tadele A, Abebe A, Gemechu W, Gemeda N, Ashebir R, Sileshi M, Tolcha Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:185-192
Published Date: 15 January 2021
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
Kalra S, Unnikrishnan AG, Baruah MP, Sahay R, Bantwal G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:165-184
Published Date: 15 January 2021
miR-129-3p Targeting of MCU Protects Against Glucose Fluctuation-Mediated Neuronal Damage via a Mitochondrial-Dependent Intrinsic Apoptotic Pathway
Wang B, Li Y, You C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:153-163
Published Date: 15 January 2021
Application of High-Resolution Ultrasound on Diagnosing Diabetic Peripheral Neuropathy
Huang H, Wu S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:139-152
Published Date: 14 January 2021
Caregivers’ Nutrition Knowledge and Dietary Intake of Type 1 Diabetic Children Aged 3–14 Years in Uganda
Ndahura NB, Munga J, Kimiywe J, Mupere E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:127-137
Published Date: 14 January 2021
The Association Between Hyperlipidemia and In-Hospital Outcomes in Takotsubo Cardiomyopathy
Li P, Lu X, Teng C, Hadley M, Cai P, Dai Q, Wang B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:117-126
Published Date: 12 January 2021
Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
Tarigan TJE, Dwijayanti A, Setyowati S, Louisa M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:107-116
Published Date: 12 January 2021
Association Between Low Serum Testosterone and the Development of Metabolic Syndrome in Elderly Taiwanese Men
Zhong SR, Yang HH, Liao CH, Yang DH, Tu SK, Hung CL, Liao CC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:99-106
Published Date: 11 January 2021
Metabolic Control and Determinants Among HIV-Infected Type 2 Diabetes Mellitus Patients Attending a Tertiary Clinic in Botswana
Rwegerera GM, Shailemo DHP, Pina Rivera Y, Mokgosi KO, Bale P, Oyewo TA, Luis BD, Habte D, Godman B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:85-97
Published Date: 11 January 2021
Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products
Jakab J, Miškić B, Mikšić S, Juranić B, Ćosić V, Schwarz D, Včev A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:67-83
Published Date: 8 January 2021
A Questionnaire-Based Assessment of Hunger, Speed of Eating and Food Intake in Children with Obesity
Slyper A, Shenker J, Israel A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:59-66
Published Date: 8 January 2021
Hyperosmolarity Deserves More Attention in Critically Ill COVID-19 Patients with Diabetes: A Cohort-Based Study
Gou L, Xiang M, Ran X, Wang F, Zhang S, Li S, Dong K, Chen X, Huang Y, Meng C, Fan Q, Yang Y, Yu X, Ma D, Yin P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:47-58
Published Date: 7 January 2021
The Magnitude of Diabetes Mellitus in Adult Hypertensive Patients in Northeast Ethiopia
Wuhib Shumye M, Tegegne B, Ademe S, Workneh M, Abera M, Nemera G, Balcha F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:37-45
Published Date: 6 January 2021
Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India
Verma AK, Goyal Y, Bhatt D, Beg MMA, Dev K, Alsahli MA, Rahmani AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:23-36
Published Date: 6 January 2021
A Rare Potential Pathogenic Variant in the BDNF Gene is Found in a Brazilian Patient with Severe Childhood-Onset Obesity
da Fonseca ACP, Abreu GM, Palhinha L, Zembrzuski VM, Campos Junior M, Carneiro JRI, Nogueira Neto JF, Magno FCCM, Rosado EL, Maya-Monteiro CM, Cabello GMK, Cabello PH, Bozza PT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:11-22
Published Date: 6 January 2021
Self-Care Practice and Associated Factors Among People Living with Type 2 Diabetes in Addis Ababa, Ethiopia: A Facility-Based Cross-Sectional Study
Wolderufael M, Dereje N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021, 14:1-9
Published Date: 6 January 2021
Association Between Single Nucleotide Polymorphisms in CDKAL1 and HHEX and Type 2 Diabetes in Chinese Population
Li C, Shen K, Yang M, Yang Y, Tao W, He S, Shi L, Yao Y, Li Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5113-5123
Published Date: 5 January 2021
Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
Siddiqui K, Joy SS, George TP, Mujammami M, Alfadda AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5103-5111
Published Date: 31 December 2020
Interactive Effect of IGF2BP2 rs4402960 Variant, Smoking and Type 2 Diabetes
Nfor ON, Ndzinisa NB, Tsai MH, Hsiao CH, Liaw YP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5097-5102
Published Date: 30 December 2020
Discrimination of Chronic Kidney Disease and Diabetic Nephropathy and Analysis of Their Related Influencing Factors
Liu X, Guo Y, Wu J, Yao N, Wang H, Li B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5085-5096
Published Date: 30 December 2020
Comparison of Coronary Heart Disease and Stroke in Association with Diabetic Retinopathy in Adults with Diabetes Using a National Survey
Yang GR, Li D, Li L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5079-5084
Published Date: 23 December 2020
Knowledge, Attitudes, and Practices Regarding Diabetes Mellitus Among University Students in Jeddah, Saudi Arabia
Gazzaz ZJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5071-5078
Published Date: 23 December 2020
Association of Daily Home-Based Hot Water Bathing and Glycemic Control in Ambulatory Japanese Patients with Type 2 Diabetes Mellitus During the COVID-19 Pandemic: A Multicenter Cross-Sectional Study
Kamioka H, Mori Y, Horiuchi T, Hayashi T, Ohmura K, Yamaguchi S, Kato M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5059-5069
Published Date: 22 December 2020
The Association and Interaction of Aldehyde Dehydrogenase 2 Polymorphisms with Food Group Intake and Probability of Having Non-Alcoholic Fatty Liver Disease
Hao X, Zeng Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5049-5057
Published Date: 22 December 2020
Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
Weale CJ, Matshazi DM, Davids SFG, Raghubeer S, Erasmus RT, Kengne AP, Davison GM, Matsha TE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5037-5047
Published Date: 21 December 2020
Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease
Shi R, Wu B, Niu Z, Sun H, Hu F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5025-5036
Published Date: 18 December 2020
Prevalence of Anemia and Its Associated Factors Among Adult Diabetes Mellitus Patients at Debre Tabor General Hospital, Northcentral Ethiopia
Engidaw MT, Feyisa MS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5017-5023
Published Date: 18 December 2020
2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Isolated from Averrhoa carambola L. Root Ameliorates Diabetic Nephropathy by Inhibiting the TLR4/MyD88/NF-κB Pathway [Corrigendum]
Lu S, Zhang H, Wei X, Huang X, Chen L, Jiang L, Wu X, Zhou X, Qin L, Li Y, Lin X, Huang R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5015-5016
Published Date: 16 December 2020
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
Zhang Q, Hu N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:5003-5014
Published Date: 16 December 2020
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial
Teragawa H, Morimoto T, Fujii Y, Ueda T, Sakuma M, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Ueda S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4993-5001
Published Date: 15 December 2020
Reporting and Methods in Developing Prognostic Prediction Models for Metabolic Syndrome: A Systematic Review and Critical Appraisal
Zhang H, Shao J, Chen D, Zou P, Cui N, Tang L, Wang D, Ye Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4981-4992
Published Date: 15 December 2020
Type 1 Diabetes Mellitus in Pediatric Patients and Its Impact on Relationships in the Family Environment
Madrigal MA, López M, Sánchez A, Cao MJ, Castro MJ, Jiménez JM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4973-4980
Published Date: 15 December 2020
Irrational Responses to Risk Preference Questionnaires by Patients with Diabetes with or without Retinopathy and Comparison with Those without Diabetes
Emoto N, Soga A, Fukuda I, Tanimura-Inagaki K, Harada T, Koyano HM, Goto R, Sugihara H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4961-4971
Published Date: 14 December 2020
COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
Zhu X, Yang L, Huang K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4953-4959
Published Date: 14 December 2020
Metabolic Syndrome Among Working Adults in Eastern Ethiopia
Motuma A, Gobena T, Teji Roba K, Berhane Y, Worku A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4941-4951
Published Date: 14 December 2020
Circulating miRNA Signatures Associated with Insulin Resistance in Adolescents with Obesity
Lin H, Tas E, Børsheim E, Mercer KE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4929-4939
Published Date: 10 December 2020
Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population
Chen T, Wang X, Wang X, Chen H, Xiao H, Tang H, Feng L, Xiang Z, Zou H, Shao X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4919-4927
Published Date: 10 December 2020
Prevalence, Patterns and Predictors of Chronic Complications of Diabetes Mellitus at a Large Referral Hospital in Ethiopia: A Prospective Observational Study
Sheleme T, Mamo G, Melaku T, Sahilu T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4909-4918
Published Date: 11 December 2020
Autologous Fat Grafting Promotes Macrophage Infiltration to Increase Secretion of Growth Factors and Revascularization, Thereby Treating Diabetic Rat Skin Defect
Wang Y, Zhang H, Zhou M, Yi X, Duan P, Yu A, Qi B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4897-4908
Published Date: 9 December 2020
The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail
Butalia S, Kaplan GG, Khokhar B, Haubrich S, Rabi DM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4885-4895
Published Date: 9 December 2020
Prevalence and Correlation of Metabolic Syndrome: A Cross-Sectional Study of Nearly 10 Million Multi-Ethnic Chinese Adults
Su Y, Lu Y, Li W, Xue M, Chen C, Haireti M, Li Y, Liu Z, Liu Y, Wang S, Yao H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4869-4883
Published Date: 9 December 2020
Sleep Quality and Associated Factors Among Diabetes Mellitus Patients in a Follow-Up Clinic at the University of Gondar Comprehensive Specialized Hospital in Gondar, Northwest Ethiopia: A Cross-Sectional Study
Birhanu TT, Hassen Salih M, Abate HK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4859-4868
Published Date: 9 December 2020
Forecasting the Populations of Overweight and Obese Chinese Adults
Bai R, Wu W, Dong W, Liu J, Yang L, Lyu J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4849-4857
Published Date: 8 December 2020
Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
Kebede zelalem B, Feyisa D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4839-4847
Published Date: 8 December 2020
Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
Bouldjennet F, Gjesing AP, Azzouz M, Abderrahman SA, Guecier AE, Ali S, Oudjit B, Mennadi-Lacete F, Yargui L, Boudiba A, Chibane A, Touil-Boukoffa C, Hansen T, Raache R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4829-4837
Published Date: 8 December 2020
Clinical Significance of Diabetic Dermatopathy
Naik PP, Farrukh SN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4823-4827
Published Date: 8 December 2020
Effect and Mechanism of Ganoderma lucidum Spores on Alleviation of Diabetic Cardiomyopathy in a Pilot in vivo Study
Shaher F, Wang S, Qiu H, Hu Y, Zhang Y, Wang W, AL-Ward H, Abdulghani MAM, Baldi S, Zhou S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4809-4822
Published Date: 7 December 2020
Sirt6-Mediated Endothelial-to-Mesenchymal Transition Contributes Toward Diabetic Cardiomyopathy via the Notch1 Signaling Pathway
Zhang Y, Dong Y, Xiong Z, Zhu Z, Gao F, Wang T, Man W, Sun D, Lin J, Li T, Li C, Zhao Z, Shen M, Sun D, Fan Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4801-4808
Published Date: 7 December 2020
Identifying Diabetic Macular Edema and Other Retinal Diseases by Optical Coherence Tomography Image and Multiscale Deep Learning
Zhang Q, Liu Z, Li J, Liu G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4787-4800
Published Date: 4 December 2020
Diabetic Foot Self-Care Practices Among Adult Diabetic Patients: A Descriptive Cross-Sectional Study
Hirpha N, Tatiparthi R, Mulugeta T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4779-4786
Published Date: 4 December 2020
Toll-like Receptors as a Potential Drug Target for Diabetes Mellitus and Diabetes-associated Complications
Yehualashet AS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4763-4777
Published Date: 4 December 2020
The Association of Circulating Selenium Concentrations with Diabetes Mellitus
Liao XL, Wang ZH, Liang XN, Liang J, Wei XB, Wang SH, Guo WX
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4755-4761
Published Date: 3 December 2020
Usefulness of Exercise for Home Blood Pressure Control in People with Diabetes: A Study Protocol for a Crossover Randomized Controlled Trial
Iwai K, Ushigome E, Yokota I, Majima S, Nakanishi N, Hashimoto Y, Okada H, Senmaru T, Hamaguchi M, Asano M, Yamazaki M, Fukui M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4747-4753
Published Date: 3 December 2020
Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages
Hussein A, Mahmoud SED, Awad MS, Mahmoud HEM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4737-4746
Published Date: 3 December 2020
Early Detection of Renal Impairment Among Patients with Type 2 Diabetes Mellitus Through Evaluation of Serum Cystatin C in Comparison with Serum Creatinine Levels: A Cross-Sectional Study
Asmamaw T, Genet S, Menon M, Tarekegn G, Chekol E, Geto Z, Lejisa T, Habtu W, Getahun T, Tolcha Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4727-4735
Published Date: 3 December 2020
Identification of Reactive Hypoglycemia with Different Basic BMI and Its Causes by Prolonged Oral Glucose Tolerance Test
Lv X, Fang K, Hao W, Han Y, Yang N, Yu Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4717-4726
Published Date: 2 December 2020
Correlation Between Recovery of Menstrual Cycle and Improvement of Glucose and Lipid Metabolism in Patients with Sleeve Gastrectomy in a Small Chinese Cohort Sample
Ran Y, Yi Q, Li C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4711-4715
Published Date: 1 December 2020
Age-Related Changes in Body Composition and Bone Mineral Density and Their Relationship with the Duration of Diabetes and Glycaemic Control in Type 2 Diabetes
Tang Y, Gong L, Chen X, Du Z, Hu J, Xu Z, Wu J, Li Q, Wang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4699-4710
Published Date: 1 December 2020
Association of Serum Uric Acid, Urea Nitrogen, and Urine Specific Gravity Levels at 16–18 Weeks of Gestation with the Risk of Gestational Diabetes Mellitus
Li Y, Yu T, Liu Z, Chen H, Liu Y, Wei Y, Sun R, Zhang H, Wang W, Lu Y, Zhou Y, Deng G, Zhang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4689-4697
Published Date: 1 December 2020
p53 Mediates GnRH Secretion via Lin28/let-7 System in GT1-7 Cells
Chen T, Wu H, Chen X, Xie R, Wang F, Sun H, Chen L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4681-4688
Published Date: 1 December 2020
Screening and Identification of Differentially Expressed and Adipose Growth-Related Protein-Coding Genes During the Deposition of Perirenal Adipose Tissue in Rabbits
Wang G, Du K, Xie Z, Tang R, Jia X, Chen S, Lai S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4669-4680
Published Date: 1 December 2020
The Relationship Between Serum VCAM-1 and Alzheimer’s Disease in Patients with Type 2 Diabetes Mellitus
Zhang L, Mao H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4661-4667
Published Date: 30 November 2020
Association Between Abnormal Glycemic Phenotypes and Microvascular Complications of Type 2 Diabetes Mellitus Outpatients in China
Liu G, Dou J, Zheng D, Zhang J, Wang M, Li W, Wen J, Lu J, Ji L, He Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4651-4659
Published Date: 27 November 2020
Plasma RBP4 Level in Association with Body Composition, Metabolic Profile, STRA6 and RBP4 Gene Polymorphisms in Obese Romanian Children
Boaghi A, Pop RM, Vasilache SL, Banescu C, Hutanu A, Marginean OC, Pascanu IM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4643-4650
Published Date: 27 November 2020
Development of Obesity: The Driver and the Passenger
Kopp W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4631-4642
Published Date: 27 November 2020
Estimation of Diabetes in a High-Risk Adult Chinese Population Using J48 Decision Tree Model
Pei D, Yang T, Zhang C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4621-4630
Published Date: 26 November 2020
Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin
Thewjitcharoen Y, Prasartkaew H, Tongsumrit P, Wongjom S, Boonchoo C, Butadej S, Nakasatien S, Karndumri K, Veerasomboonsin V, Krittiyawong S, Himathongkam T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4609-4620
Published Date: 26 November 2020
Type 2 Diabetes Correlates with Comorbidity and Nutritional Status but Not with Functional Health in Geriatric Ward Patients: A Cross-Sectional Study in Poland
Wojszel ZB, Magnuszewski L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4599-4607
Published Date: 26 November 2020
Dyslipidemia and Its Associated Risk Factors Among Adult Type-2 Diabetic Patients at Jimma University Medical Center, Jimma, Southwest Ethiopia
Haile K, Timerga A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4589-4597
Published Date: 26 November 2020
Effect of Elevated Ketone Body on Maternal and Infant Outcome of Pregnant Women with Abnormal Glucose Metabolism During Pregnancy
Qian M, Wu N, Li L, Yu W, Ouyang H, Liu X, He Y, Al-Mureish A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4581-4588
Published Date: 25 November 2020
Prevalence and Associated Factors of Diabetes Mellitus Among Adult Population in Hawassa Zuria Woreda, Sidama Region, Ethiopia
Seifu Y, Tsegaw D, Haji Y, Ejeso A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4571-4579
Published Date: 24 November 2020
Berberine Down-Regulated Myostatin Expression and Facilitated Metabolism via Smad Pathway in Insulin Resistant Mice
Chen L, Su X, Hu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4561-4569
Published Date: 23 November 2020
The Beneficial Role of Anchomanes difformis in STZ-Induced Reproductive Dysfunction in Male Wistar Rats
Alabi TD, de Villiers C, du Plessis SS, Monsees TK, Brooks NL, Oguntibeju OO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4543-4560
Published Date: 23 November 2020
Health-Related Quality of Life and Associated Factors Among Type Two Diabetic Patients on Follow-Up in Dessie Comprehensive Specialized Hospital, Dessie, North East Ethiopia, 2020
Girma M, Wodajo S, Ademe S, Edmealem A, W/silasie M, Mesafint G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4529-4541
Published Date: 20 November 2020
ANGPTL8 Gene Polymorphism rs2278426 Is Related to Carotid Intima–Media Thickness in T2DM
Guo C, Zhao L, Ding Y, Zhao Z, Wang C, Li L, Cai Z, Li Y, Xia H, Zhu ZZ, Yu F, Dai M, Deng X, Yuan G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4519-4528
Published Date: 20 November 2020
LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway
Cao X, Fan QL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4507-4517
Published Date: 20 November 2020
Resveratrol Inhibits Lipopolysaccharide-Induced Extracellular Matrix Accumulation and Inflammation in Rat Glomerular Mesangial Cells by SphK1/S1P2/NF-κB Pathway
Gong W, Li J, Chen W, Feng F, Deng Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4495-4505
Published Date: 20 November 2020
CHDH-PNPLA3 Gene–Gene Interactions Predict Insulin Resistance in Children with Obesity
Chirita-Emandi A, Serban CL, Paul C, Andreescu N, Velea I, Mihailescu A, Serafim V, Tiugan DA, Tutac P, Zimbru C, Puiu M, Niculescu MD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4483-4494
Published Date: 19 November 2020
Hypoglycemia After Upper Gastrointestinal Surgery: Clinical Approach to Assessment, Diagnosis, and Treatment
Sheehan A, Patti ME
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4469-4482
Published Date: 19 November 2020
Investigation of the Effect of Canagliflozin on the Disposition Index, a Marker of Pancreatic Beta Cell Function, in Patients with Type 2 Diabetes
Takahara M, Shiraiwa T, Matsuoka TA, Yamamoto K, Maeno Y, Shiraiwa Y, Yoshida Y, Katakami N, Iijima H, Katsumata H, Arakawa K, Hashimoto T, Shimomura I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4457-4468
Published Date: 18 November 2020
Diabetic Peripheral Neuropathy Increases Electrical Stimulation Threshold of Sciatic Nerve: A Prospective Parallel Cohort Study
Zhang GY, Chen YF, Dai WX, Zhang D, Huang Y, He WZ, Lin CX
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4447-4455
Published Date: 18 November 2020
miR145 Regulates the Proliferation and Apoptosis of Rat Vascular Endothelial Cells under Hyperglycemia by Targeting the ANGPT2 Gene and Involving the NFκB Signaling Pathway
Zhang W, Tang XH, Zhang JJ, He Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4435-4446
Published Date: 18 November 2020
Long Sleep Duration is Associated with Increased High-Sensitivity C-Reactive Protein: A Nationwide Study on Chinese Population
He L, Yang N, Ping F, Xu L, Li W, Li Y, Zhang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4423-4434
Published Date: 17 November 2020
Visceral Fat Area, Not Subcutaneous Fat Area, is Associated with Cardiac Hemodynamics in Type 2 Diabetes
Qiu Y, Deng X, Sha Y, Wu X, Zhang P, Chen K, Zhao Z, Wei W, Yang L, Yuan G, Zhao L, Wang D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4413-4422
Published Date: 17 November 2020
Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
Pingali U, Ali MA, Gundagani S, Nutalapati C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4401-4412
Published Date: 17 November 2020
Glycemic Control Among People Living with Diabetes and Human Immunodeficiency Virus in Ethiopia: Leveraging Clinical Care for the Looming Co-Epidemics
Melaku T, Chelkeba L, Mekonnen Z, Kumela K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4379-4399
Published Date: 17 November 2020
Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study
Wang C, Niu Q, Lv H, Li Q, Ma Y, Tan J, Liu C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4369-4378
Published Date: 16 November 2020
Prevalence of Thyroid Dysfunction in a Chinese Population with Different Glucose Intolerance Status: A Community-Based Cross-Sectional Study
Huang X, Zhang X, Zhou X, Han X, Fu Z, Li Y, Ji L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4361-4368
Published Date: 16 November 2020
Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism
Kawarasaki S, Sawazaki H, Iijima H, Ng SP, Kwon J, Mohri S, Iwase M, Jheng HF, Takahashi H, Nomura W, Inoue K, Kawada T, Goto T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4353-4359
Published Date: 16 November 2020
Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes
Deng X, Zhao L, Guo C, Yang L, Wang D, Li Y, Xia H, Wang C, Cai Z, Li L, Zhao Z, Yuan G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4341-4351
Published Date: 13 November 2020
ZG02 Improved Hepatic Glucose Metabolism and Insulin Sensitivity via Activation of AMPK/Sirt1 Signaling Pathways in a High-fat Diet/Streptozotocin-induced Type 2 Diabetes Model
Zhang Y, Zhou B, Wen M, Hu M, Peng JG, Wang Y, Fan LL, Tang L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4333-4339
Published Date: 12 November 2020
Sex-Specific Associations of Circulating Uric Acid with Risk of Diabetes Incidence: A Population-Based Cohort Study from Sweden
Chen N, Muhammad IF, Li Z, Nilsson PM, Borné Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4323-4331
Published Date: 12 November 2020
Identification of Genetic Variants for Female Obesity and Evaluation of the Causal Role of Genetically Defined Obesity in Polycystic Ovarian Syndrome
Ahn Y, Lee H, Cho YS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4311-4322
Published Date: 12 November 2020
The Association of Syntax Score with Levels of Lipoprotein(a) and Inflammatory Biomarkers in Patients with Stable Coronary Artery Disease and Different Low-Density Lipoprotein Cholesterol Levels
Xu W, Guan H, Gao D, Wang Z, Ba Y, Yang H, Shen W, Lian J, Zhou J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4297-4310
Published Date: 12 November 2020
Network Pharmacology Combined with Transcriptional Analysis to Unveil the Biological Basis of Astaxanthin in Reducing the Oxidative Stress Induced by Diabetes Mellitus
Sun X, Ji Y, Tahir A, Kang J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4281-4295
Published Date: 11 November 2020
Isomangiferin Attenuates Renal Injury in Diabetic Mice via Inhibiting Inflammation
Yue S, Xue N, Li H, Chen Z, Huang B, Wang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4273-4280
Published Date: 10 November 2020
Toll-Like Receptor 4 and Inflammatory Micro-Environment of Pancreatic Islets in Type-2 Diabetes Mellitus: A Therapeutic Perspective
Wang Z, Ni X, Zhang L, Sun L, Zhu X, Zhou Q, Yang Z, Yuan H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4261-4272
Published Date: 10 November 2020
Cost of Diabetic Foot Ulcer Management in China: A 7-Year Single-Center Retrospective Review
Lu Q, Wang J, Wei X, Wang G, Xu Y, Lu Z, Liu P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4249-4260
Published Date: 10 November 2020
Research Progress on the Experimental Animal Model of Gestational Diabetes Mellitus
He Y, Wu N, Yu W, Li L, OuYang H, Liu X, Qian M, Al-Mureish A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4235-4247
Published Date: 9 November 2020
Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice
Morieri ML, Avogaro A, Fadini GP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4221-4234
Published Date: 9 November 2020
High-Intensity Interval Training Attenuates Ketogenic Diet-Induced Liver Fibrosis in Type 2 Diabetic Mice by Ameliorating TGF-β1/Smad Signaling
Zhang Q, Shen F, Shen WQ, Xia J, Wang J, Zhao Y, Zhang Z, Sun Y, Qian M, Ding SZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4209-4219
Published Date: 6 November 2020
Erectile Dysfunction and Correlates Among Diabetic Men at Dessie Referral Hospital: North Central Ethiopia, 2020
Abeway S, Dagne K, Zegeye T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4201-4208
Published Date: 6 November 2020
Metabolic Syndrome and 5-Year Incident Hyperuricemia Among Older Chinese Adults: A Community-Based Cohort Study
Liu JH, Ma QH, Xu Y, Chen X, Pan CW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4191-4200
Published Date: 6 November 2020
Adiponectin Protects Obese Rats from Aggravated Acute Lung Injury via Suppression of Endoplasmic Reticulum Stress
Wei K, Luo J, Cao J, Peng L, Ren L, Zhang F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4179-4190
Published Date: 5 November 2020
Magnitude of Central Obesity and its Associated Factors Among Adults in Urban Areas of Northwest Ethiopia
Molla MD, Wolde HF, Atnafu A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4169-4178
Published Date: 6 November 2020
Characteristics of Physical Fitness and Cardiometabolic Risk in Chinese University Students with Normal-Weight Obesity: A Cross-Sectional Study
Tian Q, Wang H, Kaudimba KK, Guo S, Zhang H, Gao S, Wang R, Luan X, Lee JKW, Chen P, Liu T, Wang R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4157-4167
Published Date: 4 November 2020
Racial Variation in the Relationship of Glycemic Control with Fracture Risk in Elderly Patients with Diabetes
Figaro MK, Long DM, May ME, Ndetan H, Cook A, Conway RB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4153-4155
Published Date: 5 November 2020
Role of Sortilin and Matrix Vesicles in Nϵ-Carboxymethyl-Lysine-Induced Diabetic Atherosclerotic Calcification
Jing L, Li L, Ren X, Sun Z, Bao Z, Yuan G, Cai H, Wang L, Shao C, Wang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4141-4151
Published Date: 3 November 2020
Inadequacy of Vitamin D Nutritional Status in Individuals with Metabolically Unhealthy Obesity Phenotype: The Relevance of Insulin Resistance
Cordeiro A, Campos B, Pereira SE, Saboya CJ, Ramalho A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4131-4139
Published Date: 3 November 2020
Magnitude of, and Factors Associated with Cardiovascular Disease Among Type Two Diabetes Mellitus Patients
Tesfaye A, Josef H, Wube TB, Girma Z, Negasa B, Muche T, Zewude B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4123-4129
Published Date: 3 November 2020
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus
Han E, Lee M, Lee YH, Kim HS, Lee BW, Cha BS, Kang ES
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4113-4121
Published Date: 2 November 2020
Association of Circulating Irisin Levels with Adiposity and Glucose Metabolic Profiles in a Middle-Aged Chinese Population: A Cross-Sectional Study
Zhang R, Fu T, Zhao X, Qiu Y, Hu X, Shi H, Yin X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4105-4112
Published Date: 30 October 2020
Effects of Laparoscopic Sleeve Gastrectomy on Bone Mineral Density and Bone Metabolism in Chinese Patients with Obesity
Chen X, Zhang C, Li J, Liu W, Zhang J, Zhou Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4095-4103
Published Date: 29 October 2020
Antidiabetic and Anti-hyperlipidemic Effects of the Crude Hydromethanol Extract of Hagenia abyssinica (Rosaceae) Leaves in Streptozotocin-Induced Diabetic Mice
Kifle ZD, Belayneh YM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4085-4094
Published Date: 29 October 2020
Laparoscopic Sleeve Gastrectomy-Induced Decreases in FT3 and TSH are Related to Fasting C-Peptide in Euthyroid Patients with Obesity
Chen X, Zhang C, Liu W, Zhang J, Zhou Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4077-4084
Published Date: 29 October 2020
Level of Physical Activity and Its Associated Factors Among Type II Diabetes Patients in Dessie Referral Hospital, Northeast Ethiopia
Edmealem A, Ademe S, Tegegne B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4067-4075
Published Date: 29 October 2020
Association Between Inflammatory Biomarkers and Cognitive Dysfunction Analyzed by MRI in Diabetes Patients
Yang X, Chen Y, Zhang W, Zhang Z, Yang X, Wang P, Yuan H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4059-4065
Published Date: 29 October 2020
A Ten-Year Review of the Pattern and Outcome of Childhood Diabetes in Two State Teaching Hospitals in South-West Nigeria
Oluwayemi IO, Oyedeji OA, Adeniji EO, Ajite AB, Babatola AO, Adeniyi AT, Ogundare EO, Olatunya OS, Ayeni TO, Ajibola AE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4051-4057
Published Date: 28 October 2020
Clinical Significance of Serum PGC-1 Alpha Levels in Diabetes Mellitus with Myocardial Infarction Patients and Reduced ROS-Oxidative Stress in Diabetes Mellitus with Myocardial Infarction Model
Zhu N, Yan X, Li H, Wang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4041-4049
Published Date: 28 October 2020
Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia
Alzaheb RA, Altemani AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4033-4040
Published Date: 28 October 2020
Abnormal Glucose Metabolism and Associated Risk Factors Among Adults in Mekelle City, Ethiopia
Gebreegziabiher G, Belachew T, Tamiru D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4017-4032
Published Date: 27 October 2020
The Product of Red Blood Cells and Hematocrit Can Be Used as a Novel Indicator of Impaired Fasting Blood Glucose Status
Feng L, Chen H, Chen J, Xiong C, Shao X, Wang X, Ning J, Xiang Z, Wang X, Chen T, Xiao H, Tang H, Li X, Hong G, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4007-4015
Published Date: 27 October 2020
Differences in the Association Among the Vitamin D Concentration, Dietary Macronutrient Consumption, and Metabolic Syndrome Depending on Pre- and Postmenopausal Status in Korean Women: A Cross-Sectional Study [Corrigendum]
Chun H, Kim GD, Doo M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:4005-4006
Published Date: 27 October 2020
Association of Urinary Polycyclic Aromatic Hydrocarbons and Diabetes in Korean Adults: Data from the Korean National Environmental Health Survey Cycle 2 (2012–2014)
Nam YJ, Kim SH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3993-4003
Published Date: 27 October 2020
Asymptomatic Hyperuricemia Associates with Cardiometabolic Risk Indicators in Overweight/Obese but Not in Lean Adolescents
Sebekova K, Gurecka R, Podracka L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3977-3992
Published Date: 27 October 2020
Management Practice and Contributing Risk Factors for Chronic Complications Among Type 2 Diabetes Mellitus Adult Patients in Follow-Up at a Tertiary Care Teaching Hospital
Negash Z, Yismaw M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3969-3976
Published Date: 27 October 2020
Impact of Commuting Mode on Obesity Among a Working Population in Beijing, China: Adjusting for Air Pollution
Liu Y, Tao L, Zhang J, Liu J, Li H, Liu X, Luo Y, Zhang J, Wang W, Guo X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3959-3968
Published Date: 23 October 2020
Standard Puerarin Prevents Diabetic Renal Damage by Inhibiting miRNA-140-5p Expression
Xu Y, Xiong Y, Xu C, Xu C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3947-3958
Published Date: 23 October 2020
Red Blood Cell Parameters and Their Correlation with Renal Function Tests Among Diabetes Mellitus Patients: A Comparative Cross-Sectional Study
Adane T, Getaneh Z, Asrie F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3937-3946
Published Date: 23 October 2020
Triglyceride to High-Density Lipoprotein Cholesterol Ratio is an Important Determinant of Cardiovascular Risk and Poor Prognosis in Coronavirus Disease-19: A Retrospective Case Series Study
Zhang B, Dong C, Li S, Song X, Wei W, Liu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3925-3936
Published Date: 23 October 2020
Serum Human Epididymis Protein 4 Level is Associated with Cognitive Function in Patients with Diabetes Mellitus
Bai F, Li T, Li B, Li X, Zhu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3919-3924
Published Date: 22 October 2020
Knowledge, Attitude and Practice of Elderly Outpatients with Type 2 Diabetes Mellitus in National Geriatric Hospital, Vietnam
Nguyen AT, Pham HQ, Nguyen TX, Nguyen TTH, Nguyen HTT, Nguyen TN, Dinh DTK, Phan HT, Nguyen SH, Tran BX, Latkin CA, Ho RCM, Ho CS, Pham T, Vu HTT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3909-3917
Published Date: 22 October 2020
The Relationship Between Vitamin D Deficiency and Glycated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus
Zhao H, Zhen Y, Wang Z, Qi L, Li Y, Ren L, Chen S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3899-3907
Published Date: 21 October 2020
Sustained Stimulation of β2AR Inhibits Insulin Signaling in H9C2 Cardiomyoblast Cells Through the PKA-Dependent Signaling Pathway
Pei J, Xiao Z, Guo Z, Pei Y, Wei S, Wu H, Wang D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3887-3898
Published Date: 21 October 2020
Diabetes Mellitus and Tuberculosis Comorbidity and Associated Factors Among Bale Zone Health Institutions, Southeast Ethiopia
Gezahegn H, Ibrahim M, Mulat E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3879-3886
Published Date: 21 October 2020
Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
Albai O, Timar B, Paun DL, Sima A, Roman D, Timar R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3873-3878
Published Date: 21 October 2020
Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH
Hegazy MA, Mogawer SM, Alnaggar ARLR, Ghoniem OA, Abdel Samie RM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3861-3872
Published Date: 20 October 2020
Correlation Profile of Suppression of Tumorigenicity 2 and/or Interleukin-33 with Biomarkers in the Adipose Tissue of Individuals with Different Metabolic States
Hasan A, Kochumon S, Al-Ozairi E, Tuomilehto J, Al-Mulla F, Ahmad R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3839-3859
Published Date: 20 October 2020
Validity of Anthropometric Cut-Offs for Early Diagnosis of Dyslipidemia Among Ethiopian Adults
Kenate S, Tesfaye T, Berhanu Mogas S, Zawdie B, Tesfaye Y, Dadi LS, Tadesse M, Kebede A, Gudina EK, Tamiru D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3831-3837
Published Date: 20 October 2020
Mogroside IIIE Alleviates High Glucose-Induced Inflammation, Oxidative Stress and Apoptosis of Podocytes by the Activation of AMPK/SIRT1 Signaling Pathway
Xue W, Mao J, Chen Q, Ling W, Sun Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3821-3830
Published Date: 20 October 2020
Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model
El-Ebidi AM, Saleem TH, Saadi MGE, Mahmoud HA, Mohamed Z, Sherkawy HS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3807-3819
Published Date: 20 October 2020
The Oral Glucose Tolerance Test: 100 Years Later
Jagannathan R, Neves JS, Dorcely B, Chung ST, Tamura K, Rhee M, Bergman M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3787-3805
Published Date: 19 October 2020
Comparison of Diabetes-Dependent Quality of Life (ADDQoL) in Patients with T2DM in Poland, The Czech Republic, and Slovakia
Krzemińska S, Bąk E, Šáteková L, Polanská A, Hašová K, Laurinc M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3773-3786
Published Date: 19 October 2020
Childhood Maternal School Leaving Age (Level of Education) and Risk Markers of Metabolic Syndrome in Mid-Adulthood: Results from the 1958 British Birth Cohort
Iwundu C, Pang D, Pappas Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3761-3771
Published Date: 15 October 2020
Association Between Subclinical Left Ventricular Myocardial Systolic Dysfunction Detected by Strain and Strain‑Rate Imaging and Liver Steatosis and Fibrosis Detected by Elastography and Controlled Attenuation Parameter in Patients with Metabolic Syndrome
Vitel A, Sporea I, Mare R, Banciu C, Bordejevic DA, Parvanescu T, Citu IM, Tomescu MC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3749-3759
Published Date: 15 October 2020
Determinants of Diabetic Foot Ulcer Among Adult Patients with Diabetes Attending the Diabetic Clinic in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: Unmatched Case–Control Study
Woldemariam GT, Atnafu NT, Radie YT, Wolde GT, Gebreagziabher TT, Gebrehiwot TG, Teka YH, Hagos MG, Hagezom HM, Yigzaw HB, Gebremedhin HT, Mezgebo HM, Gebremariam A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3739-3747
Published Date: 15 October 2020
Assessment of Cell-Free Long Non-Coding RNA-H19 and miRNA-29a, miRNA-29b Expression and Severity of Diabetes
Alfaifi M, Verma AK, Alshahrani MY, Joshi PC, Alkhathami AG, Ahmad I, Hakami AR, Beg MMA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3727-3737
Published Date: 14 October 2020
Barriers to Self-Management of Type 2 Diabetes During COVID-19 Medical Isolation: A Qualitative Study
Shi C, Zhu H, Liu J, Zhou J, Tang W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3713-3725
Published Date: 14 October 2020
Incidence of Diabetic Foot Ulcer and Its Predictors Among Diabetes Mellitus Patients at Felege Hiwot Referral Hospital, Bahir Dar, Northwest Ethiopia: A Retrospective Follow-Up Study
Adem AM, Andargie AA, Teshale AB, Wolde HF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3703-3711
Published Date: 14 October 2020
Understanding the Multiple Effects of PCBs on Lipid Metabolism
Shan Q, Li H, Chen N, Qu F, Guo J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3691-3702
Published Date: 13 October 2020
Relationship Between Metabolic Syndrome and Bone Health – An Evaluation of Epidemiological Studies and Mechanisms Involved
Chin KY, Wong SK, Ekeuku SO, Pang KL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3667-3690
Published Date: 13 October 2020
Relationship Between Metabolic Syndrome and the Brazilian Workers’ Food Program in Male and Female Manufacturing Workers
Pereira GS, Bezerra IWL, Souza AM, Santos ICC, Nogueira Silbiger V, Costa RM, Torres KG, Oliveira AG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3655-3666
Published Date: 13 October 2020
Association of the HDL-c Level with HsCRP, IL-6, U-NAG, RBP and Cys-C in Type 2 Diabetes Mellitus, Hypertension, and Chronic Kidney Disease: An Epidemiological Survey
Li X, Su T, Xiao H, Gao P, Xiong C, Liu J, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3645-3654
Published Date: 13 October 2020
Factors Associated with the Change in Carotid Maximum Intima-Media Thickness in Patients with Moderate-to-Advanced Stage Chronic Kidney Disease
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3637-3643
Published Date: 12 October 2020
Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity
Ayza MA, Zewdie KA, Tesfaye BA, Gebrekirstos ST, Berhe DF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3627-3635
Published Date: 12 October 2020
Age, Pulse, Urea and Albumin (APUA) Model: A Tool for Predicting in-Hospital Mortality of Community-Acquired Pneumonia Adapted for Patients with Type 2 Diabetes
Ma CM, Wang N, Su QW, Yan Y, Yin FZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3617-3626
Published Date: 9 October 2020
Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
Wondmkun YT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3611-3616
Published Date: 9 October 2020
Differences in the Association Among the Vitamin D Concentration, Dietary Macronutrient Consumption, and Metabolic Syndrome Depending on Pre- and Postmenopausal Status in Korean Women: A Cross-Sectional Study
Chun H, Kim GD, Doo M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3601-3609
Published Date: 9 October 2020
The Clinical Utility of Salivary Biomarkers in the Identification of Type 2 Diabetes Risk and Metabolic Syndrome
Desai P, Donovan L, Janowitz E, Kim JY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3587-3599
Published Date: 9 October 2020
Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease
Hung MC, Chen CF, Tsou MT, Lin HH, Hwang LC, Hsu CP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3579-3585
Published Date: 9 October 2020
Diabetes and Psoriasis: Different Sides of the Same Prism
Abramczyk R, Queller JN, Rachfal AW, Schwartz SS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3571-3577
Published Date: 7 October 2020
The Association Between Femoral Artery Intima-Media Thickness and Serum Glucagon-Like Peptide-1 Levels Among Newly Diagnosed Patients with Type 2 Diabetes Mellitus
Le TD, Nguyen NPT, Nguyen ST, Nguyen HT, Tran HTT, Nguyen THL, Nguyen CD, Nguyen GT, Nguyen XT, Nguyen BD, Trinh ST, Ngo TA, Do BN, Luong TC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3561-3570
Published Date: 7 October 2020
LncRNA SNHG16 Aggravates High Glucose-Induced Podocytes Injury in Diabetic Nephropathy Through Targeting miR-106a and Thereby Up-Regulating KLF9
He X, Zeng X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3551-3560
Published Date: 8 October 2020
Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL)
Chen K, Wan X, Zhao L, Zhao S, Peng L, Yang W, Yuan J, Zhu L, Mo Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3535-3549
Published Date: 6 October 2020
Association of Apolipoprotein e2 Allele with Insulin Resistance and Risk of Type 2 Diabetes Mellitus Among an Admixed Population of Mexico
Gonzalez-Aldaco K, Roman S, Torres-Reyes LA, Panduro A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3527-3534
Published Date: 6 October 2020
Adrenal Artery Ablation for the Treatment of Hypercortisolism Based on Adrenal Venous Sampling: A Potential Therapeutic Strategy
Zhou Q, Liu X, Zhang H, Zhao Z, Li Q, He H, Zhu Z, Yan Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3519-3525
Published Date: 6 October 2020
Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
Chen L, Zhang X, Zhang L, Zheng D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3507-3518
Published Date: 6 October 2020
Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study
Osonoi T, Saito M, Koda N, Douguchi S, Nakano T, Ofuchi K, Katoh M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3497-3506
Published Date: 5 October 2020
Metabolic Syndrome in Female Police Officers and Female Office Workers: A Cross-Sectional Study in Occupations with Different Physical Activities
Strauss M, Foshag P, Brzek A, Vollenberg R, Jehn U, Leischik R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3487-3495
Published Date: 5 October 2020
Consumption of Cooked Common Beans or Saponins Could Reduce the Risk of Diabetic Complications
Calderón Guzmán D, Juárez Olguín H, Veloz Corona Q, Ortiz Herrera M, Osnaya Brizuela N, Barragán Mejía G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3481-3486
Published Date: 2 October 2020
Increased Metabolic Burden Among Blacks: A Putative Mechanism for Disparate COVID-19 Outcomes
Jean-Louis G, Turner AD, Jin P, Liu M, Boutin-Foster C, McFarlane SI, Seixas A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3471-3479
Published Date: 2 October 2020
Circulating miR-15a and miR-222 as Potential Biomarkers of Type 2 Diabetes
Sadeghzadeh S, Dehghani Ashkezari M, Seifati SM, Vahidi Mehrjardi MY, Dehghan Tezerjani M, Sadeghzadeh S, Ladan SAB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3461-3469
Published Date: 2 October 2020
Characterization and Treatment of Inflammation and Insulin Resistance in Obese Adipose Tissue
Lu Z, Li Y, Song J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3449-3460
Published Date: 1 October 2020
Effects of Plant-Based Diets on Weight Status: A Systematic Review
Tran E, Dale HF, Jensen C, Lied GA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3433-3448
Published Date: 30 September 2020
Insulin-Like Proteins in Plant Sources: A Systematic Review
Costa IS, Medeiros AF, Piuvezam G, Medeiros GCBS, Maciel BLL, Morais AHA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3421-3431
Published Date: 30 September 2020
Metabolic Syndrome and Incident Asthma in Chinese Adults: An Open Cohort Study
Wang H, Bai C, Yi M, Jia Y, Li Y, Jiang D, Chen O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3411-3420
Published Date: 29 September 2020
The Association Between Hemoglobin HbA1c with Serum Inorganic Phosphate in Children with Type 1 Diabetes
Dalili S, Koohmanaee S, Nemati SAR, Hoseini Nouri SA, Hassanzadeh Rad A, Kooti W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3405-3409
Published Date: 29 September 2020
Effect of Anthocyanins Supplementation on Serum IGFBP-4 Fragments and Glycemic Control in Patients with Fasting Hyperglycemia: A Randomized Controlled Trial
Yang L, Liu Z, Ling W, Wang L, Wang C, Ma J, Peng X, Chen J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3395-3404
Published Date: 28 September 2020
Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
Liu M, Fan F, Liu B, Jia J, Jiang Y, Sun P, He D, Liu J, Li Y, Huo Y, Li J, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3383-3393
Published Date: 28 September 2020
The Mechanism of Traditional Chinese Medicine for the Treatment of Obesity
Li C, Zhang H, Li X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3371-3381
Published Date: 25 September 2020
Carotid Artery Stiffness in Metabolic Syndrome: Sex Differences
Kruszyńska E, Łoboz-Rudnicka M, Palombo C, Vriz O, Kozakova M, Ołpińska B, Morizzo C, Łoboz-Grudzień K, Jaroch J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3359-3369
Published Date: 25 September 2020
Drug-Related Problems and Their Predictors Among Patients with Diabetes Attending the Ambulatory Clinic of Gebre Tsadik Shawo General Hospital, Southwest Ethiopia
Mechessa DF, Kebede B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3349-3357
Published Date: 25 September 2020
Urolithins Attenuate Multiple Symptoms of Obesity in Rats Fed on a High-Fat Diet
Abdulrahman AO, Kuerban A, Alshehri ZA, Abdulaal WH, Khan JA, Khan MI
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3337-3348
Published Date: 25 September 2020
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial
Cho AR, Choi WJ, Kwon YJ, Lee HS, Ahn SG, Lee JW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3325-3335
Published Date: 29 September 2020
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice
Lv J, Zhuang K, Jiang X, Huang H, Quan S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3313-3324
Published Date: 28 September 2020
Islet Transplantation Imaging in vivo
Zheng L, Wang Y, Yang B, Zhang B, Wu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3301-3311
Published Date: 23 September 2020
Arterial Stiffness and Central Hemodynamics are Associated with Low Diurnal Urinary Sodium Excretion
Del Giorno R, Ceresa C, Gabutti S, Troiani C, Gabutti L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3289-3299
Published Date: 23 September 2020
Predictors of Adherence to Self-Care Behavior Among Patients with Diabetes at Public Hospitals in West Ethiopia
Oluma A, Mosisa G, Abadiga M, Tsegaye R, Habte A, Abdissa E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3277-3288
Published Date: 18 September 2020
The Correlation of Type 2 Diabetes Status with Bone Mineral Density in Middle-Aged Adults
Yao X, Xu X, Jin F, Zhu Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3269-3276
Published Date: 16 September 2020
Metabolic Score for Visceral Fat (METS-VF) Estimation – A Novel Cost-Effective Obesity Indicator for Visceral Adipose Tissue Estimation
Kapoor N, Jiwanmall SA, Nandyal MB, Kattula D, Paravathareddy S, Paul TV, Furler J, Oldenburg B, Thomas N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3261-3267
Published Date: 16 September 2020
Association of Serum Renalase Levels and Renalase rs10887800 Polymorphism with Unstable Angina Pectoris Patients Having Metabolic Syndrome
Izadpanah P, Asadian F, Jangjou A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3249-3259
Published Date: 15 September 2020
Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk
Togfano RJ, Pescinni-Salzedas LM, Chagas EFB, Detregiachi CRP, Guiguer EL, Araujo AC, Bechara MD, Rubira CJ, Barbalho II S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3239-3248
Published Date: 24 September 2020
Ginger Extract Increases GLUT-4 Expression Preferentially Through AMPK Than PI3K Signalling Pathways in C2C12 Muscle Cells
Tajik Kord M, Pourrajab F, Hekmatimoghaddam S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3231-3238
Published Date: 15 September 2020
Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
Cosenso-Martin LN, Takaoka LY, Vilela-Martin JF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3221-3229
Published Date: 15 September 2020
Neck Circumference is Associated with Incidence of Angina Pectoris in a Large Community-Based Population
Yan B, Du H, Zhao J, Wu D, Wang J, Yang G, Wang M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3213-3220
Published Date: 15 September 2020
In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
Melesie Taye G, Bule M, Gadisa DA, Teka F, Abula T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3205-3212
Published Date: 15 September 2020
Long Non-Coding RNAs in Brown Adipose Tissue
Lai S, Du K, Shi Y, Li C, Wang G, Hu S, Jia X, Wang J, Chen S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3193-3204
Published Date: 15 September 2020
COVID’s Razor: RAS Imbalance, the Common Denominator Across Disparate, Unexpected Aspects of COVID-19
Czick M, Shapter C, Shapter R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3169-3192
Published Date: 11 September 2020
Interference of Hsa_circ_0003928 Alleviates High Glucose-Induced Cell Apoptosis and Inflammation in HK-2 Cells via miR-151-3p/Anxa2
An L, Ji D, Hu W, Wang J, Jin X, Qu Y, Zhang N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3157-3168
Published Date: 11 September 2020
Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
Ribeiro de Carvalho G, Loduca Lima V, da Veiga GL, Adami F, da Costa Aguiar Alves B, Cristiano Pereira E, Feder D, Fonseca FLA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3149-3155
Published Date: 10 September 2020
Predictors of Diabetes Self-Care Practice Among Patients with Type 2 Diabetes in Public Hospitals in Northeastern Ethiopia: A Facility-Based Cross-Sectional Study
Gulentie TM, Yesuf EM, Yazie TS, Kefale B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3137-3147
Published Date: 10 September 2020
Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats
Figueiredo ID, Lima TFO, Inácio MD, Costa MC, Assis RP, Brunetti IL, Baviera AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3117-3135
Published Date: 7 September 2020
Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis
Tabatabaei-Malazy O, Abdollahi M, Larijani B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3113-3116
Published Date: 26 August 2020
Serum ZAG and Adiponectin Levels Were Closely Related to Obesity and the Metabolically Abnormal Phenotype in Chinese Population
Liu M, Zhang K, Wang L, Yang H, Yan K, Pan H, Zhu H, Gong F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3099-3112
Published Date: 26 August 2020
Sarcopenia Coexisting with High Adiposity Exacerbates Insulin Resistance and Dyslipidemia in Saudi Adult Men
Habib SS, Alkahtani S, Alhussain M, Aljuhani O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3089-3097
Published Date: 25 August 2020
Liraglutide and Insulin Have Contrary Effects on Adipogenesis of Human Adipose-Derived Stem Cells via Wnt Pathway
Liu H, Zhan Y, Luo G, Zou L, Li Y, Lu H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3075-3087
Published Date: 1 September 2020
Malnutrition-Modulated Diabetes Mellitus in Children, Rare Disease with Atypical Presentation: Case Report
Haftu H, Gebrearegay H, Berhane A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3069-3074
Published Date: 25 August 2020
Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study
Chen P, Ma X, Chen H, Wang K, Zhou L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3059-3068
Published Date: 25 August 2020
NLRP3 Blockade Suppresses Pro-Inflammatory and Pro-Angiogenic Cytokine Secretion in Diabetic Retinopathy
Chai G, Liu S, Yang H, Du G, Chen X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3047-3058
Published Date: 25 August 2020
Effect of Pleurotus fossulatus Aqueous Extract on Biochemical Properties of Liver and Kidney in Streptozotocin-Induced Diabetic Rat
Dubey S, Yadav C, Bajpeyee A, Singh MP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3035-3046
Published Date: 24 August 2020
Down-Regulated miR-21 in Gestational Diabetes Mellitus Placenta Induces PPAR-α to Inhibit Cell Proliferation and Infiltration
Guan CY, Tian S, Cao JL, Wang XQ, Ma X, Xia HF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:3009-3034
Published Date: 24 August 2020
Insulin Resistance is Associated with Gut Permeability Without the Direct Influence of Obesity in Young Adults
Mkumbuzi L, Mfengu MMO, Engwa GA, Sewani-Rusike CR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2997-3008
Published Date: 24 August 2020
Radiologic Assessment of Muscle and Fat Stores in Long-Term Type I Diabetics Referred for Pancreas Transplant Compared to Healthy Controls
Nagaraju S, Mangus RS, Salisbury TA, Bush WJ, Davis JP, Powelson JA, Fridell JA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2989-2995
Published Date: 24 August 2020
The Association of Metabolic Syndrome and Its Components with Electrocardiogram Parameters and Abnormalities Among an Iranian Rural Population: The Fasa PERSIAN Cohort Study
Yazdanpanah MH, Sayyadipoor S, Hojati SR, Nikmanesh A, Farjam M, Homayounfar R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2975-2987
Published Date: 24 August 2020
Association Between Hypertriglyceridemic Waist Phenotype and Increased Urinary Albumin–Creatinine Ratio in Chinese Adults: The REACTION Study
Su W, Wang J, Mu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2965-2974
Published Date: 21 August 2020
Assessment of Achievement of American Diabetes Association (ADA) Targets in Patients with Type 2 Diabetes Mellitus at a Tertiary Care Centre in Eastern Nepal
Baranwal JK, Maskey R, Chaudhari RK, Sherchand O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2959-2964
Published Date: 21 August 2020
Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges
Ritchie ND, Baucom KJW, Sauder KA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2949-2957
Published Date: 19 August 2020
Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens Among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia
Alemu M, Belete MA, Gebreselassie S, Belay A, Gebretsadik D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2935-2948
Published Date: 19 August 2020
The Hidden Burden of Diabetes Mellitus in an Urban Community of Southwest Ethiopia
Tesfaye Yunka T, Berhanu Mogas S, Zawdie B, Tamiru D, Tesfaye Y, Kebede A, Tadesse M, Kebede Gudina E, Sena Dadi L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2925-2933
Published Date: 19 August 2020
Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
Wake AD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2909-2923
Published Date: 19 August 2020
Screening for Metabolic Syndrome Using an Integrated Continuous Index Consisting of Waist Circumference and Triglyceride: A Preliminary Cross-sectional Study
Liu PJ, Lou HP, Zhu YN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2899-2907
Published Date: 18 August 2020
Skipping Breakfast and Its Association with Health Risk Behaviour and Mental Health Among University Students in 28 Countries
Pengpid S, Peltzer K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2889-2897
Published Date: 18 August 2020
Associations of Gain in Weight-Related Anthropometric Indices with a Marker of Lipid Peroxidation: A Cohort Study Among Urban Adults in China
Xu T, Wang B, Cao L, Qiu W, Zhang Z, Chen A, Chen W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2877-2887
Published Date: 18 August 2020
Incidence and Intensity of Catastrophic Health-care Expenditure for Type 2 Diabetes Mellitus Care in Iran: Determinants and Inequality
Piroozi B, Mohamadi-Bolbanabad A, Moradi G, Safari H, Ghafoori S, Zarezade Y, Bidarpour F, Rezaei S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2865-2876
Published Date: 18 August 2020
Quantitative and Topographic Analysis by Immunohistochemical Expression of Ghrelin Gastric Cells in Patients with Morbid Obesity
Parada D D, Peña G KB, Vives M, Molina A, Mayayo E, Riu F, Sabench F, Del Castillo D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2855-2864
Published Date: 18 August 2020
Endoplasmic Reticulum (ER) Stress in Part Mediates Effects of Angiotensin II in Pancreatic Beta Cells
Ramalingam L, Sopontammarak B, Menikdiwela KR, Moustaid-Moussa N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2843-2853
Published Date: 18 August 2020
Altered Intrinsic Brain Activities in Patients with Diabetic Retinopathy Using Amplitude of Low-frequency Fluctuation: A Resting-state fMRI Study
Qi CX, Huang X, Shen Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2833-2842
Published Date: 13 August 2020
Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
Men P, Liu T, Zhai S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2823-2831
Published Date: 11 August 2020
Effects of Plant-Based Diets on Outcomes Related to Glucose Metabolism: A Systematic Review
Johannesen CO, Dale HF, Jensen C, Lied GA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2811-2822
Published Date: 7 August 2020
Effect of Insulin-Regulated FOXC2 Expression in Adipocyte Differentiation and Insulin Resistance
Zhang X, Wang Y, Zuo F, Su Y, Liu H, Wu B, Nian X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2801-2809
Published Date: 6 August 2020
Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
Nguyen T, Wen S, Gong M, Yuan X, Xu D, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2781-2799
Published Date: 5 August 2020
SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients
Scheen AJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2765-2779
Published Date: 5 August 2020
Effectiveness of Exercise Therapy on Gait Function in Diabetic Peripheral Neuropathy Patients: A Systematic Review of Randomized Controlled Trials
Melese H, Alamer A, Hailu Temesgen M, Kahsay G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2753-2764
Published Date: 5 August 2020
(-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway [Corrigendum]
Zhang Z, Zhang D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2751-2752
Published Date: 5 August 2020
Association of Lipid Profile with Type 2 Diabetes in First-Degree Relatives: A 14-Year Follow-Up Study in Iran
Sadeghi E, Hosseini SM, Vossoughi M, Aminorroaya A, Amini M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2743-2750
Published Date: 5 August 2020
A Review of Research Progress on Glycemic Variability and Gestational Diabetes
Yu W, Wu N, Li L, OuYang H, Qian M, Shen H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2729-2741
Published Date: 4 August 2020
Prevalence and Gender Differences of Metabolic Syndrome in Young Ketosis-Prone Type 2 Diabetic Individuals: A Retrospective Study
Du S, Zhang H, Wu H, Ye S, Li W, Su Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2719-2727
Published Date: 3 August 2020
Soluble Suppression of Tumorigenicity 2 is Directly Correlated with Glycated Hemoglobin in Individuals with an Average glycemia in the Normal/Prediabetes Range
Hasan A, Aldhahi W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2711-2718
Published Date: 3 August 2020
Glucagon-Like Peptide 1 Attenuates Lipotoxicity-Induced Islet Dysfunction in ApoE–/– Mice
Liu F, Gong L, Qin W, Cui C, Chen L, Zhang M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2701-2709
Published Date: 28 July 2020
The Barriers and Facilitators of Self-Management Among Adults with Type 2 Diabetes Mellitus: A Trans Theoretical Model (TTM)-Based Mixed Method Study in Iran
Zare M, Tarighat-Esfanjani A, Rafraf M, Shaghaghi A, Asghari-Jafarabadi M, Shamshiri M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2687-2699
Published Date: 27 July 2020
Prevalence of Metabolic Syndrome and Association with Grip Strength in Older Adults: Findings from the HOPE Study
Merchant RA, Chan YH, Lim JY, Morley JE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2677-2686
Published Date: 27 July 2020
Serum miR-503 is a Candidate Biomarker for Differentiating Metabolic Healthy Obesity from Metabolic Unhealthy Obesity
Yue HQ, Zhou YH, Guo Y, Tang CY, Wang F, Zhou HD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2667-2676
Published Date: 27 July 2020
Metabolically Healthy, but Obese Individuals and Associations with Echocardiographic Parameters and Inflammatory Biomarkers: Results from the CARLA Study
Efremov L, Lacruz ME, Tiller D, Medenwald D, Greiser KH, Kluttig A, Wienke A, Nuding S, Mikolajczyk R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2653-2665
Published Date: 27 July 2020
Obesity of G2e3 Knockout Mice Suggests That Obesity-Associated Variants Near Human G2E3 Decrease G2E3 Activity
Powell DR, Doree DD, DaCosta CM, Platt KA, Hansen GM, van Sligtenhorst I, Ding ZM, Revelli JP, Brommage R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2641-2652
Published Date: 27 July 2020
Association of TNF-α Gene Expression and Release in Response to Anti-Diabetic Drugs from Human Adipocytes in vitro
Saxena M, Ali D, Modi DR, Almarzoug MHA, Hussain SA, Manohrdas S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2633-2640
Published Date: 24 July 2020
Identification of the First PAX4-MODY Family Reported in Brazil
Abreu GM, Soares CAPD, Tarantino RM, da Fonseca ACP, de Souza RB, Pereira MFC, Cabello PH, Rodacki M, Zajdenverg L, Zembrzuski VM, Campos Junior M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2623-2631
Published Date: 24 July 2020
Lifestyle Behaviors and Socio-Demographic Factors Associated with Overweight or Obesity Among Saudi Females Attending Fitness Centers
AlTamimi AA, Albawardi NM, AlMarzooqi MA, Aljubairi M, Al-Hazzaa HM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2613-2622
Published Date: 24 July 2020
Level of Adherence to the Dietary Recommendation and Glycemic Control Among Patients with Type 2 Diabetes Mellitus in Eastern Ethiopia: A Cross-Sectional Study
Mohammed AS, Adem F, Tadiwos Y, Woldekidan NA, Degu A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2605-2612
Published Date: 23 July 2020
Perioperative Exercise Therapy in Bariatric Surgery: Improving Patient Outcomes [Corrigendum]
Pouwels S, Sanches EE, Cagiltay E, Severin R, Philips SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2603-2604
Published Date: 23 July 2020
Standardized Glycemic Management versus Conventional Glycemic Management and Postoperative Outcomes in Type 2 Diabetes Patients Undergoing Elective Surgery
Vongsumran N, Buranapin S, Manosroi W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2593-2601
Published Date: 22 July 2020
The Effects of Puerarin on Autophagy Through Regulating of the PERK/eIF2α/ATF4 Signaling Pathway Influences Renal Function in Diabetic Nephropathy
Xu X, Chen B, Huang Q, Wu Y, Liang T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2583-2592
Published Date: 20 July 2020
STEAP4 Inhibits HIF-1α/PKM2 Signaling and Reduces High Glucose-Induced Apoptosis of Retinal Vascular Endothelial Cells
Liu L, Xu H, Zhao H, Jiang C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2573-2582
Published Date: 20 July 2020
Metabolic Syndrome and Prediabetes Among Yemeni School-Aged Children
Saeed W, AL-Habori M, Saif-Ali R, Al-Eryani E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2563-2572
Published Date: 20 July 2020
Reduced Beige Adipogenic Potential in Subcutaneous Adipocytes Derived from Obese Chinese Individuals
Li H, Shen L, Zhang L, Yan B, Sun T, Guo F, Yin X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2551-2562
Published Date: 17 July 2020
Reduced Insulin Resistance Partly Mediated the Association of High Dietary Magnesium Intake with Less Metabolic Syndrome in a Large Chinese Population
Yang N, He L, Li Y, Xu L, Ping F, Li W, Zhang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2541-2550
Published Date: 17 July 2020
Thyroid Hormone Changes in Euthyroid Patients with Diabetes
Qin K, Zhang F, Wu Q, Liu Z, Huang Y, Tan J, Zhou Y, An Z, Li S, Li S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2533-2540
Published Date: 16 July 2020
Correlation Between Serum Uric Acid Level and Central Body Fat Distribution in Patients with Type 2 Diabetes
Zong J, Sun Y, Zhang Y, Yuan J, Wang X, Zhang R, Zhao X, Zhao X, Gu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2521-2531
Published Date: 16 July 2020
Diagnostic Accuracy of Body Mass Index (BMI) When Diagnosing Obesity in a Saudi Adult Population in a Primary Care Setting, Cross Sectional, Retrospective Study
Alammar M, Alsoghayer S, El-Abd K, Alkhenizan A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2515-2520
Published Date: 14 July 2020
Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
Palma CCSSV, Lopes PM, Silva ELC, Bevilaqua MFM, Bomfim AS, Gomes MB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2505-2514
Published Date: 14 July 2020
(-)-Epigallocatechin-3-Gallate Inhibits eNOS Uncoupling and Alleviates High Glucose-Induced Dysfunction and Apoptosis of Human Umbilical Vein Endothelial Cells by PI3K/AKT/eNOS Pathway
Zhang Z, Zhang D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2495-2504
Published Date: 12 July 2020
MicroRNAs and Risk Factors for Diabetic Nephropathy in Egyptian Children and Adolescents with Type 1 Diabetes
Abdelghaffar S, Shora H, Abdelatty S, Elmougy F, El Sayed R, Abdelrahman H, Soliman H, Algebaly H, Ahmed S, Alfy P, Elshiwy Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2485-2494
Published Date: 13 July 2020
lncRNA MEG8 Upregulates miR-770-5p Through Methylation and Promotes Cell Apoptosis in Diabetic Nephropathy
Zhang J, Song L, Ma Y, Yin Y, Liu X, Luo X, Sun J, Wang L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2477-2483
Published Date: 10 July 2020
Obstructive Sleep Apnea Exacerbates Glucose Dysmetabolism and Pancreatic β-Cell Dysfunction in Overweight and Obese Nondiabetic Young Adults
Li N, Fan Y, Zhou JP, Maimba OD, Zhang L, Li QY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2465-2476
Published Date: 10 July 2020
Prevalence of Metabolic Syndrome According to Causes of Physical Activity Limitation
Lee K, Ko DH, Lee JY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2455-2463
Published Date: 10 July 2020
Effect of Different Volumes of Interval Training and Continuous Exercise on Interleukin-22 in Adults with Metabolic Syndrome: A Randomized Trial
Ramos JS, Dalleck LC, Stennett RC, Mielke GI, Keating SE, Murray L, Hasnain SZ, Fassett RG, McGuckin M, Croci I, Coombes JS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2443-2453
Published Date: 9 July 2020
Aerobic Exercise and Metabolic Syndrome: The Role of Sympathetic Activity and the Redox System
Monda V, Sessa F, Ruberto M, Carotenuto M, Marsala G, Monda M, Cambria MT, Astuto M, Distefano A, Messina G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2433-2442
Published Date: 8 July 2020
Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus
Cheema AK, Kaur P, Fadel A, Younes N, Zirie M, Rizk NM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2409-2431
Published Date: 7 July 2020
The Effect of Chilgoza Pine Nut (Pinus gerardiana Wall.) on Blood Glucose and Oxidative Stress in Diabetic Rats
Hosseini SA, Vali M, Haghighi-Zade MH, Siahpoosh A, Malihi R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2399-2408
Published Date: 7 July 2020
Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
Soleimani D, Paknahad Z, Rouhani MH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2389-2397
Published Date: 7 July 2020
Systolic Blood Pressure, Cardiovascular Mortality, and All-Cause Mortality in Normoglycemia, Prediabetes, and Diabetes
Chen CL, Liu L, Huang JY, Yu YL, Lo K, Huang YQ, Feng YQ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2375-2388
Published Date: 6 July 2020
The Body Composition in Early Pregnancy is Associated with the Risk of Development of Gestational Diabetes Mellitus Late During the Second Trimester
Liu Y, Liu J, Gao Y, Zheng D, Pan W, Nie M, Ma L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2367-2374
Published Date: 6 July 2020
Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
Thomann R, Zechmann S, Alexander-David N, Jornayvaz FR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2359-2365
Published Date: 3 July 2020
The Therapeutic Role of Carotenoids in Diabetic Retinopathy: A Systematic Review
Fathalipour M, Fathalipour H, Safa O, Nowrouzi-Sohrabi P, Mirkhani H, Hassanipour S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2347-2358
Published Date: 3 July 2020
Comparative Effects of Curcumin versus Nano-Curcumin on Insulin Resistance, Serum Levels of Apelin and Lipid Profile in Type 2 Diabetic Rats
Shamsi-Goushki A, Mortazavi Z, Mirshekar MA, Mohammadi M, Moradi-Kor N, Jafari-Maskouni S, Shahraki M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2337-2346
Published Date: 3 July 2020
Evaluation of Several Anthropometric and Metabolic Indices as Correlates of Hyperglycemia in Overweight/Obese Adults
Abolhasani M, Maghbouli N, Sazgara F, Karbalai Saleh S, Tahmasebi M, Ashraf H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2327-2336
Published Date: 2 July 2020
Prevalence and Determinants of Hypertension Among Diabetic Patients in Jimma University Medical Center, Southwest Ethiopia, 2019
Abdissa D, Kene K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2317-2325
Published Date: 1 July 2020
The Role of PPARδ Agosnist GW501516 in Rats with Gestational Diabetes Mellitus
Zhou J, Zhe R, Guo X, Chen Y, Zou Y, Zhou L, Wang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2307-2316
Published Date: 30 June 2020
Urine Glucose Excretion Attenuates the Association Between Lipid Accumulation Product and Serum Uric Acid in Subjects with Prediabetes
Chen J, Liu Y, Guo H, Wang B, Sun Z, Yu J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2297-2305
Published Date: 30 June 2020
Limb Salvage and Prevention of Ulcer Recurrence in a Chronic Refractory Diabetic Foot Osteomyelitis
Jiang X, Li N, Yuan Y, Yang C, Chen Y, Ma Y, Wang J, Du D, Boey J, Armstrong DG, Deng W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2289-2296
Published Date: 30 June 2020
Role of TNF-α and FGF-2 in the Fracture Healing Disorder of Type 2 Diabetes Model Induced by High Fat Diet Followed by Streptozotocin
Huang H, Luo L, Liu Z, Li Y, Tong Z, Liu Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2279-2288
Published Date: 30 June 2020
Promotion of Adropin Expression by Hyperglycemia Is Associated with STAT3 Activation in Diabetic Rats
Kuo FY, Cheng KC, Li Y, Cheng JT, Tsai CC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2269-2277
Published Date: 29 June 2020
Progression to Abnormal Glucose Tolerance and Its Related Risk Factors Among Women with Prior Gestational Diabetes in Rural Communities of China
Mao P, Jiang S, Guo J, Jiang Y, Long Q, Tang Y, Luo J, Wiley J, Vorderstrasse A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2259-2268
Published Date: 29 June 2020
Examination of the Relationship Between Metabolic Syndrome and Obstructive Sleep Apnea in Iranian Patients with Type 2 Diabetes: A Case–Control Study
Sharifpour P, Dehvan F, Dalvand S, Ghanei Gheshlagh R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2251-2257
Published Date: 26 June 2020
Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial
Karamzad N, Faraji E, Adeli S, Carson‐Chahhoud K, Azizi S, Pourghassem Gargari B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2239-2249
Published Date: 26 June 2020
Effects of Breastfeeding and Formula Feeding on the Expression Level of FTO, CPT1A and PPAR-α Genes in Healthy Infants
Cheshmeh S, Nachvak SM, Rezvani N, Saber A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2227-2237
Published Date: 26 June 2020
Low Elevation and Physical Inactivity are Associated with a Higher Prevalence of Metabolic Syndrome in Ecuadorian Adults: A National Cross-Sectional Study
Juna CF, Cho YH, Joung H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2217-2226
Published Date: 25 June 2020
Assessing Prevalence of Hypoglycemia in a Medical Transcription Database
Uzoigwe C, Hamersky CM, Arbit DI, Weng W, Radin MS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2209-2216
Published Date: 24 June 2020
Evaluation of Urinary Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 as Diagnostic Markers for Early Nephropathy in Patients with Type 2 Diabetes Mellitus
Quang TH, Nguyet MP, Thao DP, Thi MH, Phuong Thi Dam L, Thi HH, Van AP, Luong TC, Tuyet MNT, Duy QD, Nhu BD, Duc TN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2199-2207
Published Date: 24 June 2020
Factors Associated with Untreated Depression Among Type 2 Diabetic Patients at Halaba Kulito Hospital, South Ethiopia: A Cross-Sectional Study
Azeze GA, Adema BG, Adella GA, Demissie BW, Obsa MS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2189-2198
Published Date: 24 June 2020
Prevalence of Diabetic Retinopathy and Its Associated Factors among Diabetic Patients at Debre Markos Referral Hospital, Northwest Ethiopia, 2019: Hospital-Based Cross-Sectional Study
Tilahun M, Gobena T, Dereje D, Welde M, Yideg G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2179-2187
Published Date: 24 June 2020
Activation of Nrf2 Signaling by Apelin Attenuates Renal Ischemia Reperfusion Injury in Diabetic Rats
Zhang X, Zhu Y, Zhou Y, Fei B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2169-2177
Published Date: 23 June 2020
Changes in Body Composition and FTO Whole Blood DNA Methylation Among Japanese Women: A Randomized Clinical Trial of Weight-Loss Program
Nishida H, Onishi K, Kurose S, Tsutsumi H, Miyauchi T, Takao N, Yoshiuchi S, Fujii A, Kimura Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2157-2167
Published Date: 23 June 2020
Antioxidative and Hypoglycemic Effect of Ta-ermi Extracts on Streptozotocin-Induced Diabetes
Jing S, Zhao Z, Wu J, Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2147-2155
Published Date: 23 June 2020
A Linear Relationship Between a Body Shape Index and Risk of Incident Type 2 Diabetes: A Secondary Analysis Based on a Retrospective Cohort Study in Japan
Zhao W, Tong JJ, Cao YT, Li JH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2139-2146
Published Date: 22 June 2020
Protective Effect of Benzoquinone Isolated from the Roots of Averrhoa carambola L. on Streptozotocin-Induced Diabetic Mice by Inhibiting the TLR4/NF-κB Signaling Pathway
Qin L, Zhang X, Zhou X, Wu X, Huang X, Chen M, Wu Y, Lu S, Zhang H, Xu X, Wei X, Zhang S, Huang R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2129-2138
Published Date: 22 June 2020
Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
Le TD, Nguyen NTP, Nguyen ST, Tran HTT, Nguyen LTH, Duong HH, Nguyen HM, Do BN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2119-2127
Published Date: 19 June 2020
Metabolic Score for Insulin Resistance Is Correlated to Adipokine Disorder and Inflammatory Activity in Female Knee Osteoarthritis Patients in a Chinese Population
Ding L, Gao YH, Li YR, Huang YF, Wang XY, Qi X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2109-2118
Published Date: 19 June 2020
Metformin and Micronutrient Status in Type 2 Diabetes: Does Polypharmacy Involving Acid-Suppressing Medications Affect Vitamin B12 Levels?
Wakeman M, Archer DT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2093-2108
Published Date: 18 June 2020
Yu Nu Compound Regulates Autophagy and Apoptosis Through mTOR in vivo and vitro
He C, Liu G, Zhuang S, Zhang J, Chen Y, Li H, Huang Z, Zheng Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2081-2092
Published Date: 18 June 2020
Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
Schweighofer N, Genser B, Maerz W, Kleber ME, Trummer O, Pieber TR, Obermayer-Pietsch B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2069-2080
Published Date: 18 June 2020
Prevalence and Determinants of Hyperuricemia in Type 2 Diabetes Mellitus Patients Attending Jimma Medical Center, Southwestern Ethiopia, 2019
Arersa KK, Wondimnew T, Welde M, Husen TM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2059-2067
Published Date: 18 June 2020
Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level [Corrigendum]
Wang X, Fang H, Xu G, Yang Y, Xu R, Liu Q, Xue X, Liu J, Wang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2057-2058
Published Date: 17 June 2020
Adult Obesity and Health-Related Quality of Life, Patient Activation, Work Productivity, and Weight Loss Behaviors in the United States
Rozjabek H, Fastenau J, LaPrade A, Sternbach N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2049-2055
Published Date: 17 June 2020
Alpha1-Antitrypsin in Urinary Extracellular Vesicles: A Potential Biomarker of Diabetic Kidney Disease Prior to Microalbuminuria
Ning J, Xiang Z, Xiong C, Zhou Q, Wang X, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2037-2048
Published Date: 17 June 2020
The Predictive Ability of Two Triglyceride-Associated Indices for Gestational Diabetes Mellitus and Large for Gestational Age Infant Among Chinese Pregnancies: A Preliminary Cohort Study
Liu PJ, Liu Y, Ma L, Yao AM, Chen XY, Hou YX, Wu LP, Xia LY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2025-2035
Published Date: 16 June 2020
Clustering of Elevated Blood Pressure, Elevated Blood Glucose, and Abdominal Obesity Among Adults in Dire Dawa: A Community-Based Cross-Sectional Study
Mengesha MM, Ayele BH, Beyene AS, Roba HS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2013-2024
Published Date: 16 June 2020
The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population
Li M, Zhang X, Zhou X, Han X, Zhang R, Fu Z, Wang L, Gao Y, Li Y, Ji L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:2001-2011
Published Date: 16 June 2020
Is the Obesity Paradox in Type 2 Diabetes Due to Artefacts of Biases? An Analysis of Pooled Cohort Data from the Heinz Nixdorf Recall Study and the Study of Health in Pomerania
Kowall B, Stang A, Erbel R, Moebus S, Petersmann A, Steveling A, Jöckel KH, Völzke H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1989-2000
Published Date: 16 June 2020
Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus
Zhang WS, Li XO, Zhang H, Gao C, Fang L, Yang HY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1979-1988
Published Date: 15 June 2020
Knowledge, Attitude, and Practice Toward Lifestyle Modification Among Diabetes Mellitus Patients Attending the University of Gondar Comprehensive Specialized Hospital Northwest, Ethiopia
Mekonnen CK, Abate HK, Tegegne ET
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1969-1977
Published Date: 12 June 2020
Empagliflozin Protects Against Proximal Renal Tubular Cell Injury Induced by High Glucose via Regulation of Hypoxia-Inducible Factor 1-Alpha
Ndibalema AR, Kabuye D, Wen S, Li L, Li X, Fan Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1953-1967
Published Date: 12 June 2020
Bone Morphogenetic Protein-2 and Osteopontin Gene Expression in Epicardial Adipose Tissue from Patients with Coronary Artery Disease Is Associated with the Presence of Calcified Atherosclerotic Plaques
Luna-Luna M, Criales-Vera S, Medina-Leyte D, Díaz-Zamudio M, Flores-Zapata A, Cruz-Robles D, López-Meneses M, Olvera-Cruz S, Ramírez-Marroquín S, Flores-Castillo C, Fragoso JM, Carreón-Torres E, Vargas-Barrón J, Vargas-Alarcón G, Pérez-Méndez Ó
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1943-1951
Published Date: 11 June 2020
Synergistic Association of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 on the Risk of Abnormal Glucose Regulation
Cheng YC, Li YH, Hsu CY, Lee IT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1933-1942
Published Date: 10 June 2020
The Protective Effects of Cryptochlorogenic Acid on β-Cells Function in Diabetes in vivo and vitro via Inhibition of Ferroptosis
Zhou Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1921-1931
Published Date: 8 June 2020
Association Between Atherosclerosis and Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes Mellitus
Zhang C, Wang S, Li M, Wu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1911-1920
Published Date: 8 June 2020
Optimal Cut-Offs of Body Mass Index and Waist Circumference to Identify Obesity in Chinese Type 2 Diabetic Patients
Zhao Q, Chen X, Wu J, Gong L, Hu J, Yang S, Li Q, Wang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1899-1909
Published Date: 3 June 2020
Association of Overweight, Obesity and Abdominal Obesity with Socioeconomic Status and Educational Level in Colombia
Jimenez-Mora MA, Nieves-Barreto LD, Montaño-Rodríguez A, Betancourt-Villamizar EC, Mendivil CO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1887-1898
Published Date: 3 June 2020
Hydrogen Sulfide, Adipose Tissue and Diabetes Mellitus
Zhu L, Yang B, Ma D, Wang L, Duan W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1873-1886
Published Date: 3 June 2020
Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study
Aliyari R, Hajizadeh E, Aminorroaya A, Sharifi F, Kazemi I, Baghestani AR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1863-1872
Published Date: 28 May 2020
Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
Tafere GG, Wondafrash DZ, Zewdie KA, Assefa BT, Ayza MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1855-1861
Published Date: 28 May 2020
Kukoamine B Ameliorate Insulin Resistance, Oxidative Stress, Inflammation and Other Metabolic Abnormalities in High-Fat/High-Fructose-Fed Rats
Zhao Q, Li L, Zhu Y, Hou D, Li Y, Guo X, Wang Y, Olatunji OJ, Wan P, Gong K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1843-1853
Published Date: 26 May 2020
Factors Related to Severity of Diabetic Foot Ulcer: A Systematic Review
Jalilian M, Ahmadi Sarbarzeh P, Oubari S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1835-1842
Published Date: 25 May 2020
Genetic Association of SH2B1 Gene Polymorphisms in Jordanian Arab Patients with Type 2 Diabetes Mellitus
AL-Eitan LN, Aman H, Alkhatib R, Alghamdi MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1825-1834
Published Date: 22 May 2020
Perioperative Exercise Therapy in Bariatric Surgery: Improving Patient Outcomes
Pouwels S, Sanches EE, Cagiltay E, Severin R, Philips SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1813-1823
Published Date: 25 May 2020
Serum CA125 Level Is Associated with Diabetic Retinopathy in Chinese Patients with Type 2 Diabetes
Yao L, Zhong Y, He L, Wang Y, Wu J, Geng J, Zhou Y, Zhang J, Chen J, Shan Z, Teng W, Xu Y, Chen L, Liu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1803-1812
Published Date: 22 May 2020
Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis
Lin Y, Li J, Wu D, Wang F, Fang Z, Shen G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1793-1801
Published Date: 22 May 2020
Effects of Glycated Hemoglobin Level on Bone Metabolism Biomarkers in Patients with Type 2 Diabetes Mellitus
Zhao H, Qi C, Zheng C, Gan K, Ren L, Song G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1785-1791
Published Date: 22 May 2020
Effects of Adiponectin on T2DM and Glucose Homeostasis: A Mendelian Randomization Study
Chen Z, Bai Y, Long X, Luo Q, Wen Z, Li Y, Huang S, Yan Y, Mo Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1771-1784
Published Date: 22 May 2020
Nomogram for Predicting Risk of Digestive Carcinoma Among Patients with Type 2 Diabetes
Feng LH, Bu KP, Ren S, Yang Z, Li BX, Deng CE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1763-1770
Published Date: 21 May 2020
Glycosylated Hemoglobin A1c Improves the Performance of the Nomogram for Predicting the 5-Year Incidence of Type 2 Diabetes
Ma CM, Yin FZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1753-1762
Published Date: 21 May 2020
Impacts of Pre-Diabetes or Prehypertension on Subsequent Occurrence of Cardiovascular and All-Cause Mortality among Population without Cardiovascular Diseases
Huang Y, Liu L, Huang C, Yu Y, Lo K, Huang J, Chen C, Zhou Y, Feng Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1743-1752
Published Date: 21 May 2020
Profile of Overweight and Obesity in Children and Adolescents and Frequency of Type 2 Diabetes Mellitus and Glucose Intolerance: A Study in Public School in Brazil
Zaccarelli-Marino MA, Fonseca FLA, Gascón TM, Filipini R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1733-1741
Published Date: 21 May 2020
Lipoic Acid Decreases the Expression of Poly ADP-Ribose Polymerase and Inhibits Apoptosis in Diabetic Rats
Chen J, Li Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1725-1731
Published Date: 20 May 2020
The 1α,25(OH)2D3 Analogs ZK159222 and ZK191784 Show Anti-Inflammatory Properties in Macrophage-Induced Preadipocytes via Modulating the NF-κB and MAPK Signaling
Zhu J, Wilding JPH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1715-1724
Published Date: 19 May 2020
Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice
Fu W, Ma Y, Li L, Liu J, Fu L, Guo Y, Zhang Z, Li J, Jiang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1703-1713
Published Date: 19 May 2020
Salivary Amylase Gene Copy Number Is Associated with the Obesity and Inflammatory Markers in Children
Selvaraju V, Venkatapoorna CMK, Babu JR, Geetha T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1695-1701
Published Date: 19 May 2020
The Association of Health Literacy Level with Self-Care Behaviors and Glycemic Control in a Low Education Population with Type 2 Diabetes Mellitus: A Cross-Sectional Study in Iran
Maleki Chollou K, Gaffari-fam S, Babazadeh T, Daemi A, Bahadori A, Heidari S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1685-1693
Published Date: 19 May 2020
Dual Metabolomic Platforms Identified a Novel Urinary Metabolite Signature for Hepatitis B Virus-Infected Patients with Depression
Xie J, Chen C, Hou L, Zhou C, Fang L, Chen J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1677-1683
Published Date: 18 May 2020
Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study
Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Sanada J, Fushimi Y, Mashiko A, Mune T, Kaku K, Kaneto H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1669-1676
Published Date: 15 May 2020
Serum Vitamin D, Sleep Pattern and Cardiometabolic Diseases: Findings from the National Health and Nutrition Examination Survey
Lo K, Huang Y, Liu L, Yu Y, Chen C, Huang J, Feng Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1661-1668
Published Date: 14 May 2020
A Novel Indicator of Children’s Lipid Accumulation Product Associated with Impaired Fasting Glucose in Chinese Children and Adolescents
Yuan Y, Xie H, Sun L, Wang B, Zhang L, Han H, Yao R, Sun Y, Fu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1653-1660
Published Date: 14 May 2020
The Association of Dietary Polyphenol Intake with the Risk of Type 2 Diabetes: Tehran Lipid and Glucose Study
Esfandiar Z, Hosseini-Esfahani F, Mirmiran P, Yuzbashian E, Azizi F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1643-1652
Published Date: 14 May 2020
Dairy Consumption in Relation to Hypertension Among a Large Population of University Students: The MEPHASOUS Study
Mansouri M, Pahlavani N, Sharifi F, Varmaghani M, Shokri A, Yaghubi H, Asbaghi O, Keshtkar A, Tabrizi YM, Sadeghi O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1633-1642
Published Date: 14 May 2020
Hypertension and Its Associated Factors Among Type 2 Diabetes Mellitus Patients at Debre Tabor General Hospital, Northwest Ethiopia
Akalu Y, Belsti Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1621-1631
Published Date: 13 May 2020
Magnitude of Obesity/Overweight and Its Associated Factors Among HIV/AIDS Patients on Antiretroviral Therapy in Jimma Zone Hospitals, SouthWest Ethiopia: Hospital-Based Cross-Sectional Study [Corrigendum]
Yitbarek GY, Engidaw MT, Ayele BA, Tiruneh SA, Alamir MT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1619-1620
Published Date: 13 May 2020
Prevalence of Normal-Weight Obesity in Community-Dwelling Chinese Older Adults: Results from the Beijing Longitudinal Study of Aging
Ji T, Zhang L, Tang Z, Sun F, Li Y, Ma L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1611-1617
Published Date: 12 May 2020
Daily Intake of Kaempferia parviflora Extract Decreases Abdominal Fat in Overweight and Preobese Subjects: A Randomized, Double-Blind, Placebo-Controlled Clinical Study [Corrigendum]
Yoshino S, Awa R, Miyake Y, Fukuhara I, Sato H, Ashino T, Tomita S, Kuwahara H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1609-1610
Published Date: 12 May 2020
Low Vitamin D Serum Level Is Associated with HDL-C Dyslipidemia and Increased Serum Thrombomodulin Levels of Insulin-Resistant Individuals
Saheb Sharif-Askari F, Saheb Sharif-Askari N, Halwani R, Abusnana S, Hamoudi R, Sulaiman N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1599-1607
Published Date: 12 May 2020
Optimal Body Fat Percentage Cut-Off Values in Predicting the Obesity-Related Cardiovascular Risk Factors: A Cross-Sectional Cohort Study
Macek P, Biskup M, Terek-Derszniak M, Stachura M, Krol H, Gozdz S, Zak M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1587-1597
Published Date: 12 May 2020
Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue
Zhao J, Wu Y, Rong X, Zheng C, Guo J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1575-1585
Published Date: 11 May 2020
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
Guarnotta V, Prinzi A, Pitrone M, Pizzolanti G, Giordano C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1565-1574
Published Date: 11 May 2020
Vitamin D Status and Correlation with Glucose and Lipid Metabolism in Gansu Province, China
Yang K, Liu J, Fu S, Tang X, Ma L, Sun W, Niu Y, Jing G, Niu Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1555-1563
Published Date: 7 May 2020
Increased Energy Expenditure and Energy Loss Through Feces Contribute to the Long-Term Outcome of Roux-en-Y Gastric Bypass in a Diet-Induced Obese Mouse Model
Chen K, Xiao B, Zhou Z, Peng W, Liu W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1545-1553
Published Date: 6 May 2020
Familial Partial Lipodystrophy (FPLD): Recent Insights
Bagias C, Xiarchou A, Bargiota A, Tigas S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1531-1544
Published Date: 6 May 2020
Relationship Between the Consumption of Milk-Based Oils Including Butter and Kermanshah Ghee with Metabolic Syndrome: Ravansar Non-Communicable Disease Cohort Study
Ahmadi E, Abdollahzad H, Pasdar Y, Rezaeian S, Moludi J, Nachvak SM, Mostafai R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1519-1530
Published Date: 5 May 2020
Prevalence and Associated Factors of Anxiety and Depression Among Patients with Type 2 Diabetes in Kerman, Southern Iran
Dehesh T, Dehesh P, Shojaei S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1509-1517
Published Date: 5 May 2020
Associations Between Gestational Diabetes Mellitus Risk and Folate Status in Early Pregnancy and MTHFR C677T Polymorphisms in Chinese Women
Liu PJ, Liu Y, Ma L, Yao AM, Chen XY, Hou YX, Wu LP, Xia LY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1499-1507
Published Date: 5 May 2020
Increase in Tryptase and Its Role in the Synovial Membrane of Overweight and Obese Patients with Osteoarthritis of the Knee
Takata K, Uchida K, Mukai M, Takano S, Aikawa J, Iwase D, Sekiguchi H, Miyagi M, Inoue G, Takaso M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1491-1497
Published Date: 5 May 2020
Evaluation of Antidiabetic Effect of Ethanolic Leaves Extract of Becium grandiflorum Lam. (Lamiaceae) in Streptozotocin-Induced Diabetic Mice
Gebremeskel L, Beshir Tuem K, Teklu T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1481-1489
Published Date: 4 May 2020
Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats
Omran Z, Sheikh R, Baothman OA, Zamzami MA, Alarjah M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1473-1480
Published Date: 4 May 2020
Association Between Weekend Catch-Up Sleep and Metabolic Syndrome with Sleep Restriction in Korean Adults: A Cross-Sectional Study Using KNHANES
Son SM, Park EJ, Cho YH, Lee SY, Choi JI, Lee YI, Kim YJ, Lee JG, Yi YH, Tak YJ, Hwang HR, Lee SH, Kwon RJ, Kim C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1465-1471
Published Date: 1 May 2020
Changes in Serum Nesfatin-1 After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Nonalcoholic Fatty Liver Disease
Yang K, Zhang X, Zhou Y, Chen F, Shen M, Wang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1459-1464
Published Date: 1 May 2020
Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study
Sepehrimanesh M, Niknam R, Ejtehadi F, Fattahi MR, Safarpour A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1449-1458
Published Date: 1 May 2020
Characteristics of Gastric Microbiota in GK Rats with Spontaneous Diabetes: A Comparative Study
Kang X, Zhan L, Lu X, Song J, Zhong Y, Wang Y, Yang Y, Fan Z, Jiang X, Sun R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1435-1447
Published Date: 30 April 2020
Advances with Long Non-Coding RNAs in Diabetic Peripheral Neuropathy
Wu M, Feng Y, Shi X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1429-1434
Published Date: 30 April 2020
Swimming Differentially Affects T2DM-Induced Skeletal Muscle ER Stress and Mitochondrial Dysfunction Related to MAM
Zhang Z, Cui D, Zhang T, Sun Y, Ding S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1417-1428
Published Date: 30 April 2020
Sennoside A Induces GLP-1 Secretion Through Activation of the ERK1/2 Pathway in L-Cells
Ma L, Cao X, Ye X, Ye J, Sun Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1407-1415
Published Date: 29 April 2020
The Role of JNk Signaling Pathway in Obesity-Driven Insulin Resistance
Feng J, Lu S, Ou B, Liu Q, Dai J, Ji C, Zhou H, Huang H, Ma Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1399-1406
Published Date: 29 April 2020
The Relationship of Serum 25-Hydroxyvitamin-D Level with Severity of Obstructive Sleep Apnea in Patients with Type 2 Diabetes Mellitus
Ma D, Zheng X, Dong L, Zheng C, Chen Y, Chen Z, Lin M, Li X, Li Z, Liu C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1391-1398
Published Date: 28 April 2020
Effects of Two Types of Moderate- and High-Intensity Interval Training on Serum Salusin-α and Salusin-β Levels and Lipid Profile in Women with Overweight/Obesity
Nazari M, Minasian V, Hovsepian S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1385-1390
Published Date: 24 April 2020
Progressive Loss of Corneal Nerve Fibers and Sensitivity in Rats Modeling Obesity and Type 2 Diabetes Is Reversible with Omega-3 Fatty Acid Intervention: Supporting Cornea Analyses as a Marker for Peripheral Neuropathy and Treatment
Coppey L, Davidson E, Shevalye H, Obrosov A, Torres M, Yorek MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1367-1384
Published Date: 24 April 2020
High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy
Yu ZW, Liu R, Li X, Wang Y, Fu YH, Li HY, Yuan Y, Gao XY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1359-1365
Published Date: 24 April 2020
Detrimental Effect of C-Reactive Protein on the Cardiometabolic Cells and Its Rectifying by Metabolic Surgery in Obese Diabetic Patients
Sun F, Zhao Z, Li Q, Zhou X, Li Y, Zhang H, Yan Z, He H, Ke Z, Gao Y, Li F, Tong W, Zhu Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1349-1358
Published Date: 24 April 2020
Gestational Diabetes: Exploring the Perceptions, Practices and Barriers of the Community and Healthcare Providers in Rural Bangladesh: A Qualitative Study
Biswas A, Dalal K, Abdullah ASM, Rahman AKMF, Halim A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1339-1348
Published Date: 23 April 2020
Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China
Cai X, Zhang F, Lin C, Zhang X, Wang Z, Xing H, Nie L, Han X, Ji L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1327-1338
Published Date: 23 April 2020
Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome
Albai O, Frandes M, Timar B, Paun DL, Roman D, Timar R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1317-1326
Published Date: 23 April 2020
Association Between Blood Glucose Within 24 Hours After Intensive Care Unit Admission and Prognosis: A Retrospective Cohort Study
Li L, Chen Q, Chen Q, Wu R, Wang S, Yao C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1305-1315
Published Date: 23 April 2020
Obesity Indices for Identifying Metabolic Syndrome Among Type Two Diabetes Patients Attending Their Follow-Up in Dessie Referral Hospital, North east Ethiopia
Zerga AA, Bezabih AM, Adhanu AK, Tadesse SE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1297-1304
Published Date: 23 April 2020
Association Between Metabolic Syndrome and Its Components with Severity of Acute Pancreatitis
Niknam R, Moradi J, Jahanshahi KA, Mahmoudi L, Ejtehadi F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1289-1296
Published Date: 23 April 2020
Calcium and Phosphate Levels are Among Other Factors Associated with Metabolic Syndrome in Patients with Normal Weight
Osadnik K, Osadnik T, Delijewski M, Lejawa M, Fronczek M, Reguła R, Gąsior M, Pawlas N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1281-1288
Published Date: 22 April 2020
Plantar Fasciitis in Diabetic Foot Patients: Risk Factors, Pathophysiology, Diagnosis, and Management
Gariani K, Waibel FWA, Viehöfer AF, Uçkay I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1271-1279
Published Date: 22 April 2020
miRNA-221-3p in Endothelial Progenitor Cell-Derived Exosomes Accelerates Skin Wound Healing in Diabetic Mice
Xu J, Bai S, Cao Y, Liu L, Fang Y, Du J, Luo L, Chen M, Shen B, Zhang Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1259-1270
Published Date: 22 April 2020
Magnitude of Obesity/Overweight and Its Associated Factors Among HIV/AIDS Patients on Antiretroviral Therapy in Jimma Zone Hospitals, South West Ethiopia: Hospital-Based Cross-Sectional Study
Yitbarek GY, Engidaw MT, Ayele BA, Tiruneh SA, Alamir MT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1251-1258
Published Date: 21 April 2020
Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
He X, Ma H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1243-1250
Published Date: 22 April 2020
Acute Complications of Diabetes and its Predictors among Adult Diabetic Patients at Jimma Medical Center, Southwest Ethiopia
Negera GZ, Weldegebriel B, Fekadu G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1237-1242
Published Date: 20 April 2020
Antihyperlipidemic and Antioxidative Properties of Pistacia atlantica subsp. kurdica in Streptozotocin-Induced Diabetic Mice
Hosseini S, Nili-Ahmadabadi A, Nachvak SM, Dastan D, Moradi S, Abdollahzad H, Mostafai R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1231-1236
Published Date: 20 April 2020
Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study
Shi R, Niu Z, Wu B, Zhang T, Cai D, Sun H, Hu Y, Mo R, Hu F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1215-1229
Published Date: 20 April 2020
Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients
Lee YJ, Wang CP, Hung WC, Tang WH, Chang YH, Hu DW, Lu YC, Yu TH, Wu CC, Chung FM, Hsu CC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1203-1214
Published Date: 17 April 2020
The Long Noncoding RNA Blnc1 Protects Against Diet-Induced Obesity by Promoting Mitochondrial Function in White Fat
Tang S, Zhu W, Zheng F, Gui W, Zhang W, Lin X, Li H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1189-1201
Published Date: 17 April 2020
BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease
Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Mohammadi Torbati P, Nazaran MH, Basiri A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1179-1188
Published Date: 17 April 2020
Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes
Hu X, Yang L, Yu W, Pan W, Chen X, Li Q, Zhou J, Gu X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1171-1178
Published Date: 16 April 2020
Prevalence of Metabolic Syndrome and Its Association with Sociodemographic Characteristics in Participants of a Public Chronic Disease Control Program in Medellin, Colombia, in 2018
Higuita-Gutiérrez LF, Martínez Quiroz WJ, Cardona-Arias JA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1161-1169
Published Date: 16 April 2020
microRNA Expression Profiles in Myocardium of High-Fat Diet-Induced Obesity Rat
Yang H, Xin X, Yu H, Bao Y, Jia P, Wu N, Jia D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1147-1159
Published Date: 15 April 2020
Glucocorticoid-Induced Fatty Liver Disease
Rahimi L, Rajpal A, Ismail-Beigi F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1133-1145
Published Date: 16 April 2020
Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges
Chevinsky JD, Wadden TA, Chao AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1117-1131
Published Date: 14 April 2020
Effect of Rubus anatolicus Leaf Extract on Glucose Metabolism in HepG2, CRI-D2 and C2C12 Cell Lines
Safarzad M, Marjani A, Saghaeian Jazi M, Qujeq D, Mir SM, Marjani M, Nezhadebrahimi Kaldehi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1109-1116
Published Date: 14 April 2020
Effects of Hydroxysafflor Yellow A on the PI3K/AKT Pathway and Apoptosis of Pancreatic β-Cells in Type 2 Diabetes Mellitus Rats
Lee M, Li H, Zhao H, Suo M, Liu D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1097-1107
Published Date: 9 April 2020
Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
YimamAhmed M, Hambisa Ejigu S, Zewudie Zeleke A, Yimam Hassen M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1089-1095
Published Date: 9 April 2020
The Effect of Visceral Abdominal Fat Volume on Oxidative Stress and Proinflammatory Cytokines in Subjects with Normal Weight, Overweight and Obesity
García-Sánchez A, Gámez-Nava JI, Díaz-de la Cruz EN, Cardona-Muñoz EG, Becerra-Alvarado IN, Aceves-Aceves JA, Sánchez-Rodríguez EN, Miranda-Díaz AG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1077-1087
Published Date: 8 April 2020
Resveratrol Prevents Cognitive Impairment in Type 2 Diabetic Mice by Upregulating Nrf2 Expression and Transcriptional Level
Wang X, Fang H, Xu G, Yang Y, Xu R, Liu Q, Xue X, Liu J, Wang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1061-1075
Published Date: 7 April 2020
Body Composition and the Components of Metabolic Syndrome in Type 2 Diabetes: The Roles of Disease Duration and Glycemic Control
Abulmeaty MMA, Aljuraiban GS, Alaidarous TA, Alkahtani NM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1051-1059
Published Date: 5 April 2020
Classification Accuracy of Body Mass Index for Excessive Body Fatness in Kuwaiti Adolescent Girls and Young Adult Women
Al Hammadi H, Reilly JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1043-1049
Published Date: 5 April 2020
Self-Monitoring of Blood Glucose and Hypoglycemia Association During Fasting in Ramadan Among Patients with Diabetes
Mansouri D, Khayat E, Khayat M, Aboawja M, Aseeri A, Banah F, Alsiary K, Rammal LA, Almalki AD, Hasaballah M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1035-1041
Published Date: 5 April 2020
Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
Kalirai S, Ivanova JI, Perez-Nieves M, Stephenson JJ, Hadjiyianni I, Grabner M, Pollom RD, Geremakis C, Reed BL, Fisher L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1023-1033
Published Date: 3 April 2020
TLR4 Polymorphisms (896A>G and 1196C>T) Affect the Predisposition to Diabetic Nephropathy in Type 2 Diabetes Mellitus
Khaghanzadeh N, Naderi N, Pournasrollah N, Farahbakhsh E, Kheirandish M, Samiei A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1015-1021
Published Date: 3 April 2020
Egr1 Knockdown Combined with an ACE Inhibitor Ameliorates Diabetic Kidney Disease in Mice: Blockade of Compensatory Renin Increase
Hu F, Xue R, Wei X, Wang Z, Luo S, Lin J, Yan Z, Sun L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1005-1013
Published Date: 1 April 2020
Evaluation of Hypoglycemic Therapy Through Physical Exercise in n5STZ-Induced Diabetes Rats
Ribeiro JKC, Nascimento TV, Agostinho AG, Freitas RM, Santos LHP, Machado LMQ, Leal-Cardoso JH, Moreira-Gomes MD, Ceccatto VM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:991-1004
Published Date: 1 April 2020
Low-Magnitude High-Frequency Vibration Decreases Body Weight Gain and Increases Muscle Strength by Enhancing the p38 and AMPK Pathways in db/db Mice
Ren Z, Lan Q, Chen Y, Chan YWJ, Mahady GB, Lee SMY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:979-989
Published Date: 1 April 2020
Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description
Cappellani D, Macchia E, Falorni A, Marchetti P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:963-978
Published Date: 1 April 2020
Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications
Gong M, Wen S, Nguyen T, Wang C, Jin J, Zhou L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:943-962
Published Date: 30 March 2020
Association of Dyslipidemia and Comorbidities with Risk Factors Among Diabetic Patients: A Retrospective Analysis
Gazzaz ZJ, Iftikhar R, Jameel T, Baig M, Murad MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:935-941
Published Date: 30 March 2020
Leptin Levels are Associated with Subclinical Cardiac Dysfunction in Obese Adolescents
Imerbtham T, Thitiwuthikiat P, Jongjitwimol J, Nuamchit T, Yingchoncharoen T, Siriwittayawan D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:925-933
Published Date: 27 March 2020
Associations Between Thyroid Hormones and Glycated Albumin in Euthyroid and Subclinical Hypothyroid Individuals: Results of an Observational Study
Nie X, Shen Y, Ma X, Xu Y, Wang Y, Zhou J, Bao Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:915-923
Published Date: 25 March 2020
Influence of Diabetic Retinopathy on the Relationship Between Body Mass Index and Mortality in Patients with Poorly Controlled Type 2 Diabetes
Li YH, Sheu WHH, Lee IT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:907-914
Published Date: 24 March 2020
SLC30A8, CDKAL1, TCF7L2, KCNQ1 and IGF2BP2 are Associated with Type 2 Diabetes Mellitus in Iranian Patients
Vatankhah Yazdi K, Kalantar SM, Houshmand M, Rahmanian M, Manaviat MR, Jahani MR, Kamalidehghan B, Almasi-Hashiani A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:897-906
Published Date: 24 March 2020
The Effects of 24-Week, High-Concentration Hydrogen-Rich Water on Body Composition, Blood Lipid Profiles and Inflammation Biomarkers in Men and Women with Metabolic Syndrome: A Randomized Controlled Trial
LeBaron TW, Singh RB, Fatima G, Kartikey K, Sharma JP, Ostojic SM, Gvozdjakova A, Kura B, Noda M, Mojto V, Niaz MA, Slezak J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:889-896
Published Date: 24 March 2020
Predicting Metabolic Syndrome by Visceral Adiposity Index, Body Roundness Index and a Body Shape Index in Adults: A Cross-Sectional Study from the Iranian RaNCD Cohort Data
Baveicy K, Mostafaei S, Darbandi M, Hamzeh B, Najafi F, Pasdar Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:879-887
Published Date: 24 March 2020
Incidence and Predictors of Tuberculosis among Adult Diabetic Patients, Debre Markos Referral Hospital, Northwest Ethiopia, 2018: A Retrospective Cohort Study
Gedfew M, Ayana M, Abate A, Bewket B, Haile D, Edmealem A, Andualem A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:869-878
Published Date: 23 March 2020
Urban-Rural Differences in the Trends of Type 1 and Type 2 Diabetes Among Adults Who Received Medical Treatment from Public Hospitals in Resource-Poor Community Tigray, Ethiopia
Gebremedhin G, Enqueselassie F, Deyessa N, Yifter H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:859-868
Published Date: 23 March 2020
Relationship of Two-Hour Plasma Glucose and Abdominal Visceral Fat with Bone Mineral Density and Bone Mineral Content in Women with Different Glucose Metabolism Status
Jia X, Liu L, Wang R, Liu X, Liu B, Ma N, Lu Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:851-858
Published Date: 20 March 2020
Phocea, Pseudoflavonifractor and Lactobacillus intestinalis: Three Potential Biomarkers of Gut Microbiota That Affect Progression and Complications of Obesity-Induced Type 2 Diabetes Mellitus
Wang Y, Ouyang M, Gao X, Wang S, Fu C, Zeng J, He X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:835-850
Published Date: 19 March 2020
The Impact of BMI Categories on Metabolic Abnormality Development in Chinese Adults Who are Metabolically Healthy: A 7-Year Prospective Study
Liu X, Zhang J, Wu J, Xu X, Tao L, Sun Y, Chen S, Han Y, Luo Y, Yang X, Guo X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:819-834
Published Date: 19 March 2020
Polymorphisms of the NLRC4 Gene are Associated with the Onset Age, Positive Rate of GADA and 2-h Postprandial C-Peptide in Patients with Type 1 Diabetes
Xu L, Sun X, Xia Y, Luo S, Lin J, Xiao Y, Liu Y, Wang Y, Huang G, Li X, Xie Z, Zhou Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:811-818
Published Date: 19 March 2020
The Exercise Training Modulatory Effects on the Obesity-Induced Immunometabolic Dysfunctions
Soltani N, Marandi SM, Kazemi M, Esmaeil N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:785-810
Published Date: 19 March 2020
Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study
Longo M, Scappaticcio L, Bellastella G, Pernice V, Cirillo P, Maio A, Castaldo F, Giugliano D, Esposito K, Maiorino MI
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:777-784
Published Date: 18 March 2020
The Effect of A1 Adenosine Receptor in Diabetic Megalin Loss with Caspase-1/IL18 Signaling [Corrigendum]
Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:775-776
Published Date: 18 March 2020
Comparison of Lipid Profile, Liver Enzymes, Creatine Kinase and Lactate Dehydrogenase Among Type II Diabetes Mellitus Patients on Statin Therapy
Habte ML, Melka DS, Degef M, Menon MKC, Yifter H, Feyisa TO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:763-773
Published Date: 18 March 2020
Antioxidant and Anti-Inflammatory Properties of Melatonin in Patients with Type 2 Diabetes Mellitus with Periodontal Disease Under Non-Surgical Periodontal Therapy: A Double-Blind, Placebo-Controlled Trial
Zare Javid A, Hosseini SA, Gholinezhad H, Moradi L, Haghighi-zadeh MH, Bazyar H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:753-761
Published Date: 18 March 2020
Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
David-Silva A, Esteves JV, Morais MRPT, Freitas HS, Zorn TM, Correa-Giannella ML, Machado UF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:739-751
Published Date: 17 March 2020
Using Skin Bioengineering to Highlight How Weight and Diabetes Mellitus Modify the Skin in the Lower Limbs of Super-Obese Patients
Iacopi E, Riitano N, Dini V, Berta R, Pieruzzi L, Janowska A, Anselmino M, Piaggesi A, Romanelli M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:729-738
Published Date: 16 March 2020
Effects of Topical Insulin on Wound Healing: A Review of Animal and Human Evidences
Wang J, Xu J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:719-727
Published Date: 13 March 2020
Guava Leaf Extract Attenuates Insulin Resistance via the PI3K/Akt Signaling Pathway in a Type 2 Diabetic Mouse Model
Yang Q, Wen YM, Shen J, Chen MM, Wen JH, Li ZM, Liang YZ, Xia N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:713-718
Published Date: 13 March 2020
Catalpol Promotes the Proliferation and Differentiation of Osteoblasts Induced by High Glucose by Inhibiting KDM7A
Cheng J, Xu H, Liu M, Cai J, Wang L, Hua Z, Wu X, Huo W, Lv N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:705-712
Published Date: 13 March 2020
Evaluation of Factors Affecting the Severity of Diabetic Foot Ulcer in Patients with Diabetes Referred to a Diabetes Centre in Kermanshah
Ghobadi A, Ahmadi Sarbarzeh P, Jalilian M, Abdi A, Manouchehri S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:693-703
Published Date: 13 March 2020
Deep Learning-Based Method of Diagnosing Hyperlipidemia and Providing Diagnostic Markers Automatically
Liu Y, Zhang Q, Zhao G, Liu G, Liu Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:679-691
Published Date: 11 March 2020
Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
Nader ND, Hamishehkar H, Naghizadeh A, Shadvar K, Iranpour A, Sanaie S, Chang F, Mahmoodpoor A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:671-678
Published Date: 10 March 2020
Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China
Wang X, Chen H, Shao X, Xiong C, Hong G, Chen J, Li X, You X, Gao P, Chen Y, Zou Z, Ning J, Xiao H, Zou H, Wei L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:663-670
Published Date: 4 March 2020
An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia
Derosa G, D'Angelo A, Vanelli A, Maffioli P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:653-661
Published Date: 3 March 2020
Curcumin Inhibited Podocyte Cell Apoptosis and Accelerated Cell Autophagy in Diabetic Nephropathy via Regulating Beclin1/UVRAG/Bcl2
Zhang P, Fang J, Zhang J, Ding S, Gan D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:641-652
Published Date: 3 March 2020
Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3
Hu M, Huang X, Han X, Ji L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:627-639
Published Date: 2 March 2020
Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study
Abo-Amer YEE, Sabal A, Ahmed R, Hasan NFE, Refaie R, Mostafa SM, Mohamed AA, Khalil M, Elagawy W, Abd-Elsalam S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:619-625
Published Date: 2 March 2020
The Effects of Synbiotic Supplementation on Glycemic Status, Lipid Profile, and Biomarkers of Oxidative Stress in Type 1 Diabetic Patients. A Placebo-Controlled, Double-Blind, Randomized Clinical Trial
Zare Javid A, Aminzadeh M, Haghighi-zadeh MH, Jamalvandi M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:607-617
Published Date: 2 March 2020
Comparison of the Value of Neutrophil to High-Density Lipoprotein Cholesterol Ratio and Lymphocyte to High-Density Lipoprotein Cholesterol Ratio for Predicting Metabolic Syndrome Among a Population in the Southern Coast of China
Chen T, Chen H, Xiao H, Tang H, Xiang Z, Wang X, Wang X, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:597-605
Published Date: 28 February 2020
Lower Levels of Circulating Adiponectin in Elderly Patients with Metabolic Inflammatory Syndrome: A Cross-Sectional Study
Ma L, Xu Y, Zhang Y, Ji T, Li Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:591-596
Published Date: 28 February 2020
High-Sensitivity C-Reactive Protein Leads to Increased Incident Metabolic Syndrome in Women but Not in Men: A Five-Year Follow-Up Study in a Chinese Population
Hong G, Gao P, Chen Y, Xia Y, Ke X, Shao X, Xiong C, Chen H, Xiao H, Ning J, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:581-590
Published Date: 28 February 2020
Prevalence and Associated Factors of Metabolic Syndrome Among Patients with Severe Mental Illness at Hawassa, Southern-Ethiopia
Teshome T, Kassa DH, Hirigo AT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:569-579
Published Date: 27 February 2020
Chaperone-Based Therapeutic Target Innovation: Heat Shock Protein 70 (HSP70) for Type 2 Diabetes Mellitus
Mulyani WRW, Sanjiwani MID, Sandra, Prabawa IPY, Lestari AAW, Wihandani DM, Suastika K, Saraswati MR, Bhargah A, Manuaba IBAP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:559-568
Published Date: 27 February 2020
High Glucose Downregulates Connexin 43 Expression and Its Gap Junction and Hemichannel Function in Osteocyte-like MLO-Y4 Cells Through Activation of the p38MAPK/ERK Signal Pathway
Yang L, Zhou G, Li M, Li Y, Yang L, Fu Q, Tian Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:545-557
Published Date: 26 February 2020
Protein Arginine Methyltransferase 4 Regulates Adipose Tissue Lipolysis in Type 1 Diabetic Mice
Li Y, Peng M, Zeng T, Zheng J, Liao Y, Zhang H, Yang S, Chen L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:535-544
Published Date: 26 February 2020
The Effect of Potato Protease Inhibitor II on Gastrointestinal Hormones and Satiety in Humans During Weight Reduction
Flechtner-Mors M, Thoma U, Wittmann R, Boehm BO, Mors M, Steinacker JM, Schumann U
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:521-534
Published Date: 26 February 2020
Geniposide Balances the Redox Signaling to Mediate Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells
Liu C, Hao Y, Yin F, Liu J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:509-520
Published Date: 25 February 2020
Prevalence of Diabetes Mellitus and Associated Factors in Addis Ababa Public Health Facilities, Addis Ababa, Ethiopia, 2016
Sahile AT, Bekele GE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:501-508
Published Date: 25 February 2020
PEARLS Randomized Lifestyle Trial in Pregnant Hispanic Women with Overweight/Obesity: Gestational Weight Gain and Offspring Birthweight [Corrigendum]
Trak-Fellermeier MA, Campos M, Meléndez M, Pomeroy J, Palacios C, Rivera-Viñas J, Méndez K, Febo I, Willett W, Gillman MW, Franks PW, Joshipura K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:499-500
Published Date: 25 February 2020
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes
Manzoni G, Oltolini A, Perra S, Muraca E, Ciardullo S, Pizzi M, Castoldi G, Lattuada G, Pizzi P, Perseghin G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:489-497
Published Date: 24 February 2020
The Relationship Between the Dietary Inflammatory Index and Metabolic Syndrome in Ravansar Cohort Study
Abdollahzad H, Pasdar Y, Nachvak SM, Rezaeian S, Saber A, Nazari R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:477-487
Published Date: 21 February 2020
Identification of Key Genes Involved in Diabetic Peripheral Neuropathy Progression and Associated with Pancreatic Cancer
Jian L, Yang G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:463-476
Published Date: 19 February 2020
Evaluation of Postural Stability and Transverse Abdominal Muscle Activity in Overweight Post-Stroke Patients: A Prospective, Observational Study
Kołcz A, Urbacka-Josek J, Kowal M, Dymarek R, Paprocka-Borowicz M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:451-462
Published Date: 19 February 2020
Guidelines and Considerations for Metabolic Tolerance Tests in Mice
Benedé-Ubieto R, Estévez-Vázquez O, Ramadori P, Cubero FJ, Nevzorova YA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:439-450
Published Date: 18 February 2020
Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data
Chudleigh RA, Platts J, Bain SC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:433-438
Published Date: 18 February 2020
Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
Thongtang N, Piyapromdee J, Tangkittikasem N, Samaithongcharoen K, Srikanchanawat N, Sriussadaporn S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:423-431
Published Date: 19 February 2020
Long Non-Coding RNAs Regulate Inflammation in Diabetic Peripheral Neuropathy by Acting as ceRNAs Targeting miR-146a-5p
Feng Y, Ge Y, Wu M, Xie Y, Wang M, Chen Y, Shi X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:413-422
Published Date: 18 February 2020
Analysing the Clinical Features of Pneumomediastinum Associated with Diabetic Ketoacidosis in 79 Cases
Zhang W, Chen J, Wu X, Chen L, Wei J, Xue M, Liang Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:405-412
Published Date: 17 February 2020
Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt Pathway to Improve Insulin Resistance Induced by a High-Fat Diet in Mice
Shu L, Zhao H, Huang W, Hou G, Song G, Ma H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:391-403
Published Date: 14 February 2020
Positional Vertigo and Unilateral Gradual Hearing Loss Following Sleeve Gastrectomy: A Case Report
Tabasi M, Javadinia SA, Siadat SD, Eybpoosh S, Yazdannasab MR, Kheirvari M, Elyasinia F, Bayanolhagh S, Radmanesh A, Soroush A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:387-390
Published Date: 14 February 2020
Correlation Between Diabetic Peripheral Neuropathy and Sarcopenia in Patients with Type 2 Diabetes Mellitus and Diabetic Foot Disease: A Cross-Sectional Study
Yang Q, Zhang Y, Zeng Q, Yang C, Shi J, Zhang C, Ni X, Du Z, Tang Z, Hu J, Li X, Cai J, Li Q, Cheng Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:377-386
Published Date: 13 February 2020
Silencing of KCNQ1OT1 Decreases Oxidative Stress and Pyroptosis of Renal Tubular Epithelial Cells
Zhu B, Cheng X, Jiang Y, Cheng M, Chen L, Bao J, Tang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:365-375
Published Date: 13 February 2020
Recent Advances in Neonatal Diabetes
Dahl A, Kumar S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:355-364
Published Date: 12 February 2020
Epidemiology of General, Central Obesity and Associated Cardio-Metabolic Risks Among University Employees, Ethiopia: A Cross-Sectional Study
Janakiraman B, Abebe SM, Chala MB, Demissie SF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:343-353
Published Date: 12 February 2020
A Pilot Study Assessing the Possible Combined Effect of Physical Activity and PNPLA3 rs738409 Polymorphism on the Risk for Non-Alcoholic Fatty Liver Disease in the Japanese Elderly General Population
Muto N, Oniki K, Kudo M, Obata Y, Sakamoto Y, Tokumaru N, Izuka T, Watanabe T, Otake K, Ogata Y, Saruwatari J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:333-341
Published Date: 12 February 2020
Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer
Sauriasari R, Sekar AP, Aisyah N, Syahdi RR, Matsuura E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:325-331
Published Date: 11 February 2020
Caspase-3 Promotes Diabetic Kidney Disease Through Gasdermin E-Mediated Progression to Secondary Necrosis During Apoptosis
Wen S, Wang ZH, Zhang CX, Yang Y, Fan QL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:313-323
Published Date: 10 February 2020
Khat Chewing and Type 2 Diabetes Mellitus
Badedi M, Darraj H, Hummadi A, Najmi A, Solan Y, Zakry I, Khawaji A, Zaylai S, Rajeh N, Alhafaf H, Hakami W, Bakkari A, Kriry M, Dagreri A, Haddad E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:307-312
Published Date: 10 February 2020
Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH
Hegazy M, Saleh SA, Ezzat A, Behiry ME
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:297-305
Published Date: 10 February 2020
Association Between Cognitive Impairment and Blood Pressure Among Patients with Type II Diabetes Mellitus in Southern Iran
Jamalnia S, Javanmardifard S, Akbari H, Sadeghi E, Bijani M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:289-296
Published Date: 5 February 2020
Waist–Calf Circumference Ratio Is an Independent Risk Factor of HRQoL in Centenarians
Yang S, Liu M, Wang S, Jia W, Han K, He Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:277-287
Published Date: 4 February 2020
Influences of Resistance versus Aerobic Exercise on Physiological and Physical Fitness Changes in Previously Inactive Men with Obesity: A Prospective, Single-Blinded Randomized Controlled Trial
Kim B, Kim S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:267-276
Published Date: 4 February 2020
Visceral Adiposity Index and Chronic Kidney Disease in a Non-Diabetic Population: A Cross-Sectional Study
Xiao H, Xiong C, Shao X, Gao P, Chen H, Ning J, Chen Y, Zou Z, Hong G, Li X, You X, Sheng J, Wu F, Wang X, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:257-265
Published Date: 4 February 2020
Endothelial Function in Obese Patients Treated with Bariatric Surgery
Borzì AM, Buscemi C, Corleo D, Randazzo C, Rosafio G, Pantuso G, Buscemi S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:247-256
Published Date: 4 February 2020
Determinants of Diabetic Complication Among Adult Diabetic Patients in Debre Markos Referral Hospital, Northwest Ethiopia, 2018: Unmatched Case Control Study
Kidanie BB, Alem G, Zeleke H, Gedfew M, Edemealem A, Andualem A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:237-245
Published Date: 4 February 2020
Detection of C-Peptide in Scalp Hair of Healthy Adults
Abdulateef DS, Salih JM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:227-236
Published Date: 3 February 2020
The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:215-225
Published Date: 30 January 2020
Relationship Between Self-Care Behavior and Cognitive Function in Hospitalized Adult Patients with Type 2 Diabetes: A Cross-Sectional Study
Yang J, Zhang Z, Zhang L, Su Y, Sun Y, Wang Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:207-214
Published Date: 29 January 2020
Effects of a Milk-Based Meal Replacement Program on Weight and Metabolic Characteristics in Adults with Severe Obesity
Rafey MF, Murphy CF, Abdalgwad R, Kilkelly K, Griffin H, Beatty N, O'Shea PM, Collins C, McGrath R, Hynes M, Davenport C, O'Donnell M, Finucane FM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:197-205
Published Date: 23 January 2020
DHA Protects Against Hepatic Steatosis by Activating Sirt1 in a High Fat Diet-Induced Nonalcoholic Fatty Liver Disease Mouse Model
Luo X, He Z, Sun X, Gu X, Zhang W, Gao J, Li X, Jia R, Wei J, Yu Y, Luo X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:185-196
Published Date: 22 January 2020
Adiposity Indicators as Cardio-Metabolic Risk Predictors in Adults from Country with High Burden of Obesity
Kerkadi A, Suleman D, Abu Salah L, Lotfy C, Attieh G, Bawadi H, Shi Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:175-183
Published Date: 21 January 2020
Extraglycemic Effects of SGLT2 Inhibitors: A Review of the Evidence
Bonora BM, Avogaro A, Fadini GP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:161-174
Published Date: 21 January 2020
Knowledge, Attitude and Practice Regarding Ramadan Fasting and Related Determinants in Patients with Type 2 Diabetes at a Saudi Diabetes Clinic
Alsunni AA, Albaker WI, Almansour AH, Alenazi AS, Alaftan MS, Badar A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:151-159
Published Date: 21 January 2020
Systemic Inflammation Mediates the Associations Between Abdominal Obesity Indices and Lung Function Decline in a Chinese General Population
He H, Wang B, Zhou M, Cao L, Qiu W, Mu G, Chen A, Yang S, Chen W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:141-150
Published Date: 20 January 2020
Branched Chain Amino Acids Protects Rat Mesangial Cells from High Glucose by Modulating TGF-β1 and BMP-7 [Corrigendum]
Zhang X, Liu D, He Y, Lou K, Zheng D, Han W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:139-140
Published Date: 17 January 2020
Effectiveness of Diabetes Self-Management Educational Programs For Type 2 Diabetes Mellitus Patients In Middle East Countries: A Systematic Review
Mikhael EM, Hassali MA, Hussain SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:117-138
Published Date: 13 January 2020
Early Left Ventricular Systolic Dysfunction Detected by Two-Dimensional Speckle-Tracking Echocardiography in Young Patients with Congenital Generalized Lipodystrophy
Liberato CBR, Olegario NBC, Fernandes VO, Montenegro APDR, Lima GECP, Batista LAA, Martins LV, Penaforte-Saboia JG, Liberato ILR, Lopes LF, d'Alva CB, Furtado FLB, Lima RLDM, Nóbrega LHC, Lima JG, Montenegro Junior RM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:107-115
Published Date: 13 January 2020
Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Wu YH, Wang SY, Li MX, He H, Yin WJ, Guo YH, Zhang HQ, Sun ZM, Zhang D, Wang X, Sun SY, Tang SX, Du R, Zhang CH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:99-105
Published Date: 14 January 2020
Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database
Chen TL, Lin CS, Lin JA, Yeh CC, Sung LC, Chang YC, Shih CC, Liao CC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:89-98
Published Date: 9 January 2020
Presarcopenia Is an Independent Risk Factor for Carotid Atherosclerosis in Chinese Population with Metabolic Syndrome
Cao Y, Zhong M, Zhang Y, Zheng Z, Liu Y, Ni X, Han L, Song M, Zhang W, Wang Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:81-88
Published Date: 9 January 2020
Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
Comini LO, de Oliveira LC, Borges LD, Dias HH, Batistelli CRS, da Silva LS, Moreira TR, da Silva RG, Cotta RMM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:71-80
Published Date: 9 January 2020
Comparison of Hemoglobin Alc, Glycated Albumin and Fasting Plasma Glucose for Prediction of Arterial Stiffness in Chinese Adults
Wen J, Hu F, Yang Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:65-70
Published Date: 10 January 2020
The Renoprotective Effects of Naringenin (NGN) in Gestational Pregnancy
Zhao C, Yin X, Zhao C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:53-63
Published Date: 8 January 2020
Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
Wondafrash DZ, Nire'a AT, Tafere GG, Desta DM, Berhe DA, Zewdie KA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:43-51
Published Date: 7 January 2020
Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
Pingali U, Nutalapati C, Illendulla VS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:31-42
Published Date: 7 January 2020
The Impacts of Synbiotic Supplementation on Periodontal Indices and Biomarkers of Oxidative Stress in Type 2 Diabetes Mellitus Patients with Chronic Periodontitis Under Non-Surgical Periodontal Therapy. A Double-Blind, Placebo-Controlled Trial
Bazyar H, Maghsoumi-Norouzabad L, Yarahmadi M, Gholinezhad H, Moradi L, Salehi P, Haghighi-zadeh MH, Zare Javid A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:19-29
Published Date: 6 January 2020
Stress Hyperglycemia and Complications Following Traumatic Injuries in Individuals With/Without Diabetes: The Case of Orthopedic Surgery
Di Luzio R, Dusi R, Mazzotti A, Petroni ML, Marchesini G, Bianchi G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:9-17
Published Date: 7 January 2020
The Relationship Between Abdominal Body Composition and Metabolic Syndrome After a Weight Reduction Program in Adult Men with Obesity
Liao CC, Sheu WHH, Lin SY, Lee WJ, Lee IT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020, 13:1-8
Published Date: 6 January 2020
Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes
Zhang C, Ou Q, Gu Y, Cheng G, Du R, Yuan L, Cordiner RLM, Kang D, Zhang J, Huang Q, Yu C, Kang L, Wang X, Sun X, Mo X, Tian H, Pearson ER, Meng W, Li S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2819-2828
Published Date: 3 January 2020
Assessment of Selected Serum Electrolyte and Associated Risk Factors in Diabetic Patients
Woyesa SB, Gebisa WC, Anshebo DL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2811-2817
Published Date: 3 January 2020
Prevalence of Diabetes Mellitus, Prediabetes and Its Associated Factors in Dessie Town, Northeast Ethiopia: A Community-Based Study
Endris T, Worede A, Asmelash D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2799-2809
Published Date: 31 December 2019
Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
Mba CM, Mbacham W, Sobngwi E, Mbanya JC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2791-2797
Published Date: 31 December 2019
Pattern of Obesity Among Patients with Type 2 Diabetes at a Tertiary Healthcare Center in Northern Nigeria
Gezawa ID, Uloko AE, Gwaram BA, Ibrahim DA, Ugwu ET, Mohammed IY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2785-2790
Published Date: 30 December 2019
Psychometric Evaluation of the Farsi Version of the Self-Care of Diabetes Inventory in Iranian Patients with Diabetes
Ebadi A, Ausili D, Albatineh AN, Salarvand S, Ghanei Ghashlagh R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2775-2784
Published Date: 30 December 2019
Differential Expression of Human N-Alpha-Acetyltransferase 40 (hNAA40), Nicotinamide Phosphoribosyltransferase (NAMPT) and Sirtuin-1 (SIRT-1) Pathway in Obesity and T2DM: Modulation by Metformin and Macronutrient Intake
Alshahrani A, AlDubayee M, Zahra M, Alsebayel FM, Alammari N, Alsudairy F, Almajed M, Aljada A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2765-2774
Published Date: 27 December 2019
Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation
Feng Q, Liu C, Gao W, Geng X, Dai N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2755-2763
Published Date: 27 December 2019
Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
Lee J, Cho YK, Kim HS, Jung CH, Park JY, Lee WJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2745-2753
Published Date: 27 December 2019
The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia
Al Amri T, Bahijri S, Al-Raddadi R, Ajabnoor G, Al Ahmadi J, Jambi H, Borai A, Tuomilehto J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2735-2743
Published Date: 24 December 2019
Predictors of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Taiwanese Patients with Type 2 Diabetes Mellitus
Lin YH, Huang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2725-2733
Published Date: 24 December 2019
The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
Hendy OM, Rabie H, El Fouly A, Abdel-Samiee M, Abdelmotelb N, Elshormilisy AA, Allam M, Ali ST, Bahaa EL-Deen NM, Abdelsattar S, Mohamed SM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2715-2723
Published Date: 19 December 2019
The OXTR Polymorphism Stratified the Correlation of Oxytocin and Glucose Homeostasis in Non-Diabetic Subjects
Chang HH, Chang WH, Chi MH, Peng YC, Huang CC, Yang YK, Chen PS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2707-2713
Published Date: 19 December 2019
Type 2 Diabetes-Associated Genetic Polymorphisms as Potential Disease Predictors
Witka BZ, Oktaviani DJ, Marcellino M, Barliana MI, Abdulah R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2689-2706
Published Date: 18 December 2019
Small Molecules, Big Promises: Improvement of Psoriasis Severity and Glucidic Markers with Apremilast: A Case Report
Lanna C, Cesaroni GM, Mazzilli S, Bianchi L, Campione E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2685-2688
Published Date: 17 December 2019
Detection of Secondary Metabolites as Biomarkers for the Early Diagnosis and Prevention of Type 2 Diabetes
Al-Aama JY, Al Mahdi HB, Salama MA, Bakur KH, Alhozali A, Mosli HH, Bahijri SM, Bahieldin A, Willmitzer L, Edris S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2675-2684
Published Date: 17 December 2019
Perinatal Outcomes in Mexican Women with Untreated Mild Gestational Diabetes Mellitus Diagnosed by the International Association of Diabetes and Pregnancy Study Groups Criteria
Martínez-Cruz N, Rapisarda AMC, Soriano-Ortega KP, Arce-Sánchez L, Cianci A, Ortega-Gonzalez C, Torres-Herrera U, Espino-Y-Sosa S, Estrada-Gutierrez G, Montoya-Estrada A, Romo-Yañez J, Reyes-Muñoz E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2667-2674
Published Date: 16 December 2019
Predictors of Insulin Treatment During Pregnancy and Abnormal Postpartum Glucose Metabolism in Patients with Gestational Diabetes Mellitus
Tang L, Xu S, Li P, Li L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2655-2665
Published Date: 12 December 2019
Relationship Between Skeletal Muscle Mass Indexes and Muscular Function, Metabolic Profile and Bone Mineral Density in Women with Recommendation for Bariatric Surgery
Crispim Carvalho NN, Baccin Martins VJ, Modesto Filho J, Bandeira F, Fernandes Pimenta FC, de Brito Alves JL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2645-2654
Published Date: 12 December 2019
Dysregulation of DPP4 Is Associated with the AMPK/JAK2/STAT3 Pathway in Adipocytes Under Insulin Resistance Status and Liraglutide Intervention
Cheng F, Yuan G, He J, Shao Y, Zhang J, Guo X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2635-2644
Published Date: 11 December 2019
ATP-Binding Cassette Transporter A1 (ABCA 1) Expression in Adipose Tissue and Its Modulation with Insulin Resistance in Obesity [Corrigendum]
Vincent V, Thakkar H, Aggarwal S, Mridha AR, Ramakrishnan L, Singh A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2633-2634
Published Date: 11 December 2019
Interactive Nutrition Education Is More Effective in Terms of Improved Levels of Glycated Hemoglobin in Adolescent Patients with Poorly Controlled Type 1 Diabetes – A Randomized Study
Dłużniak-Gołaska K, Panczyk M, Szypowska A, Sińska B, Szostak-Węgierek D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2619-2631
Published Date: 10 December 2019
lncRNA GAS5/miR-452-5p Reduces Oxidative Stress and Pyroptosis of High-Glucose-Stimulated Renal Tubular Cells
Xie C, Wu W, Tang A, Luo N, Tan Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2609-2617
Published Date: 9 December 2019
Ursolic Acid Treatment Alleviates Diabetic Kidney Injury By Regulating The ARAP1/AT1R Signaling Pathway
Ma TK, Xu L, Lu LX, Cao X, Li X, Li LL, Wang X, Fan QL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2597-2608
Published Date: 9 December 2019
Vitamin B12 Deficiency and Foot Ulcers in Type 2 Diabetes Mellitus: A Case–Control Study
Badedi M, Darraj H, Hummadi A, Solan Y, Zakri I, Khawaji A, Daghreeri M, Budaydi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2589-2596
Published Date: 6 December 2019
A New Compound Heterozygous Mutation Of BSCL2 In A Chinese Zhuang Ethnic Family With Congenital Generalized Lipodystrophy
Qin Y, Zhang X, Xiang L, Shan Q, Li S, Yan J, Lin F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2583-2587
Published Date: 5 December 2019
Diet, Diabetes Status, and Personal Experiences of Individuals with Type 2 diabetes Who Self-Selected and Followed a Low Carbohydrate High Fat diet
Webster CC, Murphy TE, Larmuth KM, Noakes TD, Smith JA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2567-2582
Published Date: 5 December 2019
Dynamics of Epicardiac Fat and Heart Function in Type 2 Diabetic Patients Initiated with SGLT-2 Inhibitors
Braha A, Timar B, Diaconu L, Lupusoru R, Vasiluta L, Sima A, Vlad A, Munteanu M, Albai A, Cipu D, Timar R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2559-2566
Published Date: 5 December 2019
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
Avgerinos I, Liakos A, Tsapas A, Bekiari E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2549-2557
Published Date: 3 December 2019
Type 1 Diabetes and Bone Fragility: Links and Risks
Starup-Linde J, Hygum K, Harsløf T, Langdahl B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2539-2547
Published Date: 3 December 2019
Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)
Liu W, Huang X, Zhang X, Cai X, Han X, Zhou X, Chen L, Zhang R, Gong S, Wang Y, Ji L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2531-2537
Published Date: 2 December 2019
Oral Semaglutide In The Management Of Type 2 Diabetes: A Report On The Evidence To Date
Pearson S, Kietsiriroje N, Ajjan RA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2515-2529
Published Date: 2 December 2019
The Effects of Type 2 Diabetes and Postoperative Pneumonia on the Mortality in Inpatients with Surgery
Ma C, Liu Q, Li M, Ji M, Zhang J, Zhang B, Yin FZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2507-2513
Published Date: 29 November 2019
Threshold Effects in the Relationship Between Serum Non-High-Density Lipoprotein Cholesterol and Metabolic Syndrome
Wang S, Tu J, Pan Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2501-2506
Published Date: 29 November 2019
Diabetes Self-Management Education (DSME) – Effect on Knowledge, Self-Care Behavior, and Self-Efficacy Among Type 2 Diabetes Patients in Ethiopia: A Controlled Clinical Trial
Hailu FB, Moen A, Hjortdahl P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2489-2499
Published Date: 29 November 2019
TeDia - A Telemedicine-Based Treatment Model for Inpatient and Interprofessional Diabetes Care
Röhling M, Redaélli M, Simic D, Lorrek K, Samel C, Schneider P, Kempf K, Stock S, Martin S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2479-2487
Published Date: 29 November 2019
Slowly Progressive Type 1 Diabetes Mellitus: Current Knowledge And Future Perspectives
Nishimura A, Matsumura K, Kikuno S, Nagasawa K, Okubo M, Mori Y, Kobayashi T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2461-2477
Published Date: 28 November 2019
TNF-α (−308) Gene Polymorphism and Type 2 Diabetes Mellitus in Ethiopian Diabetes Patients
Ayelign B, Genetu M, Wondmagegn T, Adane G, Negash M, Berhane N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2453-2459
Published Date: 28 November 2019
Identification of Transcriptional Metabolic Dysregulation in Subtypes of Pituitary Adenoma by Integrated Bioinformatics Analysis
Hu J, Yin H, Li B, Yang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2441-2451
Published Date: 27 November 2019
Branched Chain Amino Acids Protects Rat Mesangial Cells from High Glucose by Modulating TGF-β1 and BMP-7
Zhang X, Liu D, He Y, Lou K, Zheng D, Han W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2433-2440
Published Date: 28 November 2019
Clinic, Anthropometric And Metabolic Changes In Adults With Class III Obesity Classified As Metabolically Healthy And Metabolically Unhealthy
Loureiro LM, Cordeiro A, Mendes R, Luna M, Pereira S, Saboya CJ, Ramalho A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2419-2431
Published Date: 27 November 2019
Abdominal Fat Is Directly Associated With Inflammation In Persons With Type-2 Diabetes Regardless Of Glycemic Control – A Jordanian Study
Bawadi H, Katkhouda R, Tayyem R, Kerkadi A, Bou Raad S, Subih H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2411-2417
Published Date: 22 November 2019
Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
Tripolino C, Irace C, Cutruzzolà A, Parise M, Barone M, Scicchitano C, Cortese C, Gnasso A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2405-2410
Published Date: 20 November 2019
The Impact Of Structured Exercise Programs On Metabolic Syndrome And Its Components: A Systematic Review
Joseph MS, Tincopa MA, Walden P, Jackson E, Conte ML, Rubenfire M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2395-2404
Published Date: 18 November 2019
The Relationship Between Aspartate Aminotransferase To Alanine Aminotransferase Ratio And Metabolic Syndrome In Adolescents In Northeast China
Lin S, Tang L, Jiang R, Chen Y, Yang S, Li L, Li P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2387-2394
Published Date: 18 November 2019
The Association Between Normal BMI With Central Adiposity And Proinflammatory Potential Immunoglobulin G N-Glycosylation
Liu D, Li Q, Dong J, Li D, Xu X, Xing W, Zhang X, Cao W, Hou H, Wang H, Song M, Tao L, Kang X, Meng Q, Wang W, Guo X, Wang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2373-2385
Published Date: 14 November 2019
Social Media Use By People With Diabetes In Saudi Arabia: A Survey About Purposes, Benefits And Risks
Alzahrani A, Alanzi T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2363-2372
Published Date: 13 November 2019
Fluid Therapy For Pediatric Patients With Diabetic Ketoacidosis: Current Perspectives
Jayashree M, Williams V, Iyer R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2355-2361
Published Date: 12 November 2019
Increased Risk Of Type 2 Diabetes And Abnormal FPG Due To Shift Work Differs According To Gender: A Retrospective Cohort Study Among Thai Workers In Bangkok, Thailand
Hanprathet N, Lertmaharit S, Lohsoonthorn V, Rattananupong T, Ammaranond P, Jiamjarasrangsi W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2341-2354
Published Date: 12 November 2019
Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin Secretion Via Wnt/β-Catenin Signaling
Xiao XH, Huang QY, Qian XL, Duan J, Jiao XQ, Wu LY, Huang QY, Li J, Lai XN, Shi YB, Xiong LX
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2325-2339
Published Date: 13 November 2019
Polymorphism Of The APM1 Gene In Subjects With Central Obesity Related To Lower High-Density Lipoprotein Cholesterol
Barliana MI, Yolanda PD, Rostinawati T, Ng H, Alfian SD, Abdulah R, Diantini A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2317-2324
Published Date: 6 November 2019
Is There A Non-Essential Hospitalization Day In Inpatients With Diabetes Under Medical Insurance? Evidence From An Observational Study In China
Tao S, Li H, Xie Y, Chen J, Feng Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2309-2316
Published Date: 6 November 2019
The Role Of Adiponectin, TNF-α And Glutathione In The Pathogenesis And Evolution Of Type 1 Diabetes
Szabo CE, Ilieș RF, Aioanei CS, Catana A, Creț V, Șerban RS, Pop IV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2303-2308
Published Date: 5 November 2019
Essential Role Of High Glucose-Induced Overexpression Of PKCβ And PKCδ In GLP-1 Resistance In Rodent Cardiomyocytes
Pan X, Chen J, Wang T, Zhang M, Wang H, Gao H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2289-2302
Published Date: 4 November 2019
The Characteristics Of Abdominal Fat Distribution In Japanese Adolescents With Type 2 Diabetes Mellitus
Abe Y, Urakami T, Hara M, Yoshida K, Mine Y, Aoki M, Suzuki J, Saito E, Yoshino Y, Iwata F, Okada T, Morioka I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2281-2288
Published Date: 1 November 2019
Effects Of PPARγ2 Pro12Ala Variant On Adipocyte Phenotype Dependent Of DHA
Wan R, Ding Z, Xia S, Zheng L, Lu J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2273-2279
Published Date: 1 November 2019
Mitigating The Burden Of Diabetes In Sub-Saharan Africa Through An Integrated Diagonal Health Systems Approach
Mercer T, Chang AC, Fischer L, Gardner A, Kerubo I, Tran DN, Laktabai J, Pastakia S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2261-2272
Published Date: 31 October 2019
Usefulness Of Surrogate Markers Of Body Fat Distribution For Predicting Metabolic Syndrome In Middle-Aged And Older Korean Populations
Shin KA, Kim YJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2251-2259
Published Date: 1 November 2019
Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice
He J, Zhang J, Dong L, Dang X, Wang L, Cheng L, Huang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2237-2249
Published Date: 1 November 2019
How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases
Kopp W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2221-2236
Published Date: 24 October 2019
Protective Effects Of Astragalus Polysaccharides On Oxidative Stress In High Glucose-Induced Or SOD2-Silenced H9C2 Cells Based On PCR Array Analysis
Sun Q, Wu X, Wang H, Chen W, Zhao X, Yang Y, Chen W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2209-2220
Published Date: 25 October 2019
The Epidemic Of The Metabolic Syndrome Among The Palestinians In The Gaza Strip
Jamee AS, Aboyans V, Magne J, Preux PM, Lacroix P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2201-2208
Published Date: 22 October 2019
Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol
Zhao H, Shu L, Huang W, Wang W, Song G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2193-2200
Published Date: 21 October 2019
Can Low SHBG Serum Concentration Be A Good Early Marker Of Male Hypogonadism In Metabolic Syndrome?
Jarecki P, Herman WA, Pawliczak E, Lacka K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2181-2191
Published Date: 21 October 2019
AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation
Zhang YZ, Zhang YL, Huang Q, Huang C, Jiang ZL, Cai F, Shen JF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2165-2179
Published Date: 23 October 2019
Effects Of Exercise Training With Dietary Restriction On Arterial Stiffness, Central Hemodynamic Parameters And Cardiac Autonomic Function In Obese Adolescents
Huang J, Lai Q, Wang D, Yin H, Liao J, Wang S, Xu F, Hou X, Hu M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2157-2163
Published Date: 17 October 2019
Jinmaitong Ameliorates Diabetic Peripheral Neuropathy Through Suppressing TXNIP/NLRP3 Inflammasome Activation In The Streptozotocin-Induced Diabetic Rat Model
Sun Q, Wang C, Yan B, Shi X, Shi Y, Qu L, Liang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2145-2155
Published Date: 17 October 2019
Efficacy Of Acceptance And Commitment Therapy For Emotional Distress In The Elderly With Type 2 Diabetes: A Randomized Controlled Trial
Maghsoudi Z, Razavi Z, Razavi M, Javadi M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2137-2143
Published Date: 17 October 2019
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
Simes BC, MacGregor GG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2125-2136
Published Date: 14 October 2019
Lymphocyte To High-Density Lipoprotein Ratio As A New Indicator Of Inflammation And Metabolic Syndrome
Chen H, Xiong C, Shao X, Ning J, Gao P, Xiao H, Chen Y, Zou Z, Hong G, Li X, Shao M, Sheng J, Yang X, You X, Zou H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2117-2123
Published Date: 14 October 2019
Effects Of Saffron Supplementation On Inflammation And Metabolic Responses In Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Ebrahimi F, Sahebkar A, Aryaeian N, Pahlavani N, Fallah S, Moradi N, Abbasi D, Hosseini AF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2107-2115
Published Date: 14 October 2019
Upregulation Of Renal GLUT2 And SGLT2 Is Involved In High-Fat Diet-Induced Gestational Diabetes In Mice
Jiang YK, Xin KY, Ge HW, Kong FJ, Zhao G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2095-2105
Published Date: 14 October 2019
Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population
Wu Z, Jiang Y, Jia J, He D, Sun P, Li J, Huo Y, Fan F, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2085-2093
Published Date: 11 October 2019
A Novel Indicator Of Lipid Accumulation Product Associated With Metabolic Syndrome In Chinese Children And Adolescents
Zhang Y, Hu J, Li Z, Li T, Chen M, Wu L, Liu W, Han H, Yao R, Fu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2075-2083
Published Date: 10 October 2019
Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients
Chen YC, Hsu BG, Wang JH, Lee CJ, Tsai JP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2065-2073
Published Date: 8 October 2019
Exosomes from β-cells alleviated hyperglycemia and enhanced angiogenesis in islets of streptozotocin-induced diabetic mice
Sun Y, Mao Q, Shen C, Wang C, Jia W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2053-2064
Published Date: 8 October 2019
Hypertriglyceridemia-Related Pancreatitis In Patients With Type 2 Diabetes: Links And Risks
Shemesh E, Zafrir B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2041-2052
Published Date: 7 October 2019
The Relationship Between The Electromyographic Activity Of Rectus And Oblique Abdominal Muscles And Bioimpedance Body Composition Analysis - A Pilot Observational Study
Ptaszkowski K, Wlodarczyk P, Paprocka-Borowicz M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2033-2040
Published Date: 7 October 2019
A Retrospective Time Trend Study Of Diabetes Overtreatment In Geriatric Patients
Wojszel ZB, Kasiukiewicz A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2023-2032
Published Date: 4 October 2019
Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice
Rockwood S, Mason D, Lord R, Lamar P, Prozialeck W, Al-Nakkash L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2011-2021
Published Date: 3 October 2019
The Impact Of Hyperuricemia On Cardiometabolic Risk Factors In Patients With Diabetes Mellitus: A Cross-Sectional Study
Gaita L, Timar R, Lupascu N, Roman D, Albai A, Potre O, Timar B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:2003-2010
Published Date: 3 October 2019
Potential role of phytochemicals in metabolic syndrome prevention and therapy
Francini-Pesenti F, Spinella P, Calò LA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1987-2002
Published Date: 1 October 2019
Dual GIP–GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential
Bastin M, Andreelli F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1973-1985
Published Date: 30 September 2019
A Differential Diagnosis Model For Diabetic Nephropathy And Non-Diabetic Renal Disease In Patients With Type 2 Diabetes Complicated With Chronic Kidney Disease
Yang Z, Feng L, Huang Y, Xia N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1963-1972
Published Date: 30 September 2019
Plant-derived oleanolic acid ameliorates markers associated with non-alcoholic fatty liver disease in a diet-induced pre-diabetes rat model
Gamede M, Mabuza L, Ngubane P, Khathi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1953-1962
Published Date: 1 October 2019
Multivariable Logistic Regression And Back Propagation Artificial Neural Network To Predict Diabetic Retinopathy
Yao L, Zhong Y, Wu J, Zhang G, Chen L, Guan P, Huang D, Liu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1943-1951
Published Date: 25 September 2019
NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
Wan Z, Fan Y, Liu X, Xue J, Han Z, Zhu C, Wang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1931-1942
Published Date: 20 September 2019
Serum CTRP3 Levels In Obese Children: A Potential Protective Adipokine Of Obesity, Insulin Sensitivity And Pancreatic β Cell Function
Chen T, Wang F, Chu Z, Shi X, Sun L, Lv H, Zhou W, Shen J, Chen L, Hou M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1923-1930
Published Date: 20 September 2019
Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
Spooner KL, Guinan G, Koller S, Hong T, Chang AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1913-1921
Published Date: 19 September 2019
A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
Rana K, Reid J, Rosenwasser JN, Lewis T, Sheikh-Ali M, Choksi RR, Goldfaden RF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1897-1911
Published Date: 19 September 2019
Aortic Stiffness Index And Carotid Intima-Media Thickness Are Independently Associated With The Presence Of Microalbuminuria In Patients With Type 2 Diabetes Mellitus
Turan Y, Turan E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1889-1896
Published Date: 19 September 2019
A Comparative Prevalence Of Metabolic Syndrome Among Type 2 Diabetes Mellitus Patients In Hawassa University Comprehensive Specialized Hospital Using Four Different Diagnostic Criteria
Bizuayehu Wube T, Mohammed Nuru M, Tesfaye Anbese A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1877-1887
Published Date: 19 September 2019
Does a diabetic retinopathy educational program raise awareness among elderly diabetic patients?
Khalaf FR, Fahmy HM, Ibrahim AK, Mohamed GA, El Sayed Ez Eldeen M, Elkady A, Hetta HF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1867-1875
Published Date: 20 September 2019
Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patients
Derosa G, Pascuzzo MD, D'Angelo A, Maffioli P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1861-1865
Published Date: 18 September 2019
Lifestyle intervention for obesity: a call to transform the clinical care delivery system in Mexico
Díaz-Zavala RG, Candia-Plata MC, Martínez-Contreras TJ, Esparza-Romero J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1841-1859
Published Date: 13 September 2019
Influence of genomic ancestry and self-reported color-race in CKD in a nationwide admixed sample of Brazilian patients with type 1 diabetes
Pizarro MH, Santos DC, Melo LGN, Barros BSV, Muniz LH, Porto LC, Silva DA, Gomes MB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1831-1840
Published Date: 12 September 2019
Association between metabolic syndrome and limb muscle quantity and quality in older adults: a pilot ultrasound study
Chang KV, Yang KC, Wu WT, Huang KC, Han DS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1821-1830
Published Date: 11 September 2019
Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy
Wang T, Gao Y, Wang X, Shi Y, Xu J, Wu B, He J, Li Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1811-1820
Published Date: 11 September 2019
Anthropometric variables as cardiovascular risk predictors in a cohort of adult subjects with Turner syndrome
Álvarez-Nava F, Racines M, Witt J, Guarderas J, Estévez M, Lanes R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1795-1809
Published Date: 9 September 2019
Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes
Ito H, Matsumoto S, Izutsu T, Kusano E, Nishio S, Antoku S, Yamasaki T, Mori T, Togane M, Ando S, Tsugami E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1783-1794
Published Date: 9 September 2019
High-fat diet-induced kidney alterations in rats with metabolic syndrome: endothelial dysfunction and decreased antioxidant defense
Rangel Silvares R, Nunes Goulart da Silva Pereira E, Eduardo Ilaquita Flores E, Lino Rodrigues K, Ribeiro Silva A, Gonçalves-de-Albuquerque CF, Daliry A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1773-1781
Published Date: 6 September 2019
Attenuated serum 25-hydroxyvitamin D and vitamin D binding protein associated with cognitive impairment in patients with type 2 diabetes
Parveen R, Kapur P, Venkatesh S, Agarwal NB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1763-1772
Published Date: 9 September 2019
The effects of ginger supplementation on inflammatory, antioxidant, and periodontal parameters in type 2 diabetes mellitus patients with chronic periodontitis under non-surgical periodontal therapy. A double-blind, placebo-controlled trial
Zare Javid A, Bazyar H, Gholinezhad H, Rahimlou M, Rashidi H, Salehi P, Haghighi-zadeh MH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1751-1761
Published Date: 6 September 2019
The interplay between abdominal aortic aneurysm, metabolic syndrome and fatty liver disease: a retrospective case-control study
Mahamid M, Khoury T, Mahamid B, Sbeit W, Mari A, Nseir W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1743-1749
Published Date: 4 September 2019
Diagnostic accuracy of composite autonomic symptom scale 31 (COMPASS-31) in early detection of autonomic dysfunction in type 2 diabetes mellitus
Singh R, Arbaz M, Rai NK, Joshi R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1735-1742
Published Date: 5 September 2019
Association between new anthropometric parameters and arterial stiffness based on brachial-ankle pulse wave velocity
Choi HS, Cho YH, Lee SY, Park EJ, Kim YJ, Lee JG, Yi YH, Tak YJ, Hwang HR, Lee SH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1727-1733
Published Date: 3 September 2019
Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats
Mi J, He W, Lv J, Zhuang K, Huang H, Quan S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1717-1725
Published Date: 3 September 2019
Gross saponin of Tribulus terrestris improves erectile dysfunction in type 2 diabetic rats by repairing the endothelial function of the penile corpus cavernosum
Zhang H, Tong WT, Zhang CR, Li JL, Meng H, Yang HG, Chen M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1705-1716
Published Date: 2 September 2019
Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
Li Z, Yang P, Liang Y, Xia N, Li Y, Su H, Pan H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1697-1703
Published Date: 3 September 2019
MicroRNA-126: a promising biomarker for angiogenesis of diabetic wounds treated with negative pressure wound therapy
Zhang D, Li Z, Wang Z, Zeng F, Xiao W, Yu A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1685-1696
Published Date: 3 September 2019
Comparison of self-care in non-cardiac diabetic patients
Asghari F, Nobahar M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1675-1683
Published Date: 2 September 2019
Beneficial effects of Japanese sake yeast supplement on biochemical, antioxidant, and anti-inflammatory factors in streptozotocin-induced diabetic rats
Davoodi M, Karimooy FN, Budde T, Ortega-Martinez S, Moradi-Kor N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1667-1673
Published Date: 2 September 2019
Efficacy of a new local limb salvage treatment for limb-threatening diabetic foot wounds - a randomized controlled study
Yakoot M, Abdelatif M, Helmy S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1659-1665
Published Date: 2 September 2019
IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway
Wu X, Yu T, Ji N, Huang Y, Gao L, Shi W, Yan Y, Li H, Ma L, Wu K, Wu Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1645-1657
Published Date: 29 August 2019
Association between glycated hemoglobin (HbA1c) and the lipid profile in patients with type 2 diabetes mellitus at a tertiary care hospital: a retrospective study
Alzahrani SH, Baig M, Aashi MM, Al-shaibi FK, Alqarni DA, Bakhamees WH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1639-1644
Published Date: 29 August 2019
Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids
Zhu W, Niu X, Wang M, Li Z, Jiang HK, Li C, Caton SJ, Bai Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1625-1638
Published Date: 29 August 2019
Correlation analysis of metabolic syndrome and its components with thyroid nodules
Liu J, Wang C, Tang X, Fu S, Jing G, Ma L, Sun W, Li Y, Wu D, Niu Y, Niu Q, Guo H, Song P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1617-1623
Published Date: 30 August 2019
Regulation of alternative splicing in obesity-induced hypertension
Dlamini Z, Hull R, Makhafola TJ, Mbele M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1597-1615
Published Date: 28 August 2019
The effect of A1 adenosine receptor in diabetic megalin loss with caspase-1/IL18 signaling
Tian D, Shi X, Zhao Y, Peng X, Zou L, Xu L, Ma Y, Wen Y, Faulhaber-Walter R, Chen L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1583-1596
Published Date: 28 August 2019
K-means clustering of overweight and obese population using quantile-transformed metabolic data
Li L, Song Q, Yang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1573-1582
Published Date: 23 August 2019
An easily ignored factor for CAN-fine particulate exposure [Response to Letter]
Vasheghani M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1571-1572
Published Date: 23 August 2019
Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study
Ren R, Ma Y, Deng F, Li T, Wang H, Wei J, Jiang X, He M, Tian M, Liu D, Chen B, Deng W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1563-1569
Published Date: 22 August 2019
Empagliflozin in type 1 diabetes
Mathieu C, Van Den Mooter L, Eeckhout B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1555-1561
Published Date: 22 August 2019
Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
Ma S, Sun W, Gao L, Liu S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1543-1553
Published Date: 21 August 2019
Prevalence and identification of type 1 diabetes in Chinese adults with newly diagnosed diabetes
Tang X, Yan X, Zhou H, Yang X, Niu X, Liu J, Ji Q, Ji L, Li X, Zhou Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1527-1541
Published Date: 28 August 2019
Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials
Wang N, Yang T, Li J, Zhang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1513-1526
Published Date: 22 August 2019
Impact of arterial hypertension and type 2 diabetes on cardiac autonomic modulation in obese individuals with recommendation for bariatric surgery
Carvalho NNC, de Oliveira Junior FA, da Silva G, Baccin Martins VJ, Braga VA, Costa-Silva JH, Fernandes Pimenta FC, de Brito Alves JL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1503-1511
Published Date: 21 August 2019
Comparison of the effect of two therapeutic exercises on the inflammatory and physiological conditions and complications of diabetic neuropathy in female patients
Nadi M, Bambaeichi E, Marandi SM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1493-1501
Published Date: 20 August 2019
Aging-associated impairment in metabolic compensation by subcutaneous adipose tissue promotes diet-induced fatty liver disease in mice
Taketani H, Nishikawa T, Nakajima H, Kodo K, Sugimoto S, Aoi W, Horike S, Meguro-Horike M, Ishiba H, Seko Y, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Itoh Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1473-1492
Published Date: 23 August 2019
The relationship of mitochondrial dysfunction and the development of insulin resistance in Cushing’s syndrome
Ježková J, Ďurovcová V, Wenchich L, Hansíková H, Zeman J, Hána V, Marek J, Lacinová Z, Haluzík M, Kršek M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1459-1471
Published Date: 19 August 2019
Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride
Woodman OL, Ortega JM, Hart JL, Klein T, Potocnik S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1449-1458
Published Date: 16 August 2019
Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being
Moukayed M, Grant WB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1437-1447
Published Date: 16 August 2019
Estrogen receptor inhibition enhances cold-induced adipocyte beiging and glucose tolerance
Lapid K, Lim A, Berglund ED, Lu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1419-1436
Published Date: 14 August 2019
Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus
Bukhsh A, Khan TM, Sarfraz Nawaz M, Sajjad Ahmed H, Chan KG, Goh BH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1409-1417
Published Date: 14 August 2019
Skeletal muscle mass to visceral fat area ratio is an important determinant associated with type 2 diabetes and metabolic syndrome
Wang Q, Zheng D, Liu J, Fang L, Li Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1399-1407
Published Date: 14 August 2019
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1397-1398
Published Date: 14 August 2019
Prevalence and clinical characteristics of metabolically unhealthy obesity in an Iranian adult population
Rahmanian K, Shojaei M, Sotoodeh Jahromi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1387-1395
Published Date: 13 August 2019
Urinary biomarkers for diagnosing poststroke depression in patients with type 2 diabetes mellitus
Liang ZH, Jia YB, Li ZR, Li M, Wang ML, Yun YL, Yu LJ, Shi L, Zhu RX
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1379-1386
Published Date: 13 August 2019
Ambient air pollution exposure and obesity-related traits in Korean adults
Hwang SE, Kwon H, Jeong SM, Kim HJ, Park JH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1365-1377
Published Date: 9 August 2019
2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione isolated from Averrhoa carambola L. root ameliorates diabetic nephropathy by inhibiting the TLR4/MyD88/NF-κB pathway
Lu S, Zhang H, Wei X, Huang X, Chen L, Jiang L, Wu X, Zhou X, Qin L, Li Y, Lin X, Huang R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1355-1363
Published Date: 7 August 2019
The barriers against initiating insulin therapy among patients with diabetes living in Yazd, Iran
Shafie Pour MR, Sadeghiyeh T, Hadavi M, Besharati M, Bidaki R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1349-1354
Published Date: 7 August 2019
Impact of Ginkgo biloba extract and magnetized water on the survival rate and functional capabilities of pancreatic β-cells in type 2 diabetic rat model
Saleh A, Anwar MM, Zayed AE, Ezz Eldeen MES, Afifi G, Alnashiri HM, Gomaa AMS, Abd-Elkareem M, Abou-Elhamd AS, Shaheen ES, Mohamed GA, Hetta HF, Kotb AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1339-1347
Published Date: 7 August 2019
Correlation of acidosis-adjusted potassium level and cardiovascular outcomes in diabetic ketoacidosis: a systematic review
Usman A, Makmor Bakry M, Mustafa N, Rehman IU, Bukhsh A, Lee SWH, Khan TM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1323-1338
Published Date: 6 August 2019
Empowerment of patients with type 2 diabetes: current perspectives
Gómez-Velasco DV, Almeda-Valdes P, Martagón AJ, Galán-Ramírez GA, Aguilar-Salinas CA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1311-1321
Published Date: 6 August 2019
A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation
Zhang C, Zhu X, Li L, Ma T, Shi M, Yang Y, Fan Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1297-1309
Published Date: 2 August 2019
Risk analysis of systemic levels of estrogen and adipokines as well as estrogen receptors from PBMCs in childbearing and perimenopausal women with obesity
Fan H, Chen S, Gao B, Ding S, Zhao Q, Li C, Asakawa T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1287-1295
Published Date: 1 August 2019
The association between omentin and diabetes: a systematic review and meta-analysis of observational studies
As´habi A, Sadeghi M, Arab A, Hajianfar H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1277-1286
Published Date: 31 July 2019
An easily ignored factor for CAN-fine particulate exposure [Letter]
Sun H, Liang M, Zheng N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1275-1276
Published Date: 31 July 2019
Decreased GFR and its joint association with type 2 diabetes and hypertension with prevalence and severity of carotid plaque in a community population in China
Che Q, Yang Y, Cheng G, Jia J, Fan F, Li J, Huo Y, Chen D, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1263-1273
Published Date: 26 July 2019
mRNAs expression profiles of high glucose-induced memory in human umbilical vein endothelial cells
Jin G, Wang Q, Pei X, Li X, Hu X, Xu E, Li M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1249-1261
Published Date: 23 July 2019
Association of salivary C-reactive protein with the obesity measures and markers in children
Selvaraju V, Babu JR, Geetha T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1239-1247
Published Date: 23 July 2019
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1225-1237
Published Date: 24 July 2019
Gene expression profiling reveals candidate biomarkers and probable molecular mechanism in diabetic peripheral neuropathy
Zhou H, Zhang W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1213-1223
Published Date: 23 July 2019
Plausible relationship between homocysteine and obesity risk via MTHFR gene: a meta-analysis of 38,317 individuals implementing Mendelian randomization
Fu L, Li Y, Luo D, Deng S, Hu YQ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1201-1212
Published Date: 23 July 2019
Diabetes care in public health facilities in India: a situational analysis using a mixed methods approach
Tripathy JP, Sagili KD, Kathirvel S, Trivedi A, Nagaraja SB, Bera OP, Reddy KK, Satyanarayana S, Khanna A, Chadha SS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1189-1199
Published Date: 19 July 2019
Metabolic factors that affect health-related quality of life in type 2 diabetes patients: a multivariate regression analysis
Dehesh T, Dehesh P, Gozashti MH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1181-1188
Published Date: 19 July 2019
A cross-sectional study of risk factors and hypertension among adolescent Senior High School students
Amponsem-Boateng C, Zhang W, Oppong TB, Opolot G, Kumi Duodu Kyere E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1173-1180
Published Date: 24 July 2019
Characterization of variable presentations of diabetic ketoacidosis based on blood ketone levels and major society diagnostic criteria: a new view point on the assessment of diabetic ketoacidosis
Lee K, Park IB, Yu SH, Kim SK, Kim SH, Seo DH, Hong S, Jeon JY, Kim DJ, Kim SW, Choi CS, Lee DH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1161-1171
Published Date: 16 July 2019
Osteoarthritis patients with high haemoglobin A1c have increased Toll-like receptor 4 and matrix metalloprotease-13 expression in the synovium
Murata K, Uchida K, Takano S, Shoji S, Iwase D, Inoue G, Aikawa J, Yokozeki Y, Sekiguchi H, Takaso M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1151-1159
Published Date: 16 July 2019
Impact of food pattern on glycemic control among type 2 diabetic patients: a cross-sectional study in the United Arab Emirates
Sadiya A, Mnla R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1143-1150
Published Date: 16 July 2019
Teneligliptin and “Thorough QTc study”: thorough enough?
Ghosal S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1141-1142
Published Date: 15 July 2019
Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study
Hadi Alijanvand M, Aminorroaya A, Kazemi I, Aminorroaya Yamini S, Janghorbani M, Amini M, Mansourian M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1123-1139
Published Date: 15 July 2019
Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus
Ogbonna SU, Ezeani IU, Okafor CI, Chinenye S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1113-1122
Published Date: 12 July 2019
Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis
Hegazy MA, Samy MA, Tawfik A, Naguib MM, Ezzat A, Behiry ME
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1105-1111
Published Date: 11 July 2019
Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats
Qin Q, Lin N, Huang H, Zhang X, Cao X, Wang Y, Li P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1091-1103
Published Date: 10 July 2019
Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives
Rudland VL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1081-1089
Published Date: 10 July 2019
Smoking results in accumulation of ectopic fat in the liver
Kato A, Li Y, Ota A, Naito H, Yamada H, Nihashi T, Hotta Y, Chiang C, Hirakawa Y, Aoyama A, Tamakoshi K, Yatsuya H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1075-1080
Published Date: 9 July 2019
Genetic variants linked to T2DM risk in Kurdish populations [Retraction]
Golsheh S, Keshavarzi F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1073-1074
Published Date: 8 July 2019
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1057-1072
Published Date: 8 July 2019
Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment
Urakami T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1047-1056
Published Date: 8 July 2019
Metabolic syndrome is associated with peripheral endothelial dysfunction amongst men
Taher R, Sara JD, Heidari B, Toya T, Lerman LO, Lerman A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1035-1045
Published Date: 5 July 2019
Sex disparities in the epidemic of type 2 diabetes in Mexico: national and state level results based on the Global Burden of Disease Study, 1990–2017
Dávila-Cervantes CA, Agudelo-Botero M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1023-1033
Published Date: 8 July 2019
Liraglutide ameliorates nonalcoholic fatty liver disease in diabetic mice via the IRS2/PI3K/Akt signaling pathway
Yang P, Liang Y, Luo Y, Li Z, Wen Y, Shen J, Li R, Zheng H, Gu HF, Xia N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1013-1021
Published Date: 4 July 2019
SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions
Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1001-1012
Published Date: 3 July 2019
Personalized intervention to improve stress and sleep patterns for glycemic control and weight management in obese Emirati patients with type 2 diabetes: a randomized controlled clinical trial
Mussa BM, Schauman M, Kumar V, Skaria S, Abusnana S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:991-999
Published Date: 28 June 2019
Replication of previous genome-wide association studies of HKDC1, BACE2, SLC16A11 and TMEM163 SNPs in a gestational diabetes mellitus case–control sample from Han Chinese population
Tan YX, Hu SM, You YP, Yang GL, Wang W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:983-989
Published Date: 27 June 2019
Identification of dynamic molecular networks in peripheral blood mononuclear cells in type 1 diabetes mellitus
Li L, Pan Z, Yang X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:969-982
Published Date: 25 June 2019
QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
Erande S, Sarwardekar S, Desai B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:961-967
Published Date: 21 June 2019
Optimal management of diabetic foot osteomyelitis: challenges and solutions
Lázaro Martínez JL, García Álvarez Y, Tardáguila-García A, García Morales E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:947-959
Published Date: 21 June 2019
Prevalence and socio-behavioral factors associated with sugar-sweetened beverages consumption among 15 years and older persons in South Africa
Pengpid S, Peltzer K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:937-945
Published Date: 21 June 2019
Relationship between body-roundness index and metabolic syndrome in type 2 diabetes
Liu B, Liu B, Wu G, Yin F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:931-935
Published Date: 19 June 2019
Prognostic factors for cesarean section outcome of pregnant women with gestational diabetes mellitus: a systematic review and meta-analysis
Wang J, Chen K, Jin X, Li X, An P, Yang N, Chen Y, Fang Y, Mu Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:913-929
Published Date: 21 June 2019
Higher blood pressure increases arterial stiffness modified by blood glucose levels in a Chinese community-based study
Dai X, Yang Y, Cheng GL, Jia J, Fan FF, Li JP, Huo Y, Liu Z, Chen D, Zhang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:901-911
Published Date: 24 June 2019
Self-reported oral health and quality of life in patients with type 2 diabetes mellitus in primary care: a multi-center cross-sectional study
Verhulst MJL, Teeuw WJ, Gerdes VEA, Loos BG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:883-899
Published Date: 18 June 2019
GLP-1 mediates the modulating effect of thymoquinone on feeding behaviors in diabetic rats
Lee SP, Kuo FY, Cheng JT, Wu MC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:873-881
Published Date: 12 June 2019
Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women
Albracht-Schulte K, Rosairo S, Ramalingam L, Wijetunge S, Ratnayake RMCJ, Kotakadeniya HMSRB, Dawson JA, Kalupahana NS, Moustaid-Moussa N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:863-872
Published Date: 10 June 2019
Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia
Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, Zakri I, Sabai A, Darraj M, Mutawwam DA, Daghreeri M, Sayed S, Alaallah W, Alfadhly A, Alsabaani A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:853-862
Published Date: 5 June 2019
Current management strategies to target the increasing incidence of diabetes within Pakistan [Corrigendum]
Basit A, Fawwad A, Siddiqui SA, Baqa K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:851-852
Published Date: 4 June 2019
Validation and cross-cultural adaptation of the depression Patient’s Health Questionnaire – 9 in the Romanian population of patients with Type 2 Diabetes Mellitus
Lupascu N, Timar B, Albai A, Roman D, Potre O, Timar R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:841-849
Published Date: 30 May 2019
Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy
Jiang X, Yu J, Wang X, Ge J, Li N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:827-839
Published Date: 30 May 2019
The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
Mai BH, Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:821-826
Published Date: 27 May 2019
Obesity: outcome of standardized life-style change in a rehabilitation clinic. An observational study
Haslacher H, Fallmann H, Waldhäusl C, Hartmann E, Wagner OF, Waldhäusl WK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:813-820
Published Date: 27 May 2019
Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis
Liu B, Mao X, Huang D, Li F, Dong N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:801-811
Published Date: 27 May 2019
Mobile application intervention to promote self-management in insulin-requiring type 1 and type 2 diabetes individuals: protocol for a mixed methods study and non-blinded randomized controlled trial
Adu MD, Malabu UH, Malau-Aduli AEO, Malau-Aduli BS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:789-800
Published Date: 24 May 2019
Assessment of insulin sensitivity and secretion in patients with fibrocalculous pancreatic diabetes
Aiswarya Y, Shivaprasad C, Anish K, Sridevi A, Anupam B, Amit G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:779-788
Published Date: 22 May 2019
Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology
Li XY, Shen L, Ji HF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:771-778
Published Date: 17 May 2019
Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
Kunavisarut T, Sriussadaporn S, Lertwattanarak R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:761-770
Published Date: 21 May 2019
Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study
Muo IM, MacDonald SD, Madan R, Park SJ, Gharib AM, Martinez PE, Walter MF, Yang SB, Rodante JA, Courville AB, Walter PJ, Cai H, Glicksman M, Guerrieri GM, Ben-Dor RR, Ouwerkerk R, Mao S, Chung JH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:743-759
Published Date: 27 May 2019
Immunogenetics of new onset diabetes after transplantation in Kuwait
Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:731-742
Published Date: 20 May 2019
Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis [Corrigendum]
Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:729-730
Published Date: 22 May 2019
The obstacles to diabetes self-management education and support from healthcare professionals’ perspectives: a nationwide survey
Preechasuk L, Sriussadaporn P, Likitmaskul S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:717-727
Published Date: 16 May 2019
Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy
Ahmed AEA, Sakhr HM, Hassan MH, El-Amir MI, Ameen HH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:703-716
Published Date: 14 May 2019
Plasma cholinesterase is associated with Chinese adolescent overweight or obesity and metabolic syndrome prediction
Han Y, Ma Y, Liu Y, Zhao Z, Zhen S, Yang X, Xu Z, Wen D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:685-702
Published Date: 14 May 2019
The association of the fat mass and obesity-associated gene (FTO) rs9939609 polymorphism and the severe obesity in a Brazilian population
da Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Nogueira Neto JF, Cabello GMK, Cabello PH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:667-684
Published Date: 23 May 2019
Downregulation of MALAT1 alleviates saturated fatty acid-induced myocardial inflammatory injury via the miR-26a/HMGB1/TLR4/NF-κB axis
Jia P, Wu N, Jia D, Sun Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:655-665
Published Date: 7 May 2019
Prevalence and correlates of underweight and overweight/obesity among women in India: results from the National Family Health Survey 2015–2016
Pengpid S, Peltzer K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:647-653
Published Date: 3 May 2019
An automatic diagnostic system based on deep learning, to diagnose hyperlipidemia
Zhang Q, Liu Y, Liu G, Zhao G, Qu Z, Yang W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:637-645
Published Date: 3 May 2019
MRI assessment of ectopic fat accumulation in pancreas, liver and skeletal muscle in patients with obesity, overweight and normal BMI in correlation with the presence of central obesity and metabolic syndrome
Pieńkowska J, Brzeska B, Kaszubowski M, Kozak O, Jankowska A, Szurowska E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:623-636
Published Date: 3 May 2019
Eight-week of low-intensive lifestyle modification does improve insulin resistance in adults with metabolic syndrome
Lin YH, Huang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:613-621
Published Date: 2 May 2019
Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
Bakr Zaki M, Abulsoud AI, Elsisi AM, Doghish AS, Mansour OAE, Amin AI, Elrebehy MA, Mohamed MY, Goda MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:601-611
Published Date: 6 May 2019
Barriers of medication adherence in patients with type-2 diabetes: a pilot qualitative study
Rezaei M, Valiee S, Tahan M, Ebtekar F, Ghanei Gheshlagh R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:589-599
Published Date: 1 May 2019
The association between cardiac autonomic neuropathy and diabetes control
Vasheghani M, Sarvghadi F, Beyranvand MR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:581-587
Published Date: 30 April 2019
Prevalence of metabolic syndrome in dialysis and transplant patients
AlShelleh S, AlAwwa I, Oweis A, AlRyalat SA, Al-Essa M, Saeed I, Alhawari HH, Alzoubi KH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:575-579
Published Date: 29 April 2019
Anti-inflammatory and angiogenic effects of exercise training in cardiac muscle of diabetic mice
Broderick TL, Sennott JM, Gutkowska J, Jankowski M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:565-573
Published Date: 26 April 2019
Clinical effectiveness of quercetin supplementation in the management of weight loss: a pooled analysis of randomized controlled trials
Huang H, Liao D, Dong Y, Pu R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:553-563
Published Date: 24 April 2019
Cystic fibrosis-related diabetes: optimizing care with a multidisciplinary approach
Frost F, Dyce P, Ochota A, Pandya S, Clarke T, Walshaw MJ, Nazareth DS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:545-552
Published Date: 26 April 2019
The relationship between hypertriglyceridemic-waist phenotype and vitamin D status in type 2 diabetes
Ma CM, Yin FZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:537-543
Published Date: 23 April 2019
Cardiovascular risk profile, oxygen uptake, and perceived exertion rate in children with obesity: the interactive effect of exercise intensity and duration
Elnaggar RK, Elshazly FA, Abdelbasset WK, Ahmed AS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:527-536
Published Date: 17 April 2019
Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
Xie J, Li N, Jiang X, Chai L, Chen JJ, Deng W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:519-526
Published Date: 17 April 2019
Association between lipid accumulation product and diabetic retinopathy based on a community-based survey in Chinese with type 2 diabetes
Wu J, Zhong Y, Yue S, Guan P, Zhang G, Liu L, Chen L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:513-518
Published Date: 16 April 2019
Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date
Howell R, Wright AM, Clements JN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:505-512
Published Date: 17 April 2019
Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease
Shida T, Oshida N, Oh S, Okada K, Shoda J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:495-503
Published Date: 15 April 2019
Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers
Zahran AM, Sayed SK, Abd El Hafeez HA, Khalifa WA, Mohamed NA, Hetta HF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:485-493
Published Date: 12 April 2019
Prevalence of metabolic syndrome and its associated factors in Chinese patients with ankylosing spondylitis
Liu M, Huang Y, Huang Z, Huang Q, Guo X, Wang Y, Deng W, Huang Z, Li T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:477-484
Published Date: 11 April 2019
Factors influencing insulin sensitivity during hyperinsulinemic-euglycemic clamp in healthy Korean male subjects
Shin D, Eom YS, Chon S, Kim BJ, Yu KS, Lee DH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:469-476
Published Date: 10 April 2019
Prevalence of abnormal glucose homeostasis in Chinese patients with non-transfusion-dependent thalassemia
Luo Y, Bajoria R, Lai Y, Pan H, Li Q, Zhang Z, Yang P, Chatterjee R, Liang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:457-468
Published Date: 11 April 2019
Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
Hinnen D, Kruger DF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:447-455
Published Date: 4 April 2019
Low-dose computed tomography of urolithiasis in obese patients: a feasibility study to evaluate image reconstruction algorithms
Chang DH, Slebocki K, Khristenko E, Herden J, Salem J, Große Hokamp N, Mammadov K, Hellmich M, Kabbasch C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:439-445
Published Date: 5 April 2019
Genetic variants linked to T2DM risk in Kurdish populations
Golsheh S, Keshavarzi F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:431-437
Published Date: 5 April 2019
Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
Kratochvilova H, Lacinova Z, Klouckova J, Kavalkova P, Cinkajzlova A, Trachta P, Krizova J, Benes M, Dolezalova K, Fried M, Vlasakova Z, Pelikanova T, Spicak J, Mraz M, Haluzik M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:423-430
Published Date: 28 March 2019
Effects of polymorphism in FABP2 Ala54Thr on serum lipids and glycemic control in low glycemic index diets are associated with gender among Han Chinese with type 2 diabetes mellitus
Liu PJ, Liu YP, Qin HK, Xing T, Li SS, Bao YY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:413-421
Published Date: 27 March 2019
Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4
Zhao H, Shu L, Huang W, Song G, Ma H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:401-411
Published Date: 25 March 2019
Factors associated with overweight and obesity among adults in northeast Ethiopia: a cross-sectional study
Dagne S, Gelaw YA, Abebe Z, Wassie MM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:391-399
Published Date: 22 March 2019
Apelin and chemerin as promising adipokines in children with type 1 diabetes mellitus
Elsehmawy AAEW, El-Toukhy SE, Seliem NMA, Moustafa RS, Mohammed DS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:383-389
Published Date: 22 March 2019
Increase in mast cell marker expression in the synovium of obese patients with osteoarthritis of the knee
Uchida K, Takano S, Inoue G, Iwase D, Aikawa J, Takata K, Tazawa R, Kawakubo A, Sekiguchi H, Takaso M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:377-382
Published Date: 21 March 2019
Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study
Talwalkar P, Deshmukh V, Bhole M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:369-376
Published Date: 20 March 2019
Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
Szanto KB, Li J, Cordero P, Oben JA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:357-367
Published Date: 19 March 2019
The role of concordant and discordant comorbidities on performance of self-care behaviors in adults with type 2 diabetes: a systematic review
Aga F, Dunbar SB, Kebede T, Gary RA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:333-356
Published Date: 18 March 2019
Galectin-3 as a prognostic biomarker for diabetic nephropathy
Hodeib H, Hagras MM, Abdelhai D, Watany MM, Selim A, Tawfik MA, Elsebaey MA, Elshweikh SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:325-331
Published Date: 13 March 2019
Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease
Soleimani D, Ranjbar G, Rezvani R, Goshayeshi L, Razmpour F, Nematy M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:315-324
Published Date: 12 March 2019
The relationship between serum-free insulin-like growth factor-1 and metabolic syndrome in school adolescents of northeast China
Xie S, Jiang R, Xu W, Chen Y, Tang L, Li L, Li P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:305-313
Published Date: 5 March 2019
Optimizing glycemic control in type 2 diabetic patients through the use of a low-carbohydrate, high-fat, ketogenic diet: a review of two patients in primary care
Rallis S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:299-303
Published Date: 5 March 2019
Measurement of diabetes, prediabetes and their associated risk factors in Myanmar 2014
Latt TS, Zaw KK, Ko K, Hlaing MM, Ohnmar M, Oo ES, Thein KMM, Yuasa M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:291-298
Published Date: 4 March 2019
Diabetic muscle infarction: often misdiagnosed and mismanaged
Verjee MA, Abdelsamad NA, Qureshi S, Malik RA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:285-290
Published Date: 5 March 2019
ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity
Vincent V, Thakkar H, Aggarwal S, Mridha AR, Ramakrishnan L, Singh A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:275-284
Published Date: 25 February 2019
Morbidity associated with overweight and obesity in health personnel: a 10-year retrospective of hospital-based cohort study in Taiwan
Yeh TL, Chen HH, Chiu HH, Chiu YH, Hwang LC, Wu SL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:267-274
Published Date: 7 March 2019
Identification of the MC4R start lost mutation in a morbidly obese Brazilian patient
Fonseca ACP, Abreu GM, Zembrzuski VM, Campos Junior M, Carneiro JRI, Magno FCCM, Rosado EL, Nogueira Neto JF, Cabello GMK, Cabello PH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:257-266
Published Date: 21 February 2019
Interaction between dietary patterns and TCF7L2 polymorphisms on type 2 diabetes mellitus among Uyghur adults in Xinjiang Province, China
Cai J, Zhang Y, Nuli R, Zhang Y, Abudusemaiti M, Kadeer A, Tian X, Xiao H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:239-255
Published Date: 14 February 2019
PEARLS randomized lifestyle trial in pregnant Hispanic women with overweight/obesity: gestational weight gain and offspring birthweight
Trak-Fellermeier MA, Campos M, Meléndez M, Pomeroy J, Palacios C, Rivera-Viñas J, Méndez K, Febo I, Willett W, Gillman MW, Franks PW, Joshipura K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:225-238
Published Date: 18 February 2019
Cardioprotective effects of a ruthenium (II) Schiff base complex in diet-induced prediabetic rats
Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:217-223
Published Date: 14 February 2019
Canagliflozin review – safety and efficacy profile in patients with T2DM
Jakher H, Chang TI, Tan M, Mahaffey KW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:209-215
Published Date: 1 February 2019
Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
Sun Y, Dai W, Liang Y, Yang P, Yang Q, Liang M, Xia N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:199-207
Published Date: 30 January 2019
Leptin resistance: underlying mechanisms and diagnosis
Gruzdeva O, Borodkina D, Uchasova E, Dyleva Y, Barbarash O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:191-198
Published Date: 25 January 2019
The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010–2011
Khang AR, Lee HW, Yi DW, Kang YH, Son SM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:181-190
Published Date: 24 January 2019
Effect of kiwifruit on metabolic health in patients with cardiovascular risk factors: a systematic review and meta-analysis
Suksomboon N, Poolsup N, Lin W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:171-180
Published Date: 23 January 2019
Analysis of the diet quality and dietary habits of children and adolescents with type 1 diabetes
Dłużniak-Gołaska K, Panczyk M, Szostak-Węgierek D, Szypowska A, Sińska B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:161-170
Published Date: 17 January 2019
Effects of duodenal–jejunal bypass surgery in ameliorating nonalcoholic steatohepatitis in diet-induced obese rats
Yu HH, Hsieh MC, Wu SY, Sy ED, Shan YS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:149-159
Published Date: 17 January 2019
Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people
Xin YL, Wang Y, Chi J, Zhu X, Zhao H, Zhao S, Wang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:139-147
Published Date: 17 January 2019
Metabolic syndrome as a risk factor for high intraocular pressure: the Korea National Health and Nutrition Examination Survey 2008–2010
Yi YH, Cho YH, Kim YJ, Lee SY, Lee JG, Kong EH, Cho BM, Tak YJ, Hwang HR, Lee SH, Park EJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:131-137
Published Date: 14 January 2019
Different risk factors for cognitive impairment among community-dwelling elderly, with impaired fasting glucose or diabetes
Xiu S, Zheng Z, Liao Q, Chan P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:121-130
Published Date: 9 January 2019
Effects of omega-3 polyunsaturated fatty-acid supplementation on neuropathic pain symptoms and sphingosine levels in Mexican-Americans with type 2 diabetes
Durán AM, Salto LM, Câmara J, Basu A, Paquien I, Beeson WL, Firek A, Cordero-MacIntyre Z, De León M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:109-120
Published Date: 8 January 2019
Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice
Campbell CL, Yu R, Li F, Zhou Q, Chen D, Qi C, Yin Y, Sun J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:97-107
Published Date: 4 January 2019
Current management strategies to target the increasing incidence of diabetes within Pakistan
Basit A, Fawwad A, Siddiqui SA, Baqa K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:85-96
Published Date: 27 December 2018
Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
Fasil A, Biadgo B, Abebe M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:75-83
Published Date: 21 December 2018
Comparison of three meta-analytic methods using data from digital interventions on type 2 diabetes
Kebede MM, Peters M, Heise TL, Pischke CR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:59-73
Published Date: 19 December 2018
Physical activity increases the resistin concentration in hemodialyzed patients without metabolic syndrome
Hornik B, Duława J, Szewieczek J, Durmała J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:43-57
Published Date: 18 December 2018
Initial outcomes of one anastomosis gastric bypass at a single institution
Jamal W, Zagzoog MM, Sait SH, Alamoudi AO, Abo’ouf S, Alghamdi AA, Bamashmous RO, Maghrabi AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:35-41
Published Date: 24 December 2018
Psychosocial interventions for reducing diabetes distress in vulnerable people with type 2 diabetes mellitus: a systematic review and meta-analysis
Mathiesen AS, Egerod I, Jensen T, Kaldan G, Langberg H, Thomsen T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:19-33
Published Date: 17 December 2018
Self-management knowledge and practice of type 2 diabetes mellitus patients in Baghdad, Iraq: a qualitative study
Mikhael EM, Hassali MA, Hussain SA, Shawky N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019, 12:1-17
Published Date: 17 December 2018
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
Cheng KC, Li Y, Chang WT, Kuo FY, Chen ZC, Cheng JT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:901-911
Published Date: 7 December 2018
Salubrinal abrogates palmitate-induced leptin resistance and endoplasmic reticulum stress via nuclear factor kappa-light-chain-enhancer of activated B cell pathway in mHypoE-44 hypothalamic neurons
Zhang M, Jiang X, Qu M, Gu H, Sha Q, Hua F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:893-899
Published Date: 6 December 2018
Serum trace elements in insulin-dependent and non-insulin-dependent diabetes: a comparative study
Ahmed AM, Khabour OF, Awadalla AH, Waggiallah HA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:887-892
Published Date: 4 December 2018
Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis
Huang H, Chi H, Liao D, Zou Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:875-886
Published Date: 29 November 2018
Genistein diet does not modify crypt morphology in the ob/ob mouse jejunum: a comparison of cryostat and clearing techniques
Sandoval-Skeet N, Kaufman JA, Castro MJ, Al-Nakkash L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:863-873
Published Date: 29 November 2018
A paradigm shift for the prevention and treatment of individual and global obesity
Slyper AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:855-861
Published Date: 29 November 2018
TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
Dar MS, Bég SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:845-853
Published Date: 28 November 2018
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
Seko Y, Nishikawa T, Umemura A, Yamaguchi K, Moriguchi M, Yasui K, Kimura M, Iijima H, Hashimoto T, Sumida Y, Okanoue T, Itoh Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:835-843
Published Date: 27 November 2018
Dysfunctional phagocytosis capacity, granulocyte recruitment and inflammatory factor secretion of Kupffer cells in diabetes mellitus reversed by Lidocaine
Wang R, Sheng M, Shi F, Zhao Y, Zhao L, Wu J, Wu G, Song Q
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:827-834
Published Date: 26 November 2018
Madelung’s disease – progressive, excessive, and symmetrical deposition of adipose tissue in the subcutaneous layer: case report and literature review
Szewc M, Sitarz R, Moroz N, Maciejewski R, Wierzbicki R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:819-825
Published Date: 26 November 2018
Early detection of metabolic dysregulation using water T2 analysis of biobanked samples
Mishra I, Jones C, Patel V, Deodhar S, Cistola DP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:807-818
Published Date: 23 November 2018
Is there an association between liraglutide use and female breast cancer in a real-world setting?
Funch D, Mortimer K, Li L, Norman H, Major-Pedersen A, Olsen AH, Kaltoft MS, Dore DD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:791-806
Published Date: 22 November 2018
Diets high in vegetables, fruits, cereals, and tubers as a protective factor for metabolic syndrome in bank employees
Cattafesta M, Salaroli LB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:781-790
Published Date: 21 November 2018
Examining the association between diabetes, depressive symptoms, and suicidal ideation among Aboriginal Canadian peoples living off-reserve: a cross-sectional, population-based study
Elamoshy R, Bird Y, Thorpe LU, Moraros J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:767-780
Published Date: 22 November 2018
An epidemiologic study on symptomatic pelvic organ prolapse in obese Chinese women: a population-based study in China
Li Z, Xu T, Li Z, Gong J, Liu Q, Wang Y, Wang J, Xia Z, Zhu L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:761-766
Published Date: 16 November 2018
Long-term outcomes following completion of a structured nutrition and exercise lifestyle intervention program for patients with metabolic syndrome
Joseph MS, Konerman MA, Zhang M, Wei B, Brinza E, Walden P, Jackson EA, Rubenfire M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:753-759
Published Date: 15 November 2018
Relationship between early menarche, obesity, and disordered eating behaviors: a school-based cross-sectional survey in Northern Saudi Arabia
Almuhlafi M, Abu Jamilah K, Almutairi AF, Salam M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:743-751
Published Date: 15 November 2018
Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure
Huang H, Liao D, Pu R, Cui Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:729-742
Published Date: 14 November 2018
Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study
Ahmadieh H, Itani H, Itani S, Sidani K, Kassem M, Farhat K, Jbeily M, Itani A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:717-728
Published Date: 8 November 2018
Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
Conway BN, Badders AN, Costacou T, Arthur JM, Innes KE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:707-716
Published Date: 15 November 2018
Barberry in the treatment of obesity and metabolic syndrome: possible mechanisms of action
Firouzi S, Malekahmadi M, Ghayour-Mobarhan M, Ferns G, Rahimi HR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:699-705
Published Date: 8 November 2018
COSMIC project: consensus on the objectives of the metabolic syndrome in clinic
Pedro-Botet J, Ascaso JF, Barrios V, De la Sierra A, Escalada J, Millan J, Mostaza JM, Pérez-Martínez P, Pintó X, Salas-Salvadó J, Valdivielso P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:683-697
Published Date: 31 October 2018
Astragalus polysaccharides inhibit oxidation in high glucose-challenged or SOD2-silenced H9C2 cells
Chen W, Sun Q, Ju J, Chen W, Zhao X, Zhang Y, Yang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:673-681
Published Date: 24 October 2018
Influence of gastric bypass surgery on resting energy expenditure, body composition, physical activity, and thyroid hormones in morbidly obese patients
Mirahmadian M, Hasani M, Taheri E, Qorbani M, Hosseini S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:667-672
Published Date: 23 October 2018
Depressive symptoms among elderly diabetic patients in Vietnam
Vu HTT, Nguyen TX, Nguyen HTT, Le TA, Nguyen TN, Nguyen AT, Nguyen TTH, Nguyen HL, Nguyen CT, Tran BX, Latkin CA, Pham T, Zhang MW, Ho RC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:659-665
Published Date: 23 October 2018
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus
Gouda M, Matsukawa M, Iijima H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:647-658
Published Date: 17 October 2018
Quick guide to type 2 diabetes self-management education: creating an interdisciplinary diabetes management team
Chester B, Stanely WG, Geetha T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:641-645
Published Date: 17 October 2018
To fast or not to fast during the month of Ramadan? A comprehensive survey on religious beliefs and practices among Moroccan diabetic patients
Al-Balhan E, Khabbache H, Laaziz A, Watfa A, Mhamdi A, Del Puente G, Bragazzi NL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:633-640
Published Date: 16 October 2018
Effects of Caralluma russeliana stem extract on some physiological parameters in streptozotocin-induced diabetic male rats
Zari TA, Al-Thebaiti MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:619-631
Published Date: 12 October 2018
Plasma stearoyl-CoA desaturase activity indices and bile acid concentrations after a low-fat meal: association with a genetic variant in the FTO gene
Skuladottir GV, Oskarsdottir H, Pisanu C, Sjödin M, Lindberg J, Mwinyi J, Schiöth HB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:611-618
Published Date: 9 October 2018
Can reducing sitting time in the university setting improve the cardiometabolic health of college students?
Butler KM, Ramos JS, Buchanan CA, Dalleck LC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:603-610
Published Date: 8 October 2018
Urinary TGF-β1 was not independently associated with renal function in diabetes mellitus
Sauriasari R, Pratiwi MY
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:597-602
Published Date: 8 October 2018
Factors associated with adherence to diabetes care recommendations among children and adolescents with type 1 diabetes: a facility-based study in two urban diabetes clinics in Uganda [Corrigendum]
Kyokunzire C, Matovu N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:595-596
Published Date: 5 October 2018
Obesity management in Prader–Willi syndrome: current perspectives
Crinò A, Fintini D, Bocchini S, Grugni G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:579-593
Published Date: 4 October 2018
Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
Han J, Tang Y, Lu M, Hua H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:565-577
Published Date: 28 September 2018
Identification of key gene pathways and coexpression networks of islets in human type 2 diabetes
Li L, Pan Z, Yang S, Shan W, Yang Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:553-563
Published Date: 28 September 2018
Developmental origins of health and disease: a new approach for the identification of adults who suffered undernutrition in early life
Ferreira HS, Xavier Junior AF, Assunção ML, Uchôa TC, Lira-Neto AB, Nakano RP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:543-551
Published Date: 26 September 2018
Obesity and nonalcoholic fatty liver disease: current perspectives
Sarwar R, Pierce N, Koppe S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:533-542
Published Date: 25 September 2018
Assessment of sleep quality and its predictors among patients with diabetes in Jazan, Saudi Arabia
Darraj A, Mahfouz MS, Alsabaani A, Sani M, Alameer A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:523-531
Published Date: 25 September 2018
Metabolic syndrome and blood pressure: are they related or not?
Jonnalagadda VG, Uppulapu SK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:521-522
Published Date: 24 September 2018
Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
Mahamid M, Khoury T, Amara H, Siadi M, Mohamed J, Mari A, Shalabi R, Sholy H, Nseir W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:515-519
Published Date: 24 September 2018
Decompression nerve surgery for diabetic neuropathy: a structured review of published clinical trials
Albers JW, Jacobson R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:493-514
Published Date: 24 September 2018
Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice
Jarrar YB, Al-Essa L, Kilani A, Hasan M, Al-Qerem W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:483-492
Published Date: 25 September 2018
Nutrition therapy for type 2 diabetes: confirmed efficacy on individualized management
Wei FX, Qi XP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:479-481
Published Date: 13 September 2018
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
Hurt RT, Mundi MS, Ebbert JO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:469-478
Published Date: 4 September 2018
Efficacy of bariatric surgery in improving metabolic outcomes in patients with diabetes. A 24-month follow-up study from a single center in the UAE
Alnageeb H, Abdelgadir E, Khalifa A, Suliman M, Gautam S, Layani L, Subramaniam S, Bashier A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:459-467
Published Date: 3 September 2018
Daily intake of Kaempferia parviflora extract decreases abdominal fat in overweight and preobese subjects: a randomized, double-blind, placebo-controlled clinical study
Yoshino S, Awa R, Miyake Y, Fukuhara I, Sato H, Ashino T, Tomita S, Kuwahara H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:447-458
Published Date: 28 August 2018
Association between polymorphisms in SLC15A1 and PLA2G16 genes and development of obesity in Chinese subjects
Wang CY, Liu S, Xie XN, Luo ZY, Yang L, Tan ZR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:439-446
Published Date: 22 August 2018
Medications that cause weight gain and alternatives in Canada: a narrative review
Wharton S, Raiber L, Serodio KJ, Lee J, Christensen RAG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:427-438
Published Date: 21 August 2018
Prevalence of diabetic comorbidities and knowledge and practices of foot care among diabetic patients: a cross-sectional study
Abdulghani HM, AlRajeh AS, AlSalman BH, AlTurki LS, AlNajashi NS, Irshad M, Alharbi KH, AlBalawi YE, AlSuliman YA, Ahmad T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:417-425
Published Date: 16 August 2018
Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka
Weerarathna TP, Herath HMM, Liyanage G, Weerarathna MK, Senadeera V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:409-415
Published Date: 8 August 2018
Prevalence of the metabolic syndrome according to different criteria in the male population during the Blue November Campaign in Natal, RN, Northeastern Brazil
Espósito RC, Medeiros PJ, Silva FS, Oliveira AG, Soares Aragão CF, Oliveira Rocha HA, Moreira SA, Farias Sales VS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:401-408
Published Date: 6 August 2018
Hypomagnesemia in diabetes patients: comparison of serum and intracellular measurement of responses to magnesium supplementation and its role in inflammation
Zghoul N, Alam-Eldin N, Mak IT, Silver B, Weglicki WB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:389-400
Published Date: 2 August 2018
Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016
Tripathy JP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:381-387
Published Date: 31 July 2018
Effects of Spirulina platensis microalgae on antioxidant and anti-inflammatory factors in diabetic rats
Nasirian F, Dadkhah M, Moradi-kor N, Obeidavi Z
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:375-380
Published Date: 31 July 2018
Migraine in adults with diabetes; is there an association? Results of a population-based study
López-de-Andrés A, del Barrio JL, Hernández-Barrera V, de Miguel-Díez J, Jimenez-Trujillo I, Martinez-Huedo MA, Jimenez-García R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:367-374
Published Date: 20 July 2018
Hypoglycemic activity and constituents analysis of blueberry (Vaccinium corymbosum) fruit extracts
Huang W, Yao L, He X, Wang L, Li M, Yang YX, Wan C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:357-366
Published Date: 17 July 2018
Weight outcome after 2 years of a diet that excludes six processed foods: exploratory study of the “1,2,3 diet” in a moderately obese population
Courie R, Gaillard M, Lainas P, Hansel B, Naveau S, Dagher I, Tranchart H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:345-355
Published Date: 12 July 2018
Depression in people with type 2 diabetes: current perspectives
Darwish L, Beroncal E, Sison MV, Swardfager W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:333-343
Published Date: 10 July 2018
Effects of glucosyl-hesperidin and physical training on body weight, plasma lipids, oxidative status and vascular reactivity of rats fed with high-fat diet
Tomazini Gonçalves T, Lazaro CM, De Mateo FG, Campos MCB, Mezencio JGB, Claudino MA, Carvalho PO, Webb RC, Priviero FBM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:321-332
Published Date: 4 July 2018
Predictors of major lower limb amputation in type 2 diabetic patients referred for hospital care with diabetic foot syndrome
Shatnawi NJ, Al-Zoubi NA, Hawamdeh HM, Khader YS, Gharaibeh K, Heis HA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:313-319
Published Date: 22 June 2018
Effect of aerobic exercise on echocardiographic epicardial adipose tissue thickness in overweight individuals
Bairapareddy KC, Maiya AG, Kumar P, Nayak K, Guddattu V, Nayak V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:303-312
Published Date: 22 June 2018
Proteomic analysis to identify candidate biomarkers associated with type 1 diabetes
do Nascimento de Oliveira V, Lima-Neto, ABM, van Tilburg MF, de Oliveira Monteiro-Moreira AC, Duarte Pinto Lobo M, Rondina D, Fernandes VO, Montenegro AP, Montenegro RM Jr, Guedes MIF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:289-301
Published Date: 13 June 2018
Chronic oscillating glucose challenges disarrange innate immune homeostasis to potentiate the variation of neutrophil–lymphocyte ratio in rats with or without hidden diabetes mellitus
Yang G, Yan R, Tong H, Zhang J, Chen B, Xue X, Wang J, Chu M, Jin S, Li M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:277-288
Published Date: 13 June 2018
The influences of bariatric surgery on hemoglobin A1c in a sample of obese patients in Saudi Arabia
Ahmed AE, Alanazi WR, Ahmed RA, AlJohi W, AlBuraikan DA, AlRasheed BA, ALMuqbil BI, Al-Zahrani AA, Yousef ZM, AL-Jahdali H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:271-276
Published Date: 12 June 2018
Success of nutrition-therapy interventions in persons with type 2 diabetes: challenges and future directions
Franz MJ, MacLeod J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:265-270
Published Date: 11 June 2018
Autoamputation of diabetic toe with dry gangrene: a myth or a fact?
Al Wahbi A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:255-264
Published Date: 1 June 2018
Performance of body mass index and percentage of body fat in predicting cardiometabolic risk factors in Thai adults
Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N, Kruthkul K, Kroll MH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:241-253
Published Date: 1 June 2018
Relative handgrip strength as a marker of metabolic syndrome: the Korea National Health and Nutrition Examination Survey (KNHANES) VI (2014–2015)
Yi DW, Khang AR, Lee HW, Son SM, Kang YH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:227-240
Published Date: 23 May 2018
Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
Pollock RF, Chubb B, Valentine WJ, Heller S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:217-226
Published Date: 16 May 2018
Severity of primary open-angle glaucoma in patients with hypertension and diabetes
Khatri A, Shrestha JK, Thapa M, Khatri BK, Kharel M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:209-215
Published Date: 16 May 2018
Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNFα levels, and food intake of women with morbid obesity
Magno FCCM, Guaraná HC, Fonseca ACP, Cabello GMK, Carneiro JRI, Pedrosa AP, Ximenes AC, Rosado EL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:199-207
Published Date: 14 May 2018
Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
Kugler AJ, Thiman ML
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:187-197
Published Date: 9 May 2018
Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:183-186
Published Date: 4 May 2018
Testosterone, obesity, and waist circumference as determinants of metabolic syndrome in Saudi women
Fatani SH, Abdelbasit NA, Al-Amodi HS, Mukhtar MM, Babakr AT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:175-181
Published Date: 1 May 2018
Adjunctive therapy for glucose control in patients with type 1 diabetes
Harris K, Boland C, Meade L, Battise D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:159-173
Published Date: 27 April 2018
Plasma concentrations of zonulin are elevated in obese men with fatty liver disease
Kim AS, Ko HJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:149-157
Published Date: 23 April 2018
Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
Santos Cavaiola T, Pettus J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:133-148
Published Date: 12 April 2018
Statin on insulin and adiponectin levels: true or false prophecy?
Jonnalagadda VG, Shaik A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:131-132
Published Date: 12 April 2018
Subcutaneous to visceral fat ratio: a possible risk factor for metabolic syndrome and cardiovascular diseases
Shafqat MN, Haider M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:129-130
Published Date: 12 April 2018
Effect of dietary oils on peripheral neuropathy-related endpoints in dietary obese rats
Coppey L, Davidson E, Shevalye H, Torres ME, Yorek MA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:117-127
Published Date: 9 April 2018
Screening and management of gestational diabetes in Mexico: results from a survey of multilocation, multi-health care institution practitioners
Dainelli L, Prieto-Patron A, Silva-Zolezzi I, Sosa-Rubi SG, Espino y Sosa S, Reyes-Muñoz E, Lopez-Ridaura R, Detzel P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:105-116
Published Date: 5 April 2018
Factors associated with adherence to diabetes care recommendations among children and adolescents with type 1 diabetes: a facility-based study in two urban diabetes clinics in Uganda
Kyokunzire C, Matovu N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:93-104
Published Date: 29 March 2018
Trace elements and oxidative stress in children with type 1 diabetes mellitus
Alghobashy AA, Alkholy UM, Talat MA, Abdalmonem N, Zaki A, Ahmed IA, Mohamed RH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:85-92
Published Date: 26 March 2018
Metabolic profiling of follistatin overexpression: a novel therapeutic strategy for metabolic diseases
Singh R, Pervin S, Lee S, Kuo A, Grijalva V, David J, Vergnes L, Reddy ST
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:65-84
Published Date: 26 March 2018
The impact of carbohydrate intake and its sources on hemoglobin A1c levels in Japanese patients with type 2 diabetes not taking anti-diabetic medication
Haimoto H, Watanabe S, Komeda M, Wakai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:53-64
Published Date: 9 March 2018
Protein-induced satiation and the calcium-sensing receptor
Ojha U
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:45-51
Published Date: 9 March 2018
Decreased health-related quality of life in patients with diabetic foot problems
Sothornwit J, Srisawasdi G, Suwannakin A, Sriwijitkamol A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:35-43
Published Date: 7 March 2018
Randomized trial of amino acid mixture combined with physical activity promotion for abdominal fat reduction in overweight adults
Ueda K, Sasai H, Tsujimoto T, Sanbongi C, Ikegami S, Kobayashi H, Shioya N, Suzuki S, Nakata Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:23-33
Published Date: 26 February 2018
The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
Alzaheb RA, Altemani AH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:15-21
Published Date: 31 January 2018
Linking care of patients with obesity to outpatient weight control clinics following acute hospitalizations
Harris CM, Cheskin LJ, Gipson-Jones TL, Hartfield JA, Kisuule F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:11-14
Published Date: 24 January 2018
Obesity in Mexico: prevalence, comorbidities, associations with patient outcomes, and treatment experiences
DiBonaventura MD, Meincke H, Le Lay A, Fournier J, Bakker E, Ehrenreich A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2018, 11:1-10
Published Date: 22 December 2017
Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience
Chan WB, Chen JF, Goh SY, Vu TTH, Isip-Tan IT, Mudjanarko SW, Bajpai S, Mabunay MA, Bunnag P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:521-532
Published Date: 15 December 2017
Effects of a proposed physical activity and diet control to manage constipation in middle-aged obese women
Tantawy SA, Kamel DM, Abdelbasset WK, Elgohary HM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:513-519
Published Date: 14 December 2017
Visceral-to-subcutaneous fat ratio as a predictor of the multiple metabolic risk factors for subjects with normal waist circumference in Korea
Oh YH, Moon JH, Kim HJ, Kong MH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:505-511
Published Date: 11 December 2017
Transition from pre-diabetes to diabetes and predictors of risk in Mexican-Americans
Wu SH, McCormick JB, Curran JE, Fisher-Hoch SP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:491-503
Published Date: 6 December 2017
Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction
Gruzdeva O, Uchasova E, Dyleva Y, Akbasheva O, Karetnikova V, Shilov A, Barbarash O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:481-489
Published Date: 5 December 2017
Obesity and brain illness: from cognitive and psychological evidences to obesity paradox
Monda V, La Marra M, Perrella R, Caviglia G, Iavarone A, Chieffi S, Messina G, Carotenuto M, Monda M, Messina A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:473-479
Published Date: 21 November 2017
Obesity and morbid obesity associated with higher odds of hypoalbuminemia in adults without liver disease or renal failure
Mosli RH, Mosli HH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:467-472
Published Date: 8 November 2017
Association between metabolic syndrome and sensorineural hearing loss: a cross-sectional study of 11,114 participants
Aghazadeh-Attari J, Mansorian B, Mirza-Aghazadeh-Attari M, Ahmadzadeh J, Mohebbi I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:459-465
Published Date: 6 November 2017
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated [Corrigendum]
Irons BK, Minze MG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:457-458
Published Date: 31 October 2017
Online continuing medical education as a key link for successful noncommunicable disease self-management: the CASALUD™ Model
Gallardo-Rincón H, Saucedo-Martínez R, Mujica-Rosales R, Lee EM, Israel A, Torres-Beltran B, Quijano-González Ú, Atkinson ER, Kuri-Morales P, Tapia-Conyer R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:443-455
Published Date: 16 October 2017
Awareness of diabetic retinopathy among patients with type 2 diabetes mellitus in Jordan
Bakkar MM, Haddad MF, Gammoh YS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:435-441
Published Date: 11 October 2017
Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
Fisher VL, Tahrani AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:419-434
Published Date: 6 October 2017
Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
Wharton S, Lee J, Christensen RAG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:413-417
Published Date: 4 October 2017
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:403-412
Published Date: 29 September 2017
Metabolic syndrome remission after Roux-en-Y gastric bypass or sleeve gastrectomy
Nassour I, Almandoz JP, Adams-Huet B, Kukreja S, Puzziferri N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:393-402
Published Date: 20 September 2017
Hypertriglyceridemic waist phenotype in primary health care: comparison of two cutoff points
Braz MAD, Vieira JN, Gomes FO, Silva PR, Santos OTM, Rocha IMGD, Sousa IMD, Fayh APT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:385-391
Published Date: 12 September 2017
Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:375-383
Published Date: 13 September 2017
Type 2 diabetes in Vietnam: a cross-sectional, prevalence-based cost-of-illness study
Le NTD, Dinh Pham L, Quang Vo T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:363-374
Published Date: 29 August 2017
Novel biomarkers for prediabetes, diabetes, and associated complications
Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:345-361
Published Date: 14 August 2017
Diabetes and dyslipidemia: characterizing lipoprotein metabolism
Tomkin GH, Owens D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:333-343
Published Date: 28 July 2017
Emerging use of combination therapies for the management of type 2 diabetes – focus on saxagliptin and dapagliflozin
Yu H, Woo VC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:317-332
Published Date: 21 July 2017
The role of endoscopic therapy in obesity management: intragastric balloons and aspiration therapy
Kumar N, Sullivan S, Thompson CC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:311-316
Published Date: 6 July 2017
Dose-ranging pilot randomized trial of amino acid mixture combined with physical activity promotion for reducing abdominal fat in overweight adults
Sasai H, Ueda K, Tsujimoto T, Kobayashi H, Sanbongi C, Ikegami S, Nakata Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:297-309
Published Date: 6 July 2017
Prevalence of diabetes and obesity in association with prematurity and growth restriction
Kopec G, Shekhawat PS, Mhanna MJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:285-295
Published Date: 6 July 2017
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
Lau IT, Lee KF, So WY, Tan K, Yeung VTF
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:273-284
Published Date: 30 June 2017
Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region
Bekele S, Yohannes T, Mohammed AE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:265-271
Published Date: 22 June 2017
Diabetes in sub-Saharan Africa – from policy to practice to progress: targeting the existing gaps for future care for diabetes
Pastakia SD, Pekny CR, Manyara SM, Fischer L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:247-263
Published Date: 22 June 2017
Effects of a tailored lifestyle self-management intervention (TALENT) study on weight reduction: a randomized controlled trial
Melchart D, Löw P, Wühr E, Kehl V, Weidenhammer W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:235-245
Published Date: 19 June 2017
Off-label drugs for weight management
Hendricks EJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:223-234
Published Date: 10 June 2017
Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway
Civantos E, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, Mas S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:207-222
Published Date: 7 June 2017
Personalized multistep cognitive behavioral therapy for obesity
Dalle Grave R, Sartirana M, El Ghoch M, Calugi S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:195-206
Published Date: 1 June 2017
Changes in muscle strength after diet-induced weight reduction in adult men with obesity: a prospective study
Kim B, Tsujimoto T, So R, Zhao X, Oh S, Tanaka K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:187-194
Published Date: 9 May 2017
Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
Mendivil CO, Toloza FJK, Ricardo-Silgado ML, Morales-Álvarez MC, Mantilla-Rivas JO, Pinzón-Cortés JA, Lemus HN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:179-185
Published Date: 8 May 2017
Effect of vitamin K supplementation on insulin sensitivity: a meta-analysis
Suksomboon N, Poolsup N, Darli Ko Ko H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:169-177
Published Date: 2 May 2017
Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
Ahmadieh H, Ghazal N, Azar ST
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:161-167
Published Date: 2 May 2017
Hearing thresholds in adult Nigerians with diabetes mellitus: a case–control study
Nwosu JN, Chime EN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:155-160
Published Date: 2 May 2017
Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?
Wåhlén A, Haenni A, Johansson HE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:151-154
Published Date: 2 May 2017
Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya
Otieno CFF, Kanu JE, Karari EM, Okech-Helu V, Joshi MD, Mutai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:141-149
Published Date: 28 April 2017
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
Levin PA, Nguyen H, Wittbrodt ET, Kim SC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:123-139
Published Date: 4 April 2017
Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
Orme ME, Nguyen H, Lu JY, Thomas SA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:111-122
Published Date: 29 March 2017
Early-life chemical exposures and risk of metabolic syndrome
De Long NE, Holloway AC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:101-109
Published Date: 21 March 2017
The association of weight loss with patient experience and outcomes in a population of patients with type 2 diabetes mellitus prescribed canagliflozin
Gerlanc NM, Cai J, Tkacz J, Bolge SC, Brady BL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:89-99
Published Date: 20 March 2017
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
Courtney H, Nayar R, Rajeswaran C, Jandhyala R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:79-87
Published Date: 13 March 2017
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
Tatum JA, Meneveau MO, Brayman KL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:73-78
Published Date: 28 February 2017
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
DeBoer MD, Gurka MJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:65-72
Published Date: 20 February 2017
Association between obesity and heart rate variability indices: an intuition toward cardiac autonomic alteration – a risk of CVD
Yadav RL, Yadav PK, Yadav LK, Agrawal K, Sah SK, Islam MN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:57-64
Published Date: 17 February 2017
Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
Davies MJ, Merton KW, Vijapurkar U, Balis DA, Desai M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:47-55
Published Date: 27 January 2017
Different consecutive training protocols to design an intervention program for overweight youth: a controlled study
Fiorilli G, Iuliano E, Aquino G, Campanella E, Tsopani D, Di Costanzo A, Calcagno G, di Cagno A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:37-45
Published Date: 16 January 2017
The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse
Broderick TL, Jankowski M, Gutkowska J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:27-36
Published Date: 11 January 2017
Improvement of impaired diastolic left ventricular function after diet-induced weight reduction in severe obesity
Karimian S, Stein J, Bauer B, Teupe C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:19-25
Published Date: 7 January 2017
Role of glycemic control on hospital-related outcomes in patients with diabetes mellitus undergoing renal transplantation
Lamos EM, Wijesinha MA, Ramhamdani S, Magder LS, Silver KD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:13-17
Published Date: 5 January 2017
Coaching and barriers to weight loss: an integrative review
Muñoz Obino KF, Aguiar Pereira C, Caron-Lienert RS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2017, 10:1-11
Published Date: 23 December 2016
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
Cadegiani FA, Silva OS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:443-446
Published Date: 7 December 2016
rDNA insulin glargine U300 – a critical appraisal
Wang F, Zassman S, Goldberg PA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:425-441
Published Date: 2 December 2016
Evaluation of serum ferritin and some metal elements in type 2 diabetes mellitus patients: comparative cross-sectional study
Wolide AD, Zawdie B, Alemayehu T, Tadesse S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:417-424
Published Date: 2 December 2016
Symptom profiles of subsyndromal depression in disease clusters of diabetes, excess weight, and progressive cerebrovascular conditions: a promising new type of finding from a reliable innovation to estimate exhaustively specified multiple indicators–multiple causes (MIMIC) models
Francoeur RB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:391-416
Published Date: 8 December 2016
eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management
Rollo ME, Aguiar EJ, Williams RL, Wynne K, Kriss M, Callister R, Collins CE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:381-390
Published Date: 4 November 2016
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:371-380
Published Date: 1 November 2016
Practical combination therapy based on pathophysiology of type 2 diabetes
Levin PA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:355-369
Published Date: 31 October 2016
Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
Ghosh S, Trivedi S, Sanyal D, Modi KD, Kharb S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:347-353
Published Date: 8 November 2016
Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
Scheerer MF, Rist R, Proske O, Meng A, Kostev K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:337-345
Published Date: 31 October 2016
Myocutaneous revascularization following graded ischemia in lean and obese mice
Clark RM, Coffman B, McGuire PG, Howdieshell TR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:325-336
Published Date: 30 September 2016
Exercise portrayal in children’s television programs: analysis of the UK and Irish programming
Scully P, Reid O, Macken AP, Healy M, Saunders J, Leddin D, Cullen W, Dunne CP, O’Gorman CS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:317-324
Published Date: 23 September 2016
Management of pancreatogenic diabetes: challenges and solutions
Makuc J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:311-315
Published Date: 25 August 2016
Role of sleep quality in the metabolic syndrome
Koren D, Dumin M, Gozal D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:281-310
Published Date: 25 August 2016
Prevalence and determinants of metabolic syndrome: a cross-sectional survey of general medical outpatient clinics using National Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana
Omech B, Tshikuka JG, Mwita JC, Tsima B, Nkomazana O, Amone-P'Olak K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:273-279
Published Date: 30 August 2016
Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
Suman RK, Mohanty IR, Maheshwari U, Borde MK, Deshmukh YA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:261-272
Published Date: 29 August 2016
Teneligliptin in management of type 2 diabetes mellitus
Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:251-260
Published Date: 16 August 2016
Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
Ji L, Min KW, Oliveira J, Lew T, Duan R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:243-249
Published Date: 9 August 2016
Incremental increases in economic burden parallels cardiometabolic risk factors in the US
McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:233-241
Published Date: 2 August 2016
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
Hassoun AAK, Pathan MF, Medlej RC, Alarouj M, Shaltout I, Chawla MS, Knap D, Vaz JA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:225-232
Published Date: 26 July 2016
Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
Saunders WB, Nguyen H, Kalsekar I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:217-223
Published Date: 15 July 2016
Smartphone applications to aid weight loss and management: current perspectives
Sutton EF, Redman LM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:213-216
Published Date: 18 July 2016
The relationship between the presence of lower urinary tract symptoms and waist circumference
Oliveira MC, Varella LR, Angelo PH, Micussi MT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:207-211
Published Date: 11 July 2016
Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
Qiao Q, Ouwens MJNM, Grandy S, Johnsson K, Kostev K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:201-205
Published Date: 28 June 2016
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque
Powell DR, Gay JP, Smith M, Wilganowski N, Harris A, Holland A, Reyes M, Kirkham L, Kirkpatrick LL, Zambrowicz B, Hansen G, Platt KA, van Sligtenhorst I, Ding ZM, Desai U
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:185-199
Published Date: 22 June 2016
Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome
Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:177-184
Published Date: 1 June 2016
A qualitative study of perceptions of determinants of disease burden among young patients with type 1 diabetes and their parents in South India
Verloo H, Meenakumari M, Abraham EJ, Malarvizhi G
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:169-176
Published Date: 19 May 2016
An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method
Martin AA, Parks D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:163-168
Published Date: 19 May 2016
Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia
Birhanu AM, Alemu FM, Ashenafie TD, Balcha SA, Dachew BA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:155-162
Published Date: 11 May 2016
Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
Wu J, Jin Z, Zheng H, Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:145-153
Published Date: 10 May 2016
Metabolic syndrome and C-reactive protein in bank employees
Cattafesta M, Bissoli NS, Salaroli LB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:137-144
Published Date: 10 May 2016
Advances in the treatment of type 2 diabetes: impact of dulaglutide
Thompson AM, Trujillo JM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:125-136
Published Date: 4 May 2016
Level of control among patients with type 2 diabetes mellitus attending diabetic clinic under family medicine compared to diabetic clinic under endocrinology
AlHabdan MA, AlAteeq MA, AlJurbou FI
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:119-124
Published Date: 18 April 2016
Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
Tajuddin N, Shaikh A, Hassan A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:109-118
Published Date: 19 April 2016
Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates
Sadiya A, Abdi S, Abusnana S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:101-108
Published Date: 18 March 2016
Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia
Biadgo B, Melku M, Abebe SM, Abebe M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:91-99
Published Date: 17 March 2016
Childhood obesity: prevention is better than cure
Pandita A, Sharma D, Pandita D, Pawar S, Tariq M, Kaul A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:83-89
Published Date: 15 March 2016
Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
Schwartz SS, Katz A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:71-82
Published Date: 15 March 2016
Genistein treatment increases bone mass in obese, hyperglycemic mice
Michelin RM, Al-Nakkash L, Broderick TL, Plochocki JH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:63-70
Published Date: 15 March 2016
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:55-62
Published Date: 14 March 2016
Metabolic syndrome and associated factors among outpatients of Jimma University Teaching Hospital
Abda E, Hamza L, Tessema F, Cheneke W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:47-53
Published Date: 4 March 2016
Long-term weight loss maintenance for obesity: a multidisciplinary approach
Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, Dalle Grave R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:37-46
Published Date: 26 February 2016
Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
Kuecker CM, Vivian EM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:25-35
Published Date: 23 February 2016
Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
Pscherer S, Kostev K, Dippel FW, Rathmann W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:17-23
Published Date: 19 February 2016
Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain
Al-Haddad FA, Rajab MH, Al-Qallaf SM, Musaiger AO, Hart KH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:11-16
Published Date: 25 January 2016
A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
Tojo A, Kinugasa S, Fujita T, Wilcox CS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016, 9:1-10
Published Date: 18 January 2016
Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
Cebeci Z, Kir N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:555-566
Published Date: 16 November 2015
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
Seufert J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:543-554
Published Date: 9 November 2015
Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:535-542
Published Date: 30 October 2015
Red cell distribution width in type 2 diabetic patients
Nada AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:525-533
Published Date: 30 October 2015
Specific cut-off points for waist circumference and waist-to-height ratio as predictors of cardiometabolic risk in Black subjects: a cross-sectional study in Benin and Haiti
EL Mabchour A, Delisle H, Vilgrain C, Larco P, Sodjinou R, Batal M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:513-523
Published Date: 23 October 2015
Emerging utility of once-weekly exenatide in patients with type 2 diabetes
Goud A, Zhong J, Rajagopalan S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:505-512
Published Date: 21 October 2015
Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks
Nikokavoura EA, Johnston KL, Broom J, Wrieden WL, Rolland C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:495-503
Published Date: 14 October 2015
Long-term safety and efficacy of insulin degludec in the management of type 2 diabetes
Thuillier P, Alavi Z, Kerlan V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:483-493
Published Date: 1 October 2015
The clinical utility of aflibercept for diabetic macular edema
Stewart MW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:473-482
Published Date: 18 September 2015
Bariatric surgery outcomes: a single-center study in the United Arab Emirates
Abusnana S, Abdi S, Tagure B, Elbagir M, Maleckas A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:461-471
Published Date: 18 September 2015
Causes and consequences of obesity: epigenetics or hypokinesis?
Graham MR, Baker JS, Davies B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:455-460
Published Date: 16 September 2015
An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting
Courtney MR, Moler EJ, Osborne JA, Whitney G, Conard SE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:447-453
Published Date: 18 September 2015
Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:437-445
Published Date: 15 September 2015
C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese
Dongway AC, Faggad AS, Zaki HY, Abdalla BE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:427-435
Published Date: 4 September 2015
Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management
Palimeri S, Palioura E, Diamanti-Kandarakis E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:415-426
Published Date: 1 September 2015
Evaluation of the relationship between the pelvic floor muscles and insulin resistance
Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:409-413
Published Date: 28 August 2015
Kinin B1 and B2 receptor deficiency protects against obesity induced by a high-fat diet and improves glucose tolerance in mice
Morais RL, Silva ED, Sales VM, Filippelli-Silva R, Mori MA, Bader M, Pesquero JB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:399-407
Published Date: 26 August 2015
Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD–scid IL-2rgnull RIP-DTR mice engrafted with human islets
Yang C, Loehn M, Jurczyk A, Przewozniak N, Leehy L, Herrera PL, Shultz LD, Greiner DL, Harlan DM, Bortell R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:387-398
Published Date: 20 August 2015
A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
Gurung T, Shyangdan DS, O’Hare JP, Waugh N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:363-386
Published Date: 10 August 2015
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
Zheng X, Li S, Zhang WH, Yang H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:357-361
Published Date: 5 August 2015
Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
Mashitah MW, Azizah N, Samsu N, Indra MR, Bilal M, Yunisa MV, Arisanti AD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:347-355
Published Date: 4 August 2015
Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
Omoto S, Taniura T, Nishizawa T, Tamaki T, Shouzu A,Nomura S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:339-345
Published Date: 27 July 2015
The humanistic and economic burden associated with increasing body mass index in the EU5
Gupta S, Richard L, Forsythe A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:327-338
Published Date: 22 July 2015
Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
Yang F, Stewart M, Ye J, DeMets D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:315-325
Published Date: 20 July 2015
Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study
Penfornis A, Fiquet B, Blicklé JF, Dejager S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:303-313
Published Date: 3 July 2015
Epigenetic and developmental influences on the risk of obesity, diabetes, and metabolic syndrome
Smith CJ, Ryckman KK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:295-302
Published Date: 29 June 2015
Fixed-dose combinations in type 2 diabetes – role of the canagliflozin metformin combination
Fleming JW, Fleming LW, Davis CS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:287-294
Published Date: 25 June 2015
Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol® on glycemic control of subjects with impaired fasting glucose
Evans M, Judy WV, Wilson D, Rumberger JA, Guthrie N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:275-286
Published Date: 25 June 2015
Interventions to improve long-term weight loss in patients following bariatric surgery: challenges and solutions
McGrice M, Don Paul K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:263-274
Published Date: 23 June 2015
Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose?
Raffaelli M, Sessa L, Mingrone G, Bellantone R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:255-262
Published Date: 8 June 2015
Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: an integrated analysis of 4,328 patients
MacConell L, Gurney K, Malloy J, Zhou M, Kolterman O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:241-253
Published Date: 18 May 2015
Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolism
Fu L, Li F, Bruckbauer A, Cao Q, Cui X, Wu R, Shi H, Xue B, Zemel MB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:227-239
Published Date: 6 May 2015
Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital
Sepúlveda E, Poínhos R, Constante M, Pais-Ribeiro J, Freitas P, Carvalho D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:219-226
Published Date: 29 April 2015
Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study
Lesmana CRA, Pakasi LS, Inggriani S, Aidawati ML, Lesmana LA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:213-218
Published Date: 23 April 2015
Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients
Aziz KMA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:207-211
Published Date: 16 April 2015
Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia
Mohammed AE, Shenkute TY, Gebisa WC
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:197-206
Published Date: 15 April 2015
Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
Sosale A, Saboo B, Sosale B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:189-196
Published Date: 15 April 2015
Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
Wu J, Yan LJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:181-188
Published Date: 2 April 2015
Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
Petrella RJ, Gill DP, Berrou JP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:173-180
Published Date: 24 March 2015
Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability
Nishio S, Abe M, Ito H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:163-171
Published Date: 18 March 2015
Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients
Hitsumoto T, Shirai K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:157-162
Published Date: 10 March 2015
Daily intake of rosehip extract decreases abdominal visceral fat in preobese subjects: a randomized, double-blind, placebo-controlled clinical trial
Nagatomo A, Nishida N, Fukuhara I, Noro A, Kozai Y, Sato H, Matsuura Y
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:147-156
Published Date: 6 March 2015
Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
Srivanichakorn W, Sriwijitkamol A, Kongchoo A, Sriussadaporn S, Plengvidhya N, Lertwattanarak R, Vannasaeng S, Thongtang N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:137-145
Published Date: 2 March 2015
Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management
Nitzan O, Elias M, Chazan B, Saliba W,
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:129-136
Published Date: 26 February 2015
Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
Powell DR, Doree D, Jeter-Jones S, Ding ZM, Zambrowicz B, Sands A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:121-127
Published Date: 26 February 2015
Effect of different exercise intensities on the pancreas of animals with metabolic syndrome
Amaral F, Lima NEA, Ornelas E, Simardi L, Fonseca FLA, Maifrino LBM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:115-120
Published Date: 13 February 2015
Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
Tojo A, Hatakeyama S, Kinugasa S, Nangaku M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:103-113
Published Date: 13 February 2015
Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
Mazzilli R, Imbrogno N, Elia J, Delfino M, Bitterman O, Napoli A, Mazzilli F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:97-101
Published Date: 11 February 2015
Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins
Di Pierro F, Bellone I, Rapacioli G, Putignano P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:89-96
Published Date: 4 February 2015
GABAergic system in the endocrine pancreas: a new target for diabetes treatment
Wan Y, Wang Q, Prud’homme GJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:79-87
Published Date: 3 February 2015
The prevalence of adverse cardiometabolic responses to exercise training with evidence-based practice is low
Dalleck LC, Van Guilder GP, Richardson TB, Vella CA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:73-78
Published Date: 29 January 2015
Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study
Abebe SM, Berhane Y, Worku A, Alemu S, Mesfin N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:65-71
Published Date: 27 January 2015
Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study
Steylen PMJ, van der Heijden FMMA, Hoogendijk WJG, Verhoeven WMA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:57-63
Published Date: 23 January 2015
Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Kruger DF, LaRue S, Estepa P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:49-56
Published Date: 16 January 2015
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
Kostev K, Dippel FW, Rathmann W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:45-48
Published Date: 14 January 2015
Psychosocial interventions for the diabetic patient
Harvey JN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:29-43
Published Date: 9 January 2015
Type 2 diabetes in Brazil: epidemiology and management
Almeida-Pititto B, Dias ML, Moraes ACF, Ferreira SRG, Franco DR, Eliaschewitz FG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:17-28
Published Date: 5 January 2015
Salivary glucose concentration exhibits threshold kinetics in normal-weight, overweight, and obese children
Hartman ML, Goodson JM, Barake R, Alsmadi O, Al-Mutawa S, Ariga J, Soparkar P, Behbehani J, Behbehani K, Welty F
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:9-15
Published Date: 17 December 2014
Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics
Takahashi PY, St Sauver JL, Finney Rutten LJ, Jacobson RM, Jacobson DJ, McGree ME, Ebbert JO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015, 8:1-8
Published Date: 16 December 2014
Mechanism linking diabetes mellitus and obesity
Al-Goblan AS, Al-Alfi MA, Khan MZ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:587-591
Published Date: 4 December 2014
Genetic and epigenetic catalysts in early-life programming of adult cardiometabolic disorders
Estampador AC, Franks PW
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:575-586
Published Date: 1 December 2014
Management of adult diabetic ketoacidosis
Rosival V
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:571-573
Published Date: 28 November 2014
Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria
Adebayo RA, Ikwu AN, Balogun MO, Akintomide AO, Mene-Afejuku TO, Adeyeye VO, Bamikole OJ, Bisiriyu LA, Ajayi OE, Ogunyemi SA, Oketona OA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:565-570
Published Date: 26 November 2014
Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep
Duckett SK, Volpi-Lagreca G, Alende M, Long NM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:553-563
Published Date: 20 November 2014
Myocardial perfusion imaging for evaluation of suspected ischemia and its relationship with glycemic control in South African subjects with diabetes mellitus
Shmendi A, Pirie F, Naidoo DP, Tlou B, Pilloy W, Motala AA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:545-552
Published Date: 14 November 2014
Integrated bariatric surgery residency
Eltorai AE
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:543-544
Published Date: 13 November 2014
Variability in Zucker diabetic fatty rats: differences in disease progression in hyperglycemic and normoglycemic animals
Wang X, DuBois DC, Sukumaran S, Ayyar V, Jusko WJ, Almon RR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:531-541
Published Date: 11 November 2014
Independent and combined effect of diet and exercise in adults with prediabetes
Sénéchal M, Slaght J, Bharti N, Bouchard DR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:521-529
Published Date: 31 October 2014
Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations
Babakr AT, Elsheikh OM, Almarzouki AA, Assiri AM, Abdalla BE, Zaki HY, Fatani SH, NourEldin EM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:513-520
Published Date: 24 October 2014
Prevalence of cardiometabolic risk factors and metabolic syndrome in obese Kuwaiti adolescents
Boodai SA, Cherry LM, Sattar NA, Reilly JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:505-511
Published Date: 24 October 2014
Expression of gluconeogenic enzymes and 11β-hydroxysteroid dehydrogenase type 1 in liver of diabetic mice after acute exercise
Brust KB, Corbell KA, Al-Nakkash L, Babu JR, Broderick TL
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:495-504
Published Date: 21 October 2014
Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience
Juarez DT, Demaris KM, Goo R, Mnatzaganian CL, Wong Smith H
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:487-494
Published Date: 20 October 2014
Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications
Beatrice AM, Dutta D, Kumar M, Shivaprasad KS, Sinha A, Ray S, Chowdhury S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:481-486
Published Date: 20 October 2014
Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
MacPhail M, Mullan B, Sharpe L, MacCann C, Todd J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:469-479
Published Date: 16 October 2014
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects [Retraction]
Vinson JA, Burnham BR, Nagendran MV
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:467-468
Published Date: 16 October 2014
Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland
Huber CA, Diem P, Schwenkglenks M, Rapold R, Reich O
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:455-465
Published Date: 1 October 2014
Effect of BMI on cardiovascular and metabolic syndrome risk factors in an Appalachian pediatric population
Weber KE, Fischl AFR, Murray PJ, Conway BN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:445-453
Published Date: 25 September 2014
The effect of a lifestyle intervention on metabolic health in young women
Dunn SL, Siu W, Freund J, Boutcher SH
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:437-444
Published Date: 19 September 2014
Relationship between chronic kidney disease and metabolic syndrome: current perspectives
Nashar K, Egan BM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:421-435
Published Date: 18 September 2014
Sex differences in type 2 diabetes: focus on disease course and outcomes
Arnetz L, Ekberg NR, Alvarsson M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:409-420
Published Date: 16 September 2014
Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
Hernández-Ojeda J, Román-Pintos LM, Rodríguez-Carrízalez AD, Troyo-Sanromán R, Cardona-Muñoz EG, Alatorre-Carranza MP, Miranda-Díaz AG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:401-407
Published Date: 4 September 2014
Treating the elderly diabetic patient: special considerations
Kezerle L, Shalev L, Barski L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:391-400
Published Date: 28 August 2014
Diabetes disease progression in Goto-Kakizaki rats: effects of salsalate treatment
Wang X, DuBois DC, Cao Y, Jusko WJ, Almon RR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:381-389
Published Date: 1 August 2014
A community-based exercise intervention transitions metabolically abnormal obese adults to a metabolically healthy obese phenotype
Dalleck LC, Van Guilder GP, Richardson TB, Bredle DL, Janot JM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:369-380
Published Date: 1 August 2014
Is adherence a relevant issue in the self-management education of diabetes? A mixed narrative review
Debussche X
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:357-367
Published Date: 29 July 2014
Elevated body mass index as a risk factor for chronic kidney disease: current perspectives
Garland JS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:347-355
Published Date: 29 July 2014
Prevalence of metabolic syndrome and its components based on a harmonious definition among adults in Morocco
El Brini O, Akhouayri O, Gamal A, Mesfioui A, Benazzouz B
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:341-346
Published Date: 31 July 2014
Linking obesity with type 2 diabetes: the role of T-bet
Wali JA, Thomas HE, Sutherland APR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:331-340
Published Date: 22 July 2014
Decreased basal chloride secretion and altered cystic fibrosis transmembrane conductance regulatory protein, Villin, GLUT5 protein expression in jejunum from leptin-deficient mice
Leung L, Kang J, Rayyan E, Bhakta A, Barrett B, Larsen D, Jelinek R, Willey J, Cochran S, Broderick TL, Al-Nakkash L
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:321-330
Published Date: 21 July 2014
Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
Ohira M, Yamaguchi T, Saiki A, Ban N, Kawana H, Nagumo A, Murano T, Shirai K, Tatsuno I
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:313-319
Published Date: 17 July 2014
The effect of vagal nerve blockade using electrical impulses on glucose metabolism in nondiabetic subjects
Sathananthan M, Ikramuddin S, Swain JM, Shah M, Piccinini F, Dalla Man C, Cobelli C, Rizza RA, Camilleri M, Vella A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:305-312
Published Date: 11 July 2014
Relationship between insulin resistance and plasma vitamin D in adults
Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:297-303
Published Date: 7 July 2014
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
Oh S, Tanaka K, Noh JW, So R, Tsujimoto T, Sasai H, Kim M, Shoda J
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:289-296
Published Date: 3 July 2014
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
Holland DQ, Neumiller JJ
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:277-288
Published Date: 3 July 2014
Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
Vickers SP, Cheetham SC, Headland KR, Dickinson K, Grempler R, Mayoux E, Mark M, Klein T
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:265-275
Published Date: 1 July 2014
Management of adult diabetic ketoacidosis
Gosmanov AR, Gosmanova EO, Dillard-Cannon E
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:255-264
Published Date: 30 June 2014
AMPK activation: a therapeutic target for type 2 diabetes?
Coughlan KA, Valentine RJ, Ruderman NB, Saha AK
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:241-253
Published Date: 24 June 2014
Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
Mann KV, Raskin P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:229-239
Published Date: 24 June 2014
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
Sinha B, Gangopadhyay KK, Ghosal S
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:225-228
Published Date: 23 June 2014
Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges
Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AM
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:211-223
Published Date: 23 June 2014
Metabolic profiling of plasma amino acids shows that histidine increases following the consumption of pork
Samman S, Crossett B, Somers M, Bell KJ, Lai NT, Sullivan DR, Petocz P
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:203-210
Published Date: 19 June 2014
Retrospective study on the efficacy of a low-carbohydrate diet for impaired glucose tolerance
Maekawa S, Kawahara T, Nomura R, Murase T, Ann Y, Oeholm M, Harada M
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:195-201
Published Date: 13 June 2014
Regulation of dipeptidyl peptidase 4 production in adipocytes by glucose
Das SS, Hayashi H, Sato T, Yamada R, Hiratsuka M, Hirasawa N
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:185-194
Published Date: 24 May 2014
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
Lorber D
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:169-183
Published Date: 23 May 2014
Holistic approach to prevention and management of type 2 diabetes mellitus in a family setting
Ofori SN, Unachukwu CN
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:159-168
Published Date: 23 May 2014
Prevalence and pattern of overweight and obesity in three rural communities in southwest Nigeria
Adebayo RA, Balogun MO, Adedoyin RA, Obashoro-John OA, Bisiriyu LA, Abiodun OO
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:153-158
Published Date: 10 May 2014
Effects of body mass index-related disorders on cognition: preliminary results
Yesavage JA, Kinoshita LM, Noda A, Lazzeroni LC, Fairchild JK, Taylor J, Kulick D, Friedman L, Cheng J, Zeitzer JM, O'Hara R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:145-151
Published Date: 8 May 2014
Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq
Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:139-144
Published Date: 2 May 2014
Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature
Tran NL, Barraj LM, Heilman JM, Scrafford CG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:121-137
Published Date: 24 March 2014
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
Rigato M, Fadini GP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:107-120
Published Date: 18 March 2014
Diabetes and sexual dysfunction: current perspectives
Maiorino MI, Bellastella G, Esposito K
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:95-105
Published Date: 6 March 2014
Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
Anderson M, Powell J, Campbell KM, Taylor JR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:85-94
Published Date: 6 March 2014
Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
Joharapurkar AA, Dhanesha NA, Jain MR
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:73-84
Published Date: 28 February 2014
Evidence-based diabetes nutrition therapy recommendations are effective: the key is individualization
Franz MJ, Boucher JL, Evert AB
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:65-72
Published Date: 24 February 2014
Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
Mackenzie RWA, Elliott BT
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:55-64
Published Date: 13 February 2014
Partnering with diabetes educators to improve patient outcomes
Burke SD, Sherr D, Lipman RD
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:45-53
Published Date: 12 February 2014
Management of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
Sweeting AN, Tabet E, Caterson ID, Markovic TP
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:35-44
Published Date: 12 February 2014
Stress and the inflammatory process: a major cause of pancreatic cell death in type 2 diabetes
Montane J, Cadavez L, Novials A
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:25-34
Published Date: 3 February 2014
Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated
Irons BK, Minze MG
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:15-24
Published Date: 18 January 2014
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
Zambad SP, Tuli D, Mathur A, Ghalsasi SA, Chaudhary AR, Deshpande S, Gupta RC, Chauthaiwale V, Dutt C
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014, 7:1-14
Published Date: 21 December 2013
Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγnull mice treated with alogliptin
Jurczyk A, diIorio P, Brostowin D, Leehy L, Yang C, Urano F, Harlan DM, Shultz LD, Greiner DL, Bortell R
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:493-499
Published Date: 13 December 2013
HbA1c for diagnosis of type 2 diabetes. Is there an optimal cut point to assess high risk of diabetes complications, and how well does the 6.5% cutoff perform?
Kowall B, Rathmann W
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013, 6:477-491
Published Date: 29 November 2013